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I. 
INTRODUCTION 
The Institute of Bioinorganic and Radiophamtaceutical Chemistry of the Research Center 
Rossendo@ Inc. (FZR) herewith presents its 1993 Annual Report to document research acti- 
vities in the second year of its existence. 
The Institute's research programme and profile are derived from an awareness of the very 
important advances taking place in modern nuclear medicine. Based on sophisticated ra- 
diotracers and focused on the molecular level, nuclear medicine offers unique opportunities 
for studying tissue functions and translating the findings into ways of caring for sick people. 
For full exploitation of its potential, this discipline of in vivo chemistry requires great 
commitment to interdisciplinary research into radiotracers and a thorough appreciation of 
the complexity involved. Contributions from radiochemistry, organic and inorganic chemis- 
try, radiopharmacy, radiopharmacology, physics, biology and medicine have all to be 
combined and merge in tracer design. The Institute's profile is such that it is prepared for 
the challenge of sophisticated interdisciplinary work in order to gain deeper insights into the 
fundamentals of the chemistry and biobehaviour of biochemical tracers. 
With the emphasis on biochemical processes, positron emission tomography (PET) is the es- 
sential modality for assessing the global and regional functional status of the brain, heart or 
other organs of interest. 
The task of establishing a PET centre - which calls for substantial scientific, financial and 
administrative commitment - has so far dominated the activities of the Institute, 
Since single photon emission computed tomography (SPECT) continues to be the principal 
way of translating PET advances into broad clinical practice, specific SPECT tracers are 
one of the main subjects of research. An analogue concept of rational tracer design makes it 
possible to go from 1 1 ~  or 1 8 ~  PET tracers to 1231 SPECT tracers. A similar straightfor- 
ward concept of development of biochemical tracers does not exist for g g m ~ c ,  the work- 
horse of nuclear medicine. Technetium has an intricate coordination chemistry that does not 
go well with the organic nature of biochemical substrates. Overcoming this problem as fast 
as possible by gaining a better insight into technetium chemistry and exploiting its versatil- 
ity is a crucial task. 
With this aim in mind our Institute's SPECT tracer group has been concentrating on the 
chemistry of new radiopharmaceutically relevant technetium compounds. Research has fs- 
cused in particular on the reaction of technetium with sulphur-donor ligands and the eorre- 
sponding products. They are considered to be of special value for a new generation of spe- 
cific 99mTc tracers. Analogous rhenium compounds have also been studied in view of their 
therapeutic potential. 
The two working directions - PET and SPECT tracer research - will be closely combined in 
the hope that they mutually stimulate each other and that biochemical tracer concepts of 
PET can be transferred to technetium compounds, going from PET to SPECT. 
The subjects of our work in 1993 are described in this volume in 41 reports dealing'with 
various aspects of radiotracers for nuclear medicine. 
This first part describes synthetic work on llc-tracers and precursors. These studies have 
proved the usefulness of our concept of labelling substances in metabolically stabile posi- 
tions. Some first tracers labelled in this way accordingly are presented. Preparatory to un- 
dertaking PET studies on patients, radiopharmaceutical procedures for the preparation and 
quality control of [ I~F]  FDG have been established. 
The papers on technetium /rhenium chemistry describe our efforts to gain a deeper insight 
into the reactions taking place in intricate TcIRe-ligand systems, to design more suitable and 
variable chelate units, and to start functionalizing these complexes in order to make them 
mimics of biochemical substrates or drugs. 
Progress has been achieved in the complexation of SH-containing peptides, mainly by the 
introduction of N-alkylation, which remarkably influences the properties of the complexes, 
by systematic alteration of the peptide chain length and derivatization. 
As for novel chelate units, the concept of mixed-ligand complexes has led to a variety of 
small-sized neutral compounds. They are characterized by diffent cores ( T C ~ O  vs. ~ ~ 1 1 1 )  
and versatility in respect of substituents, which makes it possible to adjust charge, lipophil- 
icity and specific: reactivity. 
Some first steps have been undertaken towards the development of TcIRe receptor-binding 
substances, with complexes functionalized with a substituent of the dopamine D2 receptor- 
binding drug spiperone. 
Binding smdis using rat brain sections or homogenates have been carried out to character- 
ize fzandidates for receptor-binding compounds, particularly for the dopamine D2 receptor. 
The biological md biochemical section of this report also provides information on methodo- 
logicall work for rat brain microvmsel preparation, which should provide suitable models 
for evaluation sf tracers eapable of penetrating the blood-brain barrier, 
The upt&e krE meal nudid@ into normal and tumour cells has been studied to obtain in- 
si@& into the u p u e  mechsmism of tumour-affine radispharmaceuticals. 
Miscellaneous topics include 1231 labelling and quality control procedures, reports on the 
cyclotrone "Cyclone 1819" and physical quality control of the PET camera, improvement of 
99m~c-kit preparation procedures and a radioecological study on 1 4 ~  radioactivity in nee- 
dles of a Picea spec. 
11. 
RESEARCH REPORTS 
1. SUBSTANCES LABELLED IN METABOLICALLY STABLE POSITIONS: 
2. m .  SYNTHESIS OF [I-'' C ~ ~ O B E N Z E N E  
P. Mading, J. Steinbach, H. Kasper, F. Fuchtner 
Introduction 
The aim of the synthesis of "C-ring-labelled aromatics, especially benzene derivatives, is 
described in [l]. The principle of this synthesis is the reaction of the precursor 5-di-methy- 
laminopenta-2,4-dienylidene-dimethylammonium perchlorate with a "~-s~nthone contain- 
ing a C-H-acid methyl group, e.g. ["C]nitromeithane in the presence of a base catalyst in a 
suitable solvent at increased temperatures according to the following equation: 
Even the first attempts at cyclization using ["clnitromethane indicated that the conditions 
worked out on an inactive scale [l] are not suitable for fast synthesis with "C. NEt3, the 
base used proved to be too weak. The experiments performed to adapt the synthesis are de- 
scribed in the following. 
Evehentall conditions and results 
Various nonradioactive attempts at cyclization were carried out to test the much stronger 
b a e  pomsium tea-butylate in various aprotic solvents (e.g. MeCN, DMF, DMSO, di- 
o w e ,  THF, NMEYT) at various temperatures (80 "C, 110 "C, 150 "C, 170 "C). The 
extent of conversion was investigated by HPEC analysis. The optimized conditions were 
succws&lly transferred to the radi~active scale. 
["C]CH,NO~ was synthesized according to [2] by a gas-solid reaction of ["C]CH,I with 
AgNq.  The required fU~methyliodide was prepared by the classical one-pot method in- 
volving the reduction of ["~lcarbon dioxide with LiAIH4 to lithium aluminium-["C]- 
methyBa&, hydrolysis of this intermerfiate organomeMlic complex and subsequent iodization 
erf the [''~~rnethmo~ with hydrogen iodide 133. Using a nitrogen gas flow (40 mlhin) the 
["C]methyliodide generated was forced through a heated glass column (i.d. 3 mm, length 4 
cm, oven temp. 80 "C) containing silver nitrite (0.4 g). The ["Clnitromethane thus pro- 
duced was trapped in a cooled vessel containing the solvent , the precursor and the base. 
Cyclizationl aromatization to [~-~~C]nitrobenzene was achieved by heating this vessel. 
To determine the extent of conversion and the radiochemical purity, an HPLC system 
(Merck-Hitachi) was used, including a pump, a Rheodyne injector with a 20 p1 loop, a 
Separon SGX C18 column (RP-18, 5pm, 150 X 3.3 mm, LP Prague) and a DAD detector 
coupled in series with a radioactivity detector. The mobile phase consisted of phosphate 
buffer according to Sorensen (2.6 mM NaH2P04 + 5.1 mM Na2HP04; pH 7) and acetoni- 
trile at a flow rate of 0.5 mllmin with the following linear gradient of the eluents (Tab.1): 
Table 1: Linear gradient of the eluents 
Another way to synthesize f 1 ~ ] ~ ~ 3 ~ 0 2  is by conversion of ["C]CH~I with silver or so- 
dium nitrite in polar solvents [4]. We also tested this method with AgNOz in DMF at 
100°C. In comparison with the on-line column method mentioned above this procedure is 
more expensive, because the ~ C ] C H ~ N O ~  produced has to be distilled into another reaction 
vessel containing the reagents for cyclization. Another advantage of the column method is 
the fact that the column containing the silver nitrite can be reused up to 20 times without 
loss of reactivity. 
The best results in terms of extent of conversion and reaction time were obtained when the 
synthesis of [l-lic]nitrobenzene was carried out under the following conditions: 
Solvent: 250 p1 HMPT 
Precursor: 8 mg pentamethinium salt (5-dimethylaminopenta-2,4-dienylidene- 
dimethylammonium perchlorate) 
Base: 3.5 mg t-BuOK (as a solid) 
Reaction temperature: 170 "C 
Reaction time: 7 min 
In this way [l-"~]nitrobenzene was prepared with a radiochemical purity of about 92%. 
The reproducible radiochemical yields (half-life corrected) are in the range of 85&5 %, 
within an overall synthesis time ftom EOB of 25 min. 
An HPLC chromatogram by detection of radioactivity is shown in Fig. 1, the results are 
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Fig. 1: HPLC chromatogram obtained from the reaction mixture of the [l-"~lnitrobenzene 
synthesis 
Tab. 2: Results of the HPLC chromatogram 
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2. SUBSTANCES LABELLED IN METABOLICALLY STABLE POSITIONS: 
3. THE S ~ H E S I S  OF [I-'' CIMLINE - A ' I  C-RING-LABE~D 
SYiVTHONE 
P. Mading, J. Steinbach, H. Kasper 
Introduction 
The synthesis of [l-"C]nitrobenzene is described in [l]. A crucial step for synthesizing 
other "C-ring-labelled substances such as phenylalanine according to [2] is the reduction of 
[l-ll~]-nitrobenzene to "C-ring-labelled aniline. The appropriate diazonium salt is chosen 
to be the labelled synthone for further reactions. 
Experimental conditions and results 
The required [l-llC]nitrobenzene was prepared in a special cyclization/ aromatization reac- 
tion [3] by conversion of ["C]CH~NO~ with 5-dimethylaminopenta-2,4-dienylidene-di- 
methylammonium perchlorate in the presence of t-BuOK in MeCN, DMF or HMPT ac- 
cording to the following equation: 
Starting from the above reaction mixture, the following reduction was carried out by addi- 
tion of a suitable reducing agent and heating: 
To determine the extent of conversion and the radiochemical purity, an HPLC system 
(Merck-Hitachi) was used, including a pump, a Rheodyne injector with ,fa 220 PI hop, a 
Separon SGX C18 column (RP-18, 5pm, 150 X 3.3 mm, LP Prague) and a BAD detector 
coupled in series with a radioactive dewtor. The mobile phase consisted of phosphate 
buffer according to S5remen (2.6 mM NaH2P04 4- 5.1 mM Na2HP04; pH 73 and a m n i -  
trik at a flow rate of 0-5 mlJmin with the following linear gradient of the duents (Table 1). 
Table 1: Linear gradient of the eluents 
Time [min] buffer MeCN 
In the first experiments for reduction of [l-"~lnitrobenzene, using Na2S204 in DMF/H20 
at l 10°C, [l-llc]aniline was only obtained as a radioactive by-product, The main radioac- 
tive products were ionic compounds, probably consisting of N-phenylsulphamic acid and 
aminobenzene sulphonic acid [4]. 
Following this, many nonradioactive experiments were carried out in order to test other re- 
ducing agents (e.g. Na2S205, SnBr2/HBr, NaBH4, LiAlHJTHF, FeSO4/Na0H, PhNHNH2, 
HaNH2, Na2S) in suitable solvents (e.g. DMF, MeCN, THF, dioxane, DMSO, HMPT) at 
various temperatures (110 "C, 150 "C, 170 "C]. The extent of conversion was investigated 
by HPLC. The conditions of successful nonradioactive reductions were transferred to the 
radioactive scale: 
- Experiments using SnBr2/HBr in MeCN, DMF or HMPT at 110 "C or 170 'C produced 
an "C-labelled reaction product which was pr~obably bound as a colloid, because the main 
activity was at the top of the HPLC column and resisted elution. 
- An incomplete conversion of [l-"~lnitrobenuene to [l-"~laniline with many by-products 
was achieved in a further experiment using phienylhydrazine in HMPT at 170 "C. 
- The use of THF-LiAlH4 solution in HMPT at 110 "C yielded about 60 % [l-"claniline 
and two by-products, probably [ll~]azoxybenzene and ["~lazobenzene [5, 61. 
- The best results with regard to extent of conversion and reaction time were obtained by a 
synthesis of [l-"claniline using NazS as follows: 
In a one-pot process [l-llC]nitrobenzene, synthesized from [ 1 1 ~ ] ~ ~ 3 ~ 0 2 ,  8 mg of 5-dime- 
thylaminopenta-2,4-dienylidene-dimethylammonium perchlorate and 3.5 mg of t-BuOK in 
250 ~1 HMPT at 170 'C (see [l]), was reduced by adding to the reaction mixture a solution 
of 8 mg of NQS-5 l 3 2 0  in 100 p1 H20 and heating at 170 "C for 10 min. In this way [l- 
11Claniline was prepared with a radiochemical purity of about 83 %. The reproducible ra- 
cfi0e:kemical yieids (half-life corrected) are in the range of 802  5 %, within an overall syn- 
thesis time from EOB of 37 min. 
An NI&16C chrornatogm by detection of radioactivity is shown in Fig. 1, the results are 
listed in Table 2. 
radioactivity [cpml 
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, 
I 
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Fig. 1: HPLC chromatogram obtained from the reaction mixture of the [l-llc]aniline 
synthesis 
Table 2: Results of the HPLC chromatogram 
For further conversions, the [l-"claniline should be separated from all inactive and radio- 
active by-products. The separation of [l-"claniline and the testing of the further synthesis 
route to "C-ring-labelled phenylalanine according to [21 will be carried out in the near fu- 
ture. 
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3. SUBSTANCES LABELLED IN METABOLICALLY STABLE POSITIONS: 
4,PRECURSOR SMVTHESIS FOR l l ~ - ~ ~ ~ - L A B ~ ~ ~ ~  PKWDINE 
DERNAUVES 
K. Chebani, P. Mading, W. D. Habicher, J. Steinbach 
Heterocyclic compounds, in particular derivatives of pyridine, participate in biological 
processes such as redox reactions. Appropriate labelled compounds could be useful for 
tracer studies. 
Within the framework of our work on metabolically stable llC-labelled cyclic compounds, 
such as aromatics, the generation of [llClpyridine derivatives (I) is the first attempt to syn- 
thesize such heterocyclic tracers. 
QueraI synt.hetic route 
Synthesis of these [ll~lpyridine derivatives was planned, starting with a malein-dialdehyde 
dimethylacetale (11) as the precursor and [llC]-nitromethane according to equations (1) and 
(2): 
* ; l l ~  
fll~jniitromt:&ane can be formed fkom [llC]methyliodide and silver nitrite [l]. 
The IlC-iabibelled compound (111) must be reduced to its amino analogue (IV). 
The 3Fc3IZowing inhamalecular cycliztion reaction has to be expected simultaneously 
(equatian 2): 
R * R C red 1 
--j ta4 CO) CH-C=CHGH=&-~~ 4 
m m 0 
Originally we planned to synthesize [llClnicotinamide (VI) according to equation (1) with 
R=CN. The idea was to generate [11C]pyridine-3-carbonitrile (V) and to hydrolyse it to 
nicotinamide (VI) (equation 3): 
03 (W 
For the synthetic route described above the precursor "11" with R = CN (MeO)&H- 
C(CN) =CH-CH0 (VII) had to be synthesized: 
The following synthetic routes were studied for generating VII: 
1. Synthesis was started with 2,5-dimethoxy-2,5-dihydrofuran (VIII). This compound reacts 
with bromine to 3,4-dibromo-2,5-dimethoxytetrahydrofuran (IX) according to [2]. 
HBr is eliminated by potassium t-butoxide in tert-butyl alcohol as the solvent at 80 "C and 
under a nitrogen atmosphere: 
The yieid was some 80 The structures of ZX and X were proved by fH NMR spm&a. 
The 3-bromo-2,54imt=thoxy-2,5-dihydrofuran (X) formed was distilled as a colourless Pi* 
aid at 78 "C d 1-4-1 -6 kPa ( 11-12 Ton). 
Vzfous CN-Br exchange rmctiom were tried to oba;~ the 3-ey%ino-2,S-dirnetho~y-2~54i- 
h y d r o ~ n *  
One attempt was reaction of (X) with KCN in the presence of the cobalt-cyano-complex 
K3[Co(CN)d under a hydrogen atmosphere and reaction with copper(1) cyanide in DMF 
at various temperatures. IR and NMR spectroscopic investigations of the reaction prod- 
ucts showed the exchange betwelen the bromine and cyano groups to be difficult. The 
cyano compound obtained is probably instable. Similar statements have been made also 
in respect of other compounds with Br in a-position of an olefinic double bond 131. 
Another attempt was a Br-for-CN exchange on 3,4-dibromo-2,5-dimethoxy-tetrahydrofu- 
ran OX) in order to synthesize the 3-b~~~~-~-~yano-2,5-dimethox~-tetrahydrofuran, 
with subsequent HBr elimination. The substance (IX) was treated with KCN or Cu(1jCN 
in DMF at various temperatures. But the IR and NMR spectroscopic investigations 
showed that there was practically no Br-CN exchange. 
2, The following synthetic route offers another possibility of producing the precursor (VII): 
~-~e~oxyy2(5H)-furarrone (XI) was prepared by photooxidation of furfural in methanol 
[4] with a yield of about 50 % . 
Compound (XI) was converted to 4-bromo-5-methoxy-2(5H)-furanone (XII) by bromina- 
tion according to [5]: 
Acidic hydrolysis of (XII) in methanol according to [6] leads to the Z and E isomers of 
methyl-3-bromo-4,4-dimethoxy-2-butenoate (XIII) in a yield of 80 % . 
Compound (XIII) was intended to be transformed into methyf-3-cyano-4,4-dimethoxy-2-bu- 
tenoate (XIV). The ester group of (XIV) had to be reduced selectively to precursor (Vll) in 
the presence of the cyano group : 
Conversion of XI11 to XIV was not successful, i.e. instead of XIV we found polymeric 
products. This result suggests that XIV cannot be isolated, This is in agreement with l?]. 
We have to change the substituent R in 11. 
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4. SETTING UP AN APPARATUS B'OR ROUTINE PREPARATION OF 
@Ql?DG 
F. Fiichtner, J. Steinbach, E. Lijsel, R. LGcke 
Introduction 
The most widely used radiopharma=utical in positron emission tomography (PET) studies 
is 2-[18~]fluor0-2-deoxy-D-glu~ose ([l8F]Fl)~). The method commonly applied to prepare 
[~~F]FDG is based on n~cleophilic substitution using a phase-transfer catalytic reaction [l]. 
Having initially been restricted to a Ne-target for preparation of [181?]F2, we used the elec- 
trophilic reaction. The version described by Bida [2] and adapted by Steinbach [3] proved 
to be a simple and very reliable Procedure. Even with the new IBA PET-cyclotron 
"CYCLONE 1819" and the nucleo~hilic [18F]F~G synthesis based on water-target-pro- 
[ ~ ~ F I F -  now being available, this electrophilic method represents a useful stand-by 
md complementary procedure to the nucleophilic approach. 
apparatus for routine use of I [~~FIFDG based on electrophilic reaction has therefore 
been set up. 
~xperhentd 
18 The schematic layout of the PlFDG-preparation unit is shown in Fig. 1. The device 
consists of two main par@, the processing unit, situated inside the hot cell and its control 
unit. A pump, the radiation monitors and a recorder are additionally used. The arrangement 
is &Own in Fig* 2. All parts of the processing unit, such as the reaction vessel, 
elecfro-magnetic and electric stream selection valves, finings, tubes, a waste ab- 
sorber, elecaical and tube connectors, conductivity cells, radioactivity monitors (Geiger- 
EndEler tubes, 70034, VacuTec) and the manometer, are mounted on a stainless steel hou- 
sing. The processing unit is remote controlle~d by the control unit via a common 24-wh 
cabel. The tubs for the target gas, the compressed N2 (for delivering the liquids), and the 
vessels containing the liquids needed for the synthesis, are connected to the synthesis unit 
by m tubing and luer adapters. 
[ I ~ F J ~  is produced by the 2 0 ~ e ( d $ ~ e ) 1 8 ~  reaction using the 13.5 MeV deuterons of the 
Rossendorf c y c ~ ~ o n  U-120 with Ne f 0.2 X F2 as taget gas. The target gas is forced by 
its own pressure (20 bar at the b e g i ~ i ~ g )  through a column (di = 3 mm, L = 100 mm, OM- 
NIFII) filled with about 70 mm KOAC X 1.5 HOAc (extra pure MERCK) This col- 
umn is situated in a glovebox about 18 m away from the target. The [18p]p2 reacts to form 
vaE%(.d1e aceMh~ofluorite ( E ~ ~ F I A ~ Q F ) ,  which is transported through a transporting tube 
@@lye&yje~~ di=1-3 mm; do=1+8 mm, L appr 500 m). After being discharged from the 
m@ own pressure* the I'~FIACQF is transported to the synthesis unit using N2 as a 
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Fig. 1: Schematic representation of apparatus for routine production of [18f;l1;1)~ 
procedure [3], the [~~F]ACOF is directly absorbed in the reaction vessel containing a solu- 
tion of 30 mg tri-O-acetyl-D-glucal (TAG, for synthesis, MERCK - Schuchardt) in 20 m1 
trichlorofluoromethane (CFC13, for synthesis, MERCK - Schuchardt). Under these condi- 
tions the reaction between TAG and the gaseous [~~F]ACOF occurs, forming tetraacetylated 
[~~FIFDG.  The volume of the solvent is reduced to about 5 m1 by evaporation during the 
adsorption. This step takes about 15 minutes. After the adsorption of the radioactivity the 
remaining solvent is evaporated by increasing the temperature and blowing in gaseous N2. 
During evaporation the temperature of the reaction vessel is increased to 125 "C to reach 
the conditions for hydrolysis. After evaporation 2 m1 of 1 M HCl (Titrisol, MERCK) is 
added and the hydrolysis takes place to form [ ~ ~ F I F D G .  The temperature and time of 
hydrolysis were optimized before so as to minimize unhydrolysed intermediate products and 
decomposition products by analysing the synthetic mixture by HPLC [4]. The synthetic 
mixture is purified by a combination of columns. The first column (di=lO mm, L=200 
mm, OMNIFIT) is filled with 10 m1 bifunctional ion exchange resin (AG llA8, BIO-RAD) 
to retain the ionic components. On a second column (SEP PAK cartridge ALUMINA A, 
Millipore) the remaining [18F]Fm is separated from the mixture. The [ 1 8 ~ ] ~ ~ ~  is eluted 
from the columns with sterilized water (aqua ad iniectabilia, Serum-Werk Bernburg). Frac- 
tionation of the eluent in the foreruns, product 1 and product 2, is carried out by 
monitoring radioactivity on the outlet of the last column and by switching the stream 
selection valve accordingly. The main radioactive peak (product 1) is always fractionated in 
the same way so that the volume is always the same. This made it possible for us to add in 
advance the neccessary amount of NaCl (extra pure, MERCK) in order to reach an isotonic 
solution. The sterilization of the final product is achieved by sterile filtration (microporous 
membrane cellulose acetate, 0.22 pm, ALLTECH) . 
All parts of the equipment which come into contact with the precursors and the radiophar- 
maceutical are newly assembled for each production cycle from sterilized glassware and 
tubing. Before using the equipment, the liquid system and especially the chromatographic 
columns are cleaned by washing with sterilized water to ensure that the system is free of 
endotoxins (apyrogenicity) . 
Resul@ 
So far we have only been able to test the described device with a radioactivity of 
[~~F]ACOF up to 50 MBq because we have not yet received permission to work with a 
higher activity Iwd. Under these conditions the device works very well and reliably. The 
optimum time and temperature of hydrolysis were found to be 15 minutes at 125 "C. In the 
6 m1 of product 1 more than 95 Z af the radioactivity is usually found. The product has 
been chemically characterked by WPLC 14. The total preparation time after EOB is about 
40 minutes. Taking into consideration the splitting of the [ 1 g ~ ~ 2  radioactivity into 
[ ~ ~ E ~ J A C O ~ ;  and [ ~ F I N ~ F ,  ale trmporting losses (about 20 to 50 % of the [ 1 8 ~ ] ~ c 0 ~ )  
and the synthesis and chromatographic yields the total yield of [ ~ ~ F ] F D G  is between 15 
and 25 % EOB. In order to transport the [~~FIACOF over a distance of 500 m, the trans- 
porting tube must be preconditioned with cold F2 and AcOF to increase the transport yield. 
The yield of the preparation itself lies between 60 and 75 %. The preparation unit is de- 
signed to enable us to prepare [ ~ ~ F ] F D G  twice a day without having to handle directly the 
synthesis unit in the hot cell. 
Prior to application of the thus prepared [ ~ ~ F ] F D G  to humans, the system must be proved 
to meet the recognized quality criteria in at least three runs 151. For quality assurance it is 
important to have in-line process control. The built-in quality control involves monitoring 
the temperature, radioactivity and conductivity from one step to the next throughout the 
synthetic procedure. With this control we can identify most of the problems at a very early 
stage. 
With the same device set-up we have also prepared 2-[1~~]fluoro-2-deoxy-~-galactose 
( [ 1 8 ~ ] ~ ~ ~ a l ) ,  using tri-0-acetyl-D-galactal as a precursor. 
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5. DETEWWNATION OF THE CHEMICAL AND RADIOCHEIWICAL 
PURITY AM) SPECIF'IC RADIOACTIVITY OF [ ~ S ~ F D G  BY HPLC 
F. Fiichtner , K. Neubert, J. Steinbach 
Introduction 
According to the rules of good manufacturing practice (GMP) [l], quality control of the fi- 
nal product is an essential part of the quality assurance of (radio)pharmaceutical production. 
In the case of radiopharmaceuticals labelled with the short-lived PET radionuclides, special 
restrictions are imposed on quality testing: 
- time limitations between production and application, 
- analysis of small sample volumes and of extremely small concentrations and 
- handling at high radioactivity levels. 
In previous work at Rossendorf, quality control for [ 1 8 ~ ] ~ ~ ~  comprised determination of 
sterility, apyrogenicity, pH and radiochemical purity by TLC [2]. 
High performance liquid chromatography (HPLC) in combination with the radioactivity 
detection is the best control method for the radiochemical purity of [ ~ ~ F ] F D G  131. An 
anion exchange separation mechanism allows isocratic separation of carbohydrates. Using a 
strong basic eluent, the weakly acid carbohydrates form anions and are therefore retained on 
the anion exchange resin. 
The chemical and radiochemical purity and specific radioactivity can be determined simul- 
taneously by including in the chromatographic system a mass detector sensitive, enough for 
quantitative determination of the product species. 
Experimental 
T h e  requirements are met by combination of electrochemical (pulsed amperometric) 
detection (ECD) with a diode-array detection (DAD). The electrochemical principle is a 
very sensitive and selective detection method for carbohydrates, about two orders of 
magnitude more sensitive than the refractive index. If only a common amperometric de- 
tector (single potential) is used, the detector response decreases as the electrode surface be- 
comes fouled due to the oxidation process. Pulsed amperlometric detection overcomes this 
drawback [4]. DAD is an unspecific detector which provides a good overview and in some 
cases substances can be identified by means of spectroscopic data. 
[~~F]FDG produced at Rossendorf by electrophilic reaction [S] and [ ~ ~ F I F D G  prepared by 




- gradient pump 
- autosampler 
- column oven 
- DAD 
- ECD 
- radioactiuiw detector 




















M 2311 Messelektronik Dresden 
Reagents and standards 
- 1 M sodium hydroxide sodium carbonate < 0-02 % (wlv) Fluka 
- glucose Merck 
- 2-fluro-2-deoxy-D-glucose SIGMA 
Chromatographic conditions 
- column: CarboPac PA 1 (4 X 250 mm) Dionex 
- guard column: CarboPac PA 1 (4 X 60 mm) Dionex 
- column temperature: 30 "C 
- sample volume: 20 - 100 p1 
- eluent: 100 mM NaOH 
- flow rate: 1 mllmin 
b - pressure: about 14.5 MPa 
- ECD: electrochemical cell: - working electrode: gold electrode, 
- reference electrode: AgIAgCl , Cl- 
- auxiliary electrode: platinum, 
potential and time set up: [V] [msec] 
- sample oxidation: -0.35 - 0.35 50 
- electrode oxidation: -0.65 200 
- electrode reduction: 0.65 200 
- DAD: 
- A120 
Signal = 230 nm, BW=60 nm, 
Refer. = 450 nm, BW=80 nm, 
y-flow cell, CaF2, 100 p1, 0-1024 KeV 
Monosaccharide separation is carried out with a NaOH eluent. To obtain stable retention 
times for the analytes, it is very important to prepare eluents from stock solution low in 
carbonate to minimize carbonate contamination of the column. In order to exclude carbon 
dioxide during ventilation of the eluent reservoir we used a tube filled with sodium hydroxi- 
de pellets. 
After each analysis complete elution of all injected substances was checked by injection of 
an aliquot of the sample into the chromatographic system without the separation column. If 
the detector response is the same in both cases, all injected species are removed from the 
column. 
To determine the optimum detector response, the detection potential was changed system- 
atically from -0.35 to 0.35 V, using the chromatographic system with ECD. From time to 
time the working electrode surhce has to be cleaned mechanically by polishing. 
For determination of the specific radioactivity the radi0activit.y of an aliquot volume was 
measured with a dose calibrator. 
Results 
Fig. 1 shows the dependence of the ECD detector response on the working electrode poten- 
tial. Since oxidation of the mobile phase and other electro-active substances occurs with in- 
creasing working electrode potential optimum sensitivity and selectivity are obtained where 
the signal-to-noise ratio reaches a maximum and the working electrode potential is 
minimized. For this reason the working electrode potential was set at -0.08 V. This value 
differs somewhat from the literature data with f 0.05 V for FDG [4J and sugars in general 
C61 - 
detector response IPA x sec] 
, a n  .. , 
r l 
working electrode pote~ntial [V] 
Fig. 1: Dependence of the detector response of FDG, glucose and TAG on the 
working electrode potential, injection volume: 10 , ~ l ,  
concentration: 0. l mM of each 
Fig. 2 demonstrates the results of HPLC analysis of the final [ 1 8 ~ ] ~ ~ ~  produced by elee- 
trrapmc reaeticfn. The chromatogram shows the separation of F-, glucose, FDM, FDG, 
pmidly hydrolysed sugars and other initial, intermediate and final substances. 
ADC4 A. ADCA R a i W d  C.\DATAFDG\FIGURE-i-1 D 
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Fig. 2: Chromatogram of 50 p1 of final product of [I~FIFDG prepared by electrophilic 
reaction 
In respect of radiochemical purity we can see that besides the main [ ~ ~ F I F D G  peak in the 
chromatogram ( ~ 9 1  %) there are also its epimer 2-[18F]~luoro-2-deox~-~-mannose 
([~~FIFDM, =6 %), traces of [I~F]F- ( < 1 %) and partially acetylated [ ~ ~ F I F D G  deriva- 
tives ( ~ 3  %). 
To find out about chemical purity we determined the concentrations of the main components 
from the chromatograms of the DAD and ECD signals. Apart from the precursor tri-0-ace- 
tyl-D-glucal (TAG) (0.5 M), D-glucose (0.3 mM) and the FDG (6.9 mM) and FBM (0.5 
mM), there are some other peaks which do not correspond neither to the radioactive peaks 
nor to any known substances. Since no FDM standard is available, the concentration of 
FDM has to be estimated from the FDG/FBM peak ratio obtained in the analpis a d  from 
[4]. The other peaks in the chromatogram have not been identified up till now. Sgwtro- 
scopic analysing methods such MS and IR are required for this. In future traces sf  or- 
ganic solvents in the final product will be determined by GC. 
For spec@c radiowtktity we found a value of 100 GBg!mmol. This value resal@ from the 
FDG concen@a$ion determined and from the maximum radioactivity rached in former ex- 
periments with our target design and running parameters [2] .  The specific radioactivity de- 
termined is in accordance with literature data [31. 
ADC1 A. ADC-A R ~ ~ W ~ C . W A T A \ F D G \ F I O U R E - ~ U ) ~ ~ ~ . D  
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Fig. 3: Chromatogram of 20 p1 of final product of ["FIFDG synthetisized by nucleophilic 
substitution 
Additionally we also analysed final EI~FIFDG synthetized by nucleophilic substitution. 
m e  raults are shown in Fig. 3. In contrast to the electrophilic product we find a high 
degree of radiochemical purity ( [ 1 8 ~ ~ ~ ~ ~ > 9 9  %) in which no FDM is observerd, in ac- 
cordance with the principle of synthesis. The chemical composition is characterised by a 
high concentration of D-glucose (1-5 mM) and numerous unknown components. Since only 
a srurnpla were analysed, we were unable to determine the amount of FDG exactly. 
This concentration is near the detection limit of the method at about 1.5 PM. In two sam- 
pia  we determined about 3 of FDG whereas in another we did not find any. Using the 
first vdum a specific radioactivity of 0.1 mq/pmol can be calculated. This value is similar 
to the results obtained by another group E71 but differs from the literature data of about 1 
mq/~mol, which was determined by the amount of 18F introduced into the synthesis [3]. 
In conclusion it must be mentioned that in order to reach reproducible analytical results and 
a hi& system performance a major problem must be overcome. Since stronger retained 
anions in analytical samples or residual anions in the eluent itself (e.g. carbonate) are only 
slowly eluated from the column by hydroxide ions, the retention time for analytes decreases 
steadily. To reduce this effect it is necessary: 
- to avoid very high salt concentrations and organic solvents in samples and 
- to use high hydroxide eluent concentrations. 
Nevertheless, the column has to be regenerated between analytical sequences with 0.5 M 
NaOH when isotonic samples are analysed. 
Analysing practice has shown that HPLC with the described detector configuration is suit- 
able for simultanious determination of the chemical and radiochemical purity and specific 
radioactivity of [~~FIFDG.  The results are available after about 20 minutes so that the 
analysis can be carried out before application of the radiopharmaceutical. 
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6.  DETERMINATION OF THE SPECIFIC ACTIVITY OF 1123n~a1 
C. Kretzschmar, R. Scholz, F. Fiichtner, J. Steinbach 
Introduction 
In last year's annual report we described a method for reproducible quality control of vari- 
ous iodine species in a non carrier added [1231]NaI solution [l]. The quality of the m- 
dioiodine is such that it can be used in labelling processes. The [ 1 2 3 ~ ] ~ a ~  solutions investi- 
gated were produced by the Karlsruhe Nuclear Research Centre. 
The new method described enables us to determine radiochemical purity as wdl as specific 
activity. For this purpose the chromatographically determined iodine content of the solu- 
tions has to be quantified. The use of reference solutiom of known iodine croneentgatiom 
makes it possible to determine the iodine content in real [1231]~a1 solutions in gil. 
Experimental 
According to DAB 10 the specific activity of [1231]~a1 should be 5 5 Ci/mg iodine. With 
[1231]Na1 solutions of only 5 MBq, the analytical task is to determine iodine with a sensi- 
tivity of some 10 ng in an injection volume of 200 p1. The absolute radioactivity content 
was measured with the help of an isotope calibrator. 
The method described in this paper for determination of the specific activity of [1231]Na1 
is based on an ion chromatography with RP 18-columns modified with quarternary alkylam- 
monium salts. 
For the investigations a HPLC system ( Merck-Hitachi ) was used, including a pump, a 
manual injection valve with a 200 p1 sample loop, a column thermostat with column and an 
UVlVIS , an electrochemical and a radioactivity detector. 
As RP-18 support material we used LiChrospher (5pm). The glass columns (150 X 3.3 mm; 
LP-Prague) were filled with the support by a slurry technique. In order to achieve ion ex- 
change properties, an acetonitrilelwater solution of the quarternary ammonuim salt tetra-kis- 
ammonium bromide was pumped through the column up to equilibrium. The capacity of the 
ion exchange was determined by the UV break-through curve while modifying or equilibrat- 
ing the column with a UV absorbing ionic solution. 
As eluents we used Na2S04 solutions with a concentration of 10 mmol/l. Detection was ac- 
complished by measuring the UV absorption at 225 nm, or electrochemically by using a Ag 
electrode, or by measuring radioactivity with a P-flow-cell detector. 
Results 
The described ion chromatographic method was proved to1 be reproducible and sensitive 
en~ugh to determine the total content of iodine ("hot" and "cold") and its various species in 
the solution, Both UV and electrochemical ion detection were suitable for detecting the un- 
desirable "cold" iodine in the solutions being examined. For this purpose electrochemical 
detection is about 100 times more sensitive than UV detection. 
Although the [123flNaI solutions are declared n.c.a. preparations, they might be improved 
with regard to labelling procedures. 
The limit of detection in the order of 10 ng was achieved by the use of this method. The 
content in reference solutions was determined within this order of magnitude. 
The mntent of iodine in the real [l23II~aI solutions was determined quite well in this way. 
Fig. 1: Determination of iodide in a [1231]Na1 solution 
a: electrochemical detection, b: UV detection with a diode array detector 
c: radioactivity detection, retention time of iodide: 4.9 min; 
column preparation analogous to [l] 
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7. A NEW LABELLING METHOD FOR L-3-a-ME TYROSINE 
C. Kretzschmar, R. Scholz, J. Steinbach 
Introduction 
Various procedures for the labelling of L-3-a-methyltyrosine (MTy) with [1231]iodine by 
electrophilic oxydation have been described in the literature. The use of iodate or chlo- 
ramin-T or labelling with iodogene often gives yiellds of only up to 60 %. The use of iodate 
also diminishes the specific activity of the product. 
Because [1231]~1[ is a rather expensive starting material, the yield should be as high as 
possible. To increase the yield, we introduced a different method of =change labelling for 
the synthesis of ~-3-~~123Illodo-a-methyo--m1 tyrosine (1123Illodo-a-methy31-hrl~y). 
The precursor synthesis was carried out according to 
Fe 
MTy + Br2 + Br-MTy + HBr. 
The labelling procedure is performed as a Finkelstein reaction by [1231]iodinefor-bromine 
exchange: 
Experimental 
1. Precursor synthesis 
To a solution of 0.5 g methyltyrosine in 50 m1 chloroform, a catalytic amount of He powder 
was added. The mixture was stirred at room temperature. Approx. 1 g Br2 was added to the 
mixture drop by drop. The mixture stirred for two hours at room temperature and then 
for 30 minutes at 40 "C.  
After adding LOO m1 2N HCI was given to the mixture, the organic phase was separated. 
The aqueous phase was twice extracted with chloroform. 
m aqueous solution was centrifuged at 6000 rpm to remove the catalyst. Separation was 
carried out by preparative column chromatography at ambient pressure. We used 0.15 N 
~ ~ ~ 0 4  for elution. Process control was by TLC. The product in the eluate was detected by 
the ninhydrin reaction. The fractions containing the bromo amino acid were combined, and 
the water was evaporated to 2 m]. This solution was stored in the refrigerator for further 
use. The substance was characterized by UV spectra. 
2, Labelling by exchange reaction 
The labelling reaction used is analogous to the method described by Mertens [l] for ra- 
dioiodination of p-I-phenylalanine. 
100 ~1 of L-3-~r-methyltyrosine solution were added to 500 ,Ccl of a solution containing 5 
mg gentisie acid, 7 mg citric acid and 1 mg tin(I1)-sulphate in 1 m1 water. Then 30 pl of a 
solution containing 32.5 mg CuS04 X 5 H20 in 10 m1 water were added. The active iodine 
was added to the reaction mixture as [12311~a~. The vial was closed and the reaction car- 
ried out at 160 " or 150 "G for 30 minutes. 
The product is purified by HPLC on RP 8 columns with 0.15 N ~ 3 ~ 0 4  the eluent 
(Fig. 1). Quality control is ensured by the same lchromatographic procedure at an analytical 
PeveB. 
Results 
The precursor synthesis described is time consuming because of the preparative purification 
step. However we were able to produce enough substance for quite a few labelling proce- 
dures. The yield of the exchange reaction is approx. 100 % in each case. 
The long reaction time of 30 min is a disadvantage in comparison with the usual method of 
electrophilic oxidation (the labelling occurs immediately). 
The advantage of the method is the greater robustness against [1231]Na1 solutions of vary- 
ing specific activities. The high yields obtained with various [1231]Na1 solutions were inde- 
pendent of their "cold" iodine content. Furthermore, a decrease of the specific activity is 
avoided. 
Fig. l: Analytical control and preparative purification of ~-3-[~~~1]iodo-a-meth~ltyrosine 
Column: RP8 
Eluent: 0,15 N H3P04 
Retention times: void volume - all ions 
10 min gentisic acid 
32 min L-3-[l2311 iodo-a-met~~~ltyrosine 
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8. THE ROSSENDORF' PET CYCLOTRON "CYCLONE 1819" - 
A STATUS REPORT 
St. Preusche, J. Steinbach 
An important component of the Rossendorf PET Centre is the production unit for PET ra- 
dionuclides - the IBA PET cyclotron "CYCLONE 18/9". Preparations for its installation 
began in early 1992. Its main parameters are discribed in the 1992 annual report [l]. De- 
tails of the technical preparations for cyclotron installation at user's site are summarized in 
the present paper. 
The building licence issued by the "Landratsamt Dresden" (Dresden Council Department) in 
April 1993 enabled us to start construction work. After partial demolition of the concrete 
shielding of the former Van de Graff accelerator vault these important steps could be done 
within the following 6 months. 
l. Building the cyclotron vault 
The thickness of the concrete walls and ceiling of the cyclotron vault has to meet all requi- 
rements concerning the shielding of direct n- and y-radiation during operation of the cyclo- 
tron. Calculations were carried out by the supplier of the cyclotron (Siemens AG) with the 
computer programs MORSE and LEAKAGE [2]. The calculations using a predicted con- 
crete density of 2.35 g/cm3 and a free distance between targets and walls of 0.80 m gave 
the Mlowing results: 
- outer walls (cellar level) 1.40 m 
- wall to the control room 2.35 m 
- ceiling (above ground) 1.90 m (see Fig. 1). 
Our own estimations (based on [3J) are within the same range. 
The "Materialpriifungsanstdt fiir das Bauwesen Dresden" (Material Research Labora- 
toryIBuiiding) determined an average concrete density of 2.55 g/cm3 141. 
2. Csnvemi~n of rsom 
Rooms formerly used for the cyclotron U-120 were converted into (see Fig. 1) 
- csntroI room (ROB1) - hot lab (RQOld) 
- room far technical equipment (R001a) - sluice (RQOle). 
3, Wallatican of 3 faciiities for ventilation and cllimatization 
To meet the the rmanwf~cturer's requirement in terms of room parameters 3 faclities for 
ventflatio~ and efimatiz;atian were installed including complete controlling and monitoring 
$ystems (see Table 1). 
These facilities are planned to operate 24 houres a day. Three modes of operation are avail- 
able (Automatic, Full Power, Half Power). During operation of the cyclotron an under 
pressure of 30 Pa will be guaranted in the vault. In case of a breakdown of the ventilation 
facility the operation of the cyclotron will be stopped by switching off the radio frequency 
(W - 
Table 1: Facilities for ventilation and climatization 
Room No. of Current of air Pressure conditions 
ventilation fresh air exhaust air in the rooms 
facility m3lh m3lh (+)l(-)/(=) 
Control room 2 2,800 2.800 (=) 
(R001) 
Room for techn. 2 350 350 (=) 
equipment 
(ROOla) 
4. Installation of the gas supply system 
The gas supply system will be used for: 
- the gases needed for the operation of the cyclotron (H2, D2: ion sources, He: collimator 
cooling, N2: venting) 
- the gases and gas mixtures needed for the targets. 
5. Installation of the compressed air system 
Compressed air is needed for the pneumatic post system, the butterfly valves of the. oil dif- 
fusion pumps and for the inflatable rubber tube of the door for closfmg the vault airdght. 
6. Construction of the outer water cooling circuit 
For the cooling circuit of the cyclotron the mmufactwers stipulaa m inlet templerature of 
the cooling water of (16 - 18) 'C .  To fulfil this wndition a dosed ouer coding circuit w a  
planned, The. inner and outer circuits are comee:Z& thro~gh a heat exchanger (capaciog 50 
kW) in room R001a. 
Fig. l: The Rossendorf PET cyclotron: layout of the rooms 
1 - control room (R001) 2 - room for technical equipment (R001a) 
3 - cyclotron vault (R001 4 - entry room (R001c) 
5 - hot lab (R001d) 6 - sluice (R001e) 
7. Two doors f ~ r  radiation prstecttion 
During opaation of the cyclotron the cyclotron vault is closed with 2 doors for radiation 
proteeGon, mainly for protection against neutron radiation. The door to room ROOlb is a 
sliding dam made of a s-l raek with a filling of interlaced polyethylene briks (thickness 16 
cm). These briks are used for moderation of the fast neutrons. The back of this door is co- 
vered with cadmium sheet metal for absorption of the thermal neutrons. To create an under 
pressure of 30 Pa in the vault during operation of the cyclotron the door will be sealed air- 
tight by an inflatable rubber tube which has to be filled with compressed air. 
The door to room ROOlc is also a sliding door, but of two parts. With a steel rack this door 
is filled with polyethylene plates (thickness 3 cm) and the back is covered with 0.6 cm lead. 
8. Construction of box 0 (hot cell) 
The hot lab (R001d) with box 0 is the cyclotron-end terminal of the pneumatic post system 
between the cyclotron building and the radiopharmaceutical building. To handle the maxi- 
mum activity of 92 GBq within box 0 the lead shielding of box 0 has a thickness of 10 cm 
to the front and 7 cm in all other directions. The loading unit for the pneumatic post as well 
as auxiliary equipment are placed inside this box. 
9. Lengthening of the Rossendorf Activity Transport System (RATS) 
It was necessary to lengthen the existing RATS (pneumatic post and gas transport system) 
for about 80 m from the former terminal in the cyclotron building to box 0 in the hot lab. 
The new pneumatic post system was tested with this result: for the 500 m distance the time 
of flight of a small pneumatic post box is around 1 minute. The gas transport system has 
also been tested. 
10. Exhaust air emission measuring facility 
The former exhaust air chimney of the cyclotron U-120 was replaced by a chimney for both 
cyclotrons. The so-called pick-up system for exhaust air is installed in this chimney. The 
ventiIation facilities of both cyclotrons work independently of each other. The exhaust air 
tubing systems unite under the roof of the cyclotron building so that we only use one emis- 
sion measuring facility for both cyclotrons. 
The measuring facility consists of four main parts: 
- a gas monitor for continuous monitoring of radioactive gases with a short half-life 
- a continuous aerosol colIector with a constant current of air 
- a transportable gas collector unit 
- an electronic system with switches for thresholds and a lot of possibilities for presentation 
of the measured values. 
The "Sachsisches Staatsministerium fiir Umwelt und hndesentwicklung"' (Saxon State 
Ministry of Environment and Regional Development) asked the T ~ V  Bayern ~aehseni~'taLt" 
Sachsen (TUV = Association for Technical Inspection) for an expert opinion on our secu- 
rity report in compliance with the German Radiation Protection Regulations. One of the 
most important results was the statement that all our shielding measures were comidered 
adequate. Many of the TUV'S recommendations had already been fullfilled or were under 
consideration during the building phase respectivly. Other recommendations will be consi- 
dered during installation of the cyclotron, 
On October 6th 1993 our PET cyclotron was inserted into the vault. The installation of all 
components of the cyclotron is under way now. It is carried out by the manufacturers 
(IBABelgium), the supplier (Siemens AG) and the user (our PET-Tracer department) and 
will be finished within 6 months. 
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9, P ~ O M  TESTS WITH THE PET CAMERA POSITOME nrp 
H. Linemann, E. Will 
Introduction 
Preparatory to using the PET-camera POSITOME IIIp [l] for studies on patients, we car- 
ried out phantom tests in order to explore the technical potentials, simulating the conditions 
applied during clinical investigations. The tests were carried out using the methods and the 
phantom set proposed by the EEC Task Group for the PET Instrumentation Program [2]. 
The head phantom of this set (20 cm diameter, 20 cm length) was used to test the brain 
camera. 
The phantom tests also afforded us an opportunity to study the POSITOME programs and to 
write instructions for data acquisition and image reconstruction . 
The sources used for the tests were filled with I ~ ~ F I N ~ F  or [ ~ ~ c I N ~ c ~  solution up to 
$0 MBq. 
The tests performed and their results are described in this paper. 
Spatid ~adution 
As the raults for axial resolution were presented in the 1992 annual report [l], only tran- 
saial radutiun is dacribed here. 
Three glass capillaries (inside diameter 1 mm) were inserted into the phantom body parallel 
to the phantom axis in different radial positions (0, 4.5, 9 cm). The capillaries were filled 
with [18F]NaF solution (7 MBqIml), This test was carried out both with and without water 
in the phantom. 
Fig. 1 shows the profiles through the centres of the line sources for one of the three slices. 
The measured values of transaxial resolution (FWHM) are 1.2kO.1 cm for the 64*64 im- 
ages and 1.15M.05 cm for the 128*128 image. There was no significant difference between 
the results obtained for the water-filled phantom and that without. All measurements are 
with computed attenuation and scatter correction. 
One test was carried out without attenuation correction for comparison (Fig. lc). Under 
these conditions the two inner line sources show a significantly decreased tracer concentra- 
tion but the FWHM values are almost unchanged. 
Fig. l: Transaxial resolution (water phantom, lower slice, projection on x-axis) 
(a) 3 line sources, 64*64 image, computed attenuation correction 
(b) 2 line sources (on x-axis), 128*128 image, computed attenuation correction 
(c) 3 line sources, 64*64 image, no attenuation correction 
Recovery of 'hot' spheres 
The objective of this procedure is to quantify the apparent decrease in specific activity of 
small objects. This decrease is expected when the dimensions in any direction are less than 
3*EWHM (scanner resolution) 121. The recovery coefficient (RC) of an active volume is 
defined as the measured activity concentration in the volume divided by the mwured an- 
centration in a large volume with all dimensions larger than 3* FWHM. 
This test consists of two measurements, The first scan Is made with 6 holfsw spheres of dif- 
ferent diameters. These spheres are filled with samples of eqwzll specific ac~vity a d  fixed 
in the water-filled h a d  phantom. All spheres are arranged ccaplaraa in the same radid posi- 
tion (Fig. 221). The second scan is perhrmed with the h~rnogewsus h a d  phantom filled 
with active solu"tlon, For both scans the nmured specific activity divided by the inject& 
specific activity (measured with the dose calibrator) was estimated and inserted into the RC 
equation. . 
The apparent dimension of the spheres, wich is influenced by the spatial resolution of the 
camera, must be considered in close connection with the RC. Fig. 3a shows the relation be- 
tween the measured diameters (the FWHMsp values in profiles through the images) and the 
real diameters of the 6 spheres. Due to the spherical form of the sources, the apparent di- 
mensions decreases for smaller spheres. But with dimensions approximating the camera 
resolution of about 1 cm, the apparent diameters exceed the real ones. 
The recovery coefficient is dependent on the region of interest (ROI) used for the sphere 
images. For a R01 dimension which is small in comparison with the object, the RC should 
be 1 for objects with all dimensions larger than 3*FWHM (spatial resolution) if the correc- 
tions for attenuation, scatter, and dead time have been made correctly. The tests reported 
here lead to an RC of 1.02 for the largest sphere (3.7 cm diameter) and a small R01 (0.6 
cm diameter). Fig. 3b shows the RC values for R01 S equivalent to the apparent source di- 
mensions and the camera resolution respectively. The first curve can be used to correct the 
measured specific activity of small spherical structures in realistic human studies. 
Fig. 2: Spheres (diameter: 3.7, 2.2, 1.7, 1.3, 1.0 cm) in head phantom 
(a) "hot" spheres ([18F]~aF solution, 100 kBq/ml) in water @can time: 30. min) 
(b) "cold" spheres in [ ~ ~ F J N ~ F  solution (3 IrBqIrnl, scan time: 60. min) 
a) b l 
.l 
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Fig. 3: Recovery coefficient ("hot" spheres in water) 
(a) apparent diameter (FWHMSp ) as a function of the real sphere diameter D 
(b) RC as a function of the real sphere diameter D 
'Cold' spheres 
In contrast to the arrangement described above, in this test the 6 spheres were filled with 
water, with activity only in the phantom body. The correction conditions were the same as 
for the previous test. 
Fig. 2b indicates that all spheres were detected. But compared with the pictures of 'hot' 
spheres the picture seems to be more deformed due to the restricted camera resolution. The 
different statistics of the two images must also be considered in this comparison. 
The profiles through the images show a decrease in the measured tracer concentration to 
about zero only for spheres with a diameter greater than 2 cm. Smaller spheres with a di- 
ameter of about lcm are correlated with minimal tracer concentrations of 40 % of the mean 
surrounding concentration. 
Brain phantom 
As a phantom with a nearly realistic structure the Hoffman Brain Phantom [3] was used in 
addition to the EEC phantom. In this phantom the grey substance is represented by a 12 mm 
thick slice and the white substance by a 3 mm thick slice filled with active solution. Ven- 
tricles and skull are represented by compact material without radioactive substances (Fig. 
4a). These activity thicknesses are in the same relation as the metabolic rates of the sub- 
stances represented [3]. The phantom should therefore produce realistic structures if the 
whole thickness is imaged. 
A comparison of the measured picture (Fig.4b) with the phantom structures (Fig.4a) shows 
that only structures with transaxial dimensions greater than about 1 cm were imaged in 
nearly actual size. The measured activity concentration around the outer "rey substance' is 
changed by a factor of 2 measured with a small R01 (0.4*8.4 cm2). This variation is caused 
by the different width of this structure ancl the influence of the recovery eoeffieient. 
Fig.4: Hoffman Brain Phantom, (a) real structure, (b) measured picture ([18F]NaF solution, 
57 kBqIml, scan time: 15 .min, computed attenuation correction) 
Conclusion 
After the POSITOME IIIp installation described in the last annual report [l] the phantom 
investigations demonstrated the correct functioning of the camera as well as of the programs 
for data aquisition and image reconstruction. In addition, they showed the influence of re- 
stricted spatial resolution. 
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10. TECHNETIUM AND RHENIUM COMPLEXES DERIVED FROM 
SPIPERONE 
1. SYNTHESIS OF A 4-FLUOROBUTYROPH[ENONE-CONTWG 
NEUTRAL RHENIUM COMPLEX 
H. Spies, St. Noll, B. Noll, K. ~lostermannl 
1 Technische Universitiit Dresden 
The question whether coordination compounds, pneferably those of technetium, are able to 
imitate organic receptor-binding ligands is of basic interest for the design of a new genera- 
tion of biospecific Tc tracers. 
Investigations have therefore been undertaken to synthesize Tc and Re complexes showing 
structural analogies to the D2 receptor-binding ligand spiperone and to study their binding 
affinity . 
Although the spiperone molecule tolerates some structural modifications without any drastic 
change in its bonding properties [1,2], an early attempt by Ballinger et a1.133 to use 9 9 m ~ c  
labelled spiperone dithiocarbamate as a potential radiopharmaceutical for dopamine receptor 
imaging did not produce the desired result. Complex formation of spiperone dithiocar- 
bamate with the metal, probably resulting in a rather bulky 1:2 (metal to ligand) complex, 
obviously leads to complete loss of the recept& binding properties. 
Our strategy in designing of "spiperone-like" coordination compounds involves substitution 
of nonessential parts of the receptor-binding mole~cule by a chelate unit in such a manner 
that the charge, molecular weight and general shape of the new compounds will not differ 
too much from those of the original receptor-binding molecule. 
As a first step, rhenium complexes with partial structures of spiperone have been prepared. 
The resulting new class of compounds, which we call "rhenium spiperoids", consist of sul- 
phur-coordinated oxorhenium(V) chelates combined with fluorobutyrophenone (as described 
here) or a more complete molecular part of spiperone (as will be described later) as a sub- 
stituent. 
The complexes are accessible by the "3 4- 1 " synthesis principle [4J, which involv~  common 
action of both a tridentate and a monodentate Iigand on an appropriate Re(V) precursor. 
Here we describe the synthesis and properties of the first represe~~tatiue of the 'kpiperoides" 
(3-thiapentane-1.5-dithi01ato)($-fl~oropheny1-1-0~~butanethio1ato-4~o~orheni~m(V~ 3, 
The stable, crystalline compound has been characterize$ by elemena adys is  and specao- 
scopic methods. 
Synthesis follows the route as shown in Fig. l. 
0 
II 
CH, ONa C-c%-c%-c%-sH ~ ~ F & - ~ $ - & c I - E , c ~ ~  G 
_____* 
7 - _L, 
F 
Fig. l: Reaction scheme of the preparation of 3 
4-Chloro-Op-fluoro)butyrophenone reacts with thiobenzoic acid to give 4-benzoylmercapto- 
(g-fluoro)butyrophenone 1. Its hydrolysis results in 4-mercapto-(p-fluoro)butyrophenone 2. 
An equimolar mixture of Land 3-thiapentane-1.5-dithiole is allowed to react with Re(V) 
glueonate in an aqueouslacetonic solution and produces the mixed ligand complex 3 to- 
gether with several by-products. Separation of the resulting compound by semipreparative 
HPLC (Hypersil ODS 8 X 250, 0.1 % aq.tfa10. l % tfa in acetonitrile 50150) yields pure 3 
as dark brown needles mp.: 166 OC (acetonelmethanol). Yield: about 55 % (at 0.1 mmol- 
level). Elemental analysis: Calc. for C14H1802S4FRe (Mol. weight 551.75): C: 30.48, H: 
3.29, S: 23.25 X; found: C: 29.42, H: 3.24, S: 23.64 %. 
W (aetonitrilejwater): 240, 380 nm. 
IR (KBr): 969 cm-l Re=O; 1601 cm-l, 1673 cm-l C =O. 
1~ NMR (CDC13: 4.35j4.21 ppm (2xd) 2 H, 4.0 ppm (m) 2 H, 3.0 ppm (m) 2 H, 2.0 
ppm (m) 2 N XH2-C&-S-CH2-CH2-; 8.00 ppm (m) 2 H, 7.08 ppm (m) 2 H fluoro- 
gkerqyl!; 3.97 pgm [t) 2 El, 3.12 ppm (m) 2 H, 2.37 ppm (m) 2 H -CH2-CH2-CH2-. 
The mmposition of 3 follows from elemental analysis, infrared, 1~ NMR and mass spec- 
&@copy. 
The iR  specmm shows the Re=O band at 969 cm-I and the C = O vibration at 1673 cm-l. 
The 1~ NMR spectrum of 3 correponds in general with the proposed structure. The ob- 
served spectrum is rather complicated due to the presence of several methylene groups in 
the molecule and refers to nonsymmetry of the two parts of the tridentate ligand. 
The most intense peak in the electron impact mass spectrum (Fig. 2) at m/z = 552 is due to 
the molecular ion with the lg7Re isotope (natural abundance of about 63 %), while that at 
m/z = 550 corresponds to the molecular ion with the isotope l85Re (about 37 % abun- 
dance). Fragments such as m/z = 534 (M-F) and m/z = 165 (-(CH2)3-CO-CgHqF) con- 
firm the assumed composition. 
Fig. 2: Electron impact mass spectrum (15 eV) of 3 
An X-ray crystal structure determination of 3 is described in the following part 2. Binding 
studies of 3 on dopamine D1 receptors in the striatum of Wistar rats were carried out: both 
in striatum homogenates and in slices of the striatum and will be descdbed in part 3. 
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11. TECHNETIUM AND RHENIUM COMPLEXES DERn7ED EROM 
SPIPERONE 
2. X-RAY CRYSTAL STRUCTURE OF (3-THIAPENTAINE-1.5- 
DITHIOLATO) (p-FLUOROPHENYL-1-OXOBUTANETHIOLATO-4)- 
OXORHENIUMO 
H Spies, P. ~eibnitzl, St. Noll, B. No11 
1 Bundesanstalt fiir Materialforschung, Berlin 
The X-ray crystal structure of the title compound was determined. Preparation and spectro- 
scopicd characterization are described in the preceding article [l]. The X-ray data of the 
compound were collected at room temperature (296 K) with an ENRAP-NONIUS CAD 4 
diffractorneter, graphite monochromatized MO Ka radiation (A = Q.71073 W). (Crystal sys- 
tem: triclinic, space group no. PI, = 2, R =3.5 %, selected bond lengths and angles are 
listed in Table 1). 
The structure of [ReO(SSS)(S(CH2)3COC6H4F-(p))] consists of discrete monomolecular 
units. A perspective view of the complex (Fig. 1) shows that the compound has a distorted 
square-~yramidal arrangement. The metal atom lies about 0.7 A above the plane of the four 
basal donor atoms S1 - Sq. The &served square-pyramidal arrangement is found for a large 
number of five-coordinated technetium as well as for rhenium complexes. (Data of selected 
msnonuclear rhenium compounds with a square-pyramidal geometry are listed in Table 2). 
 he structure of the tridentatelmonodentate mixed-ligand complex is related to 
W(S3)(SR)I, where R is ethyl or C6H40CH3-(p), the latter described in [2]. 
Data in Table 2 show that the Re-01 bond lengths are in the range 1.63 to 1.74 (1.68 A on 
average). The Re-01 bond length of 1.686(7) A is within this range. All other bond lengths 
and angles are normal. The data reveal also that there are no special interactions between 





tedadt 3,3 t-[ethane-1,2-diylbis(iminomethylene)]bis@entane-3-thi~i)ato(3-) 
map 2,3-bis(mercaptoacetamido)propanoate(S, N, N, S-) 
MAC2 mercaptoacetyl diglycine(S, N, N, 0-) 
Fig. 1 : CELLGRAF drawing of [ReO(SSS)(S(CH2)3COCgH4F-(p))] 
Table 1: Selected bond lenghts and angles of [ReO(SSS)(S(CH2)3COCgHqF-(p))] 
Re-(S 1-S2-S3-S4) plane 0.7 
........................................................................................ 
Table 2: Mononuclear rhenium compounds with a square-pyramidal geometry 
Complex Core Re=O ReS (mean) 6 Reference 
(A) (A) (A) 
I 
6 is the displacement (A) of the rhenium atom from the square base 
1) Bond lengthening due to intermolecular O..-H---N hydrogen bond 
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12. TECHNETTUM AND RHENIUM COMPLEXES DERIVED FROM 
SPIPERONE 
3.BIOLOGICAL EVALUATION OF A 4-FLUOROBUTYROPHENONE- 
CONTAINING NEUTRAL RHENIUM COMPLEX 
R. Syhre, U. Wenzel, R. Berger 
Introduction 
Dopamine receptor agents are very important for diagnosis of diseases of the central nerv- 
ous system. A 99m~c-SPECT tracer for imaging these receptors does not yet exist in spite 
of numerous efforts. This is due to the high demands which receptor imaging agents have to 
meet in terms of basic requirements, especially as regards their biological quality. For in- 
stance, they must be able to pass through the intact blood-brain barrier following i.v. injec- 
tion, show no or little in vivo metabolism and exhibit high affinity to the specific receptor 
Ill. 
The biological screening of potential imaging agents has priority for an assessment of recep- 
tor binding properties. With a suitable choice of experimental conditions such an assessment 
is possible in vitro on the brain of the rat [2,3]. 
The first Re-coordinate compound is at present ready for use in biological screening. The 
test substance is described in the chemical part (Part 1) of this volume. Re-complex 3 is a 
model of an analogeous structure of the planned 9 9 m ~ c  radioligand. The structure of this 
complex shows similarity to the dopamine D2 receptor binding ligand spiperone. 
In the preliminary experiments it shall be tested whether this substance has an influence on 
the uptake of [3H]-spiperone into rat brain sections. The precursors have also been investi- 
gated in comparison with the test substance to recognize possible effects caused by the par- 
tial structures of the molecule. 
Principle of receptor binding studies 
Dopamine D2 receptors are proved to be different regions of the brain (Fig. la,b),espeeially 
in: 
Principle of receptor binding studies 
D2 receptors are proved to be in different regions of the brain (Fig. la,b), specially in: 
- basal ganglia (caudatelputamen, nucleus accumbens) 
- olfactory system (olfactory tubercle) 
- cortical areas like entorhinal- and frontal cortex, ccingulum 
- hippocampus (CA1 field and gyms dentatus) 
These receptors are net found in the cerebellum. 
For the described investigatiow a level of rat brain herizonbI swti~m is chosen in tvhieh 
the mgin regiom art: regis@r&. pig, S@ 
The principle of the binding studies is the following: 
Binding (total) - specific receptor binding = nonspecific binding 
The total binding is measured by the uptake of [3~~spiperone into the brain section. When a 
substance with a high affinity to the receptor (competitive ligand; dirsplacer substance) is 
added to the radioligand, then the [ 3 ~ ]  uptake is reduced by the amount of specific binding 
and represents the nonspecific binding. 
Ol Ollnrlory I ~ r l ~ c r c l e  
I .S I ,n lc~a l  sc~~l11111 
MS hfcrlirlr seplr~tii 
R I  R e ~ i c r ~ l n ~ i s  l l~n ln~r i ic  ~rrrclc~rs 
C A 1  CA, lieltl or tlre hippocarrll,t~s 
l)(; r)clllnle pyrtts 
Fig. la: Schematic representation of a horizontal section of rat brain , modified from 
M.C. MIQUEL L441 
lb: Autoradiograph after incubation with [ 3 ~ ] s ~ i ~ e r o n e  l 
the same region as l a  
In the first part of the studies for testing the evidence of a potential dopaminergic subshnce 
the compounds are used as competitive ligands. 
Re$erence substances 
The dopaminergic radioligand [3HJspiperone (specific radioactivity [3.55 TBqIrnmol]) is 
used as a reference substance for measuring the total binding. The dissociation constant 
@g) and the maximal binding (Bm,) of this receptorlligand system, depending on the ex- 
perimental conditions were described to be between 1.2 and 4.3 x 10-10 moll1 and 80 
frnollmg tissue [5]. (4-1-Butaclamol is used as a reference substance to prove the displace- 
ment. Its dissociation constants using [3H]spiperone as a radioligand are described in the 
literature with large variations (0.4 - 4.4 nmol) [6J. 
Test suBstmce 
The test substance (Re-complex 3) is used as a competitive ligand like (+)-butaclamol. The 
partial smctura of the test substance were also investigated (Table 1). 
Table 1: Structure of the Re complex and its precursors 
Studies of receptor binding 
Receptor binding studies were carried out on brain sections of rats. Details of the method 
are described in this report [7]. The uptake and distribution pattern of radioactivtiy were 
measured after incubation with solutions 1 - 5 in Table 2. 
RE-COMPLEX 3 
PARTIAL STRUC- 1 
PARTIAL STRUCTURE 2 
Table 2: Solutions for incubation 
In the first part of the studies only one concentration (5 ,umol/l) of the test substance was 
used. KD and B,, results cannot be given at the present time. Since these constants are 
missing, the following results can only be evaluated in quditative terms as regards the affin- 
ity of the Re-complex to the doparnine D2 receptor. 
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Results and discussion 
The results of the U C  measurements of brain sections after incubation with solutions 1 - 5 
are shown in Fig. 2. The uptake of radkaetivity after inerrbation wirlr r3rnspiPetone is the 
reference value (180 % uptake of radioactivilcy). This W reduced to 37 % uptake of radio- 






[ 3 ~ ]  uptake to 56 %. In comparison, the partial structures 1 and 2 influenced the [ ~ H J  up- 
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BRAM SECTION U 
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. . 56 % ("-3). l 
\ 
PARTIAL STRUCTURE 1 . PARTIAL STRUCTURE 2 
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BRAPNSEClON BRAIN SECITON 
13Hj~plake acmrdingto I3Hj-uplake acmrding 10 
Ism-SPPERONE I3HJ-SPIPERONE 
Fig. 2: 13111 uptake into brain sections after incubation with test solutions 1 -5 1 
LSC- measurements (Liquid Scintillation Counting) 
Similar results were obtained by autoradiographic studies. These studies were carried out 





Fig. 3: Reprmentation of autoradiographs (film) as wdl  as piewes and gwnti&tive da@ of 
[~HJ uptake (W ;?OOB) in comparison with LS cauat iq  i horhntal liat brain sections 
The pattern of f31ij distibution in brain sectjons demomQaters a signifimnt differendation 
in the 
 HISPI PIPER ONE (A) > Re COMPlLEX (C) > (+)-BUTACLAMOL (B) 
The quantitative interpretation of the L3~l distribution in the brain sections (BAS 2000) is 
shown in the table (Fig. 3). [3~lspiperone is also the reference for radioactivity uptake 
(100 %) . The Re complex 3 reduces the E 3 ~ ]  uptake to 55 1 and (+)-butaclamol to 25 % . 
In further investigations (determination of KD and Bmax.) it will be determined whether the 
displacing effect repesents a significant doparnine D2 receptor binding of Re complex 3. 
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13. N-ALKYLATED lMERCAPTOA~EX"J?L GLycINE DERIVATIVES AS 
='ITPURPOSE LIGANDS IN RADIO TRACER DESIGN 
PART I: S m H E S I S  OF LIGAWDS 
St. Noll, B. Noll, H. Spies, B. Johannsen, L. Dinkelborgl, W. semmlerl, 
P.E. Schulzel, M. Rndeisen2 
1 Institut far DiagnostiMorschung Berlin, Universitiit Leipzig 
Mereaptoacetyl glycine (MAG) derived ligands represent a small-sized highly reliable 
chelate system that offers potential for variolus purposes of technetium and rhenium ra- 
diotracer design. The potential grows with chemical diversity in terms of charge and vari- 
able $~bstituentS of the metal c0Inplexes. In exploring such a variability, we found that a 
very &vant;lgeous option is N-alkylation of one of the amide groups present in a MAG 
peptide chain, such as MAG3. N-alkylation has considerable consequences for the MAGn 
ligmd, which normally forms a monoanionic core and provides a pendent carboxylic group. 
48 
Since the alkylated amide group is no longer able to contribute negative charge to the metal, 
formation of a neutral oxometal(V) core results. With such an elimination of the charge at 
the core, one is able to drastically increase the lipophilicity of the complexes. In addition, 
the chain length of the alkyl group enables us to fine-tune lipophilicity. 
The following two papers provide information on synthesis and labelling with technetium- 
99m of NI-alkylated mercaptoacetyl glycine ligands and analytical characterization of the 
formed products. Biodistribution patterns were determined in Wistar rats. The ability of the 
resulting species to be accumulated in arteriosclerotic plaques was tested in rabbits. 
Synthesis of ligands 
N-alkyl-MAGn ligands 5 were prepared by reaction of the various chloroacetylamino acids 
or chloroacetyl peptides 1 with the required alkyl amines to give the N-alkyl glycines 2. 
These were chloroacetylated, yielding the precursors 3 for reaction with thiobenzoic acid to 
the S-protected compound 4. This procedure was followed by splitting off the benzoyl 
group according to a synthesis described in [l]. 
n = 0,1,2 R =methyl, hexyl, octyl, dodecyl L
All prepared substances 5 and the S-benzoylated compounds 4 are listed in Table 1. 
Compounds 5 are white or pink solids of widely differing solubility in water and organic 
solvents. 
TLC of the compounds was carried out in the Silufollln-butimollacetie acidlwater 2: 1:1 
chromatographic system (*) and in the RP18llmethanol chromatographic system (**). ChPo- 
roacetylated compounds were detected by spraying with iodine, amino acids, alkylated 
compounds and rnercaptoacetyl derivatives were sprayed with ninhydrine and b e m y l - p -  
tected substances were detected at 254 nm. 
HPLC characteristics of 42-d are shown in Fig. l. 
Tab. l : Data of compounds 4 and 5 
Compound yield m.p. TLC 
n R C %l tocl R; R;* 
4a 2 methyl 32 134 0.8 
5a 2 methyl 19 0.4 0.8 
4b 2 hexyl 5 0.8 
5b 2 hexyl 2 0.8 
4c 2 octyl 5 191 0.84 
4d 2 dodecyl 4 122 0.8 
4e 1 methyl 30 0.75 
5e 1 methyl 218 8.48 
4f 0 methyl 45 0.85 
5f 0 methyl 35 0.7 0.85 
4g 0 hexyl 14 69 0.85 
5g 0 hex y l 7' 0.8 0.75 
0 
5,o 10,0 15,O 20,O t [min] 
Fig. 1: HPLC characteristics of compounds 4a-d (Hypersil ODS, phosphate buffer pH 7.01 
methanol, 1 mllmin) 
Reaction scheme and preparation of a typical representative of 5 is shown in Fig. 2 and de- 
scribed below. 
Synthesis of rnercaptoacetyl-heq4glycyl diglycine ( N l - h e x y l - ~ ~ ~ ~ )  3 
Chloroacetyl-diglycine 
was prepared according to a procedure described in 121 





N N H N H O H  
I I 
N N H N H  
l 
3 - 4 - 
0 0 0 
CqONa r-t,r+ OH 
> HS N N H N H  
I 
Fig.2: Reaction scheme 
Hexylglycyl-diglycine 
1 g (4.8 mmol) chloroacetyl diglycine and 5 g (50 mmol) hexylamine were dissolved in 5 
m1 of ethanol. The solution was allowed to stand at room temperature for 6 days and then 
the solvent was removed by rotary evaporation. The oily residue was dissolved in 50 m1 of 
boiling acetone. After cooling to 5 ' C ,  the residue was separated, washed with cooled ace- 
tone and dried. 
Yield: (610.5 mg, 47 %) 
TLC: (Silufol//n-butanollacetic acidlwater 2: 1: 1) Rf 0.3 (ninhydrine), 
(RP 18//methanol) Rf 0.4 (ninhydrine) 
Chloroacetyl-hexylglycyl-diglycine 
0.61 g (2.2 mmol) hexylglycyl-diglycine was dissolved in 5 m1 of 1 N sodium hydroxide at 
room temperature, while stirring. After cooling the solution to 0 "C while stirring, 0.3 m1 
(3.7 mmol) chloroacetylchloride and 4 m1 of l N sodium hydroxide were added. The ice 
bath was removed and stirring was continued for 30 min. After acidification with 5 N hy- 
drochloric acid the solvent was evaporated. The yellow oil was extracted twice with hot 
acetone, the acetone was distilled and the white residue was vaeuum-dried. 
Yield: (31 1 mg, 40 %) 
TLC: (Silufollln-butanollacetic acidlwater 2: 1: 1) Rf 0.75 (iodine) 
~enzoy1mrcaptoacetyI-hccxylglycyl-diglye 4b 
311 mg (0.89 mmol) chloroacetyl hexylglycyl diglycine was dissolved in 70 m1 of anhy- 
drous methanol while stirring under a nitrogen atmosphere. 0.26 g (1.9 mmol) thiobenzoic 
acid dissolved in 5 m1 of methanol and neutralized with sodium methylate was slowly added 
to this solution under nitrogen, and stirring was continued for 12 h. The methanol was 
evaporated and the residue dissolved in 2 N hydrochloric acid. After removing the hydro- 
chloric acid, the residue was washed with water. The oily reaction product was treated with 
a small amount of methanol and the product crystallized. The crystals were washed with 
acetonitriIe and dried. 
Yield: (253.3 mg, 63 %) 
TLC: (Silufollln-butanollacetic acidlwater 2: l: 1) Rf 0.8 (UV) 
~ercaptoacety2-hqlglycyl-diglycine 5b 
27.3 mg (0.06 mmol) benzoylmercaptoacety1 hexylglycyl diglycine and 2.7 mg PdlCaC03 
(5 9%) were suspended in 2 m1 of methanol. 0.104 m1 (0,19 mmol) sodium methylate in 1 m1 
of methanol was added while stirring under a nitrogen atmosphere at 63 kPa. Stirring was 
continued for 15 min and then the mixture was acidified with methanolic cation exchange 
resin DOWEX 50WX8. The resin and the catalyst were filtered off and the solvent was 
evaporated. The residue was three times extracted with 12 m1 of benzene for and freeze- 
dried from methanol. 
Yield: (9.4 mg, 45 %) 
TLC: (Silufol//n-butanol/acetic acidlwater 2: 1 : 1) Rf 0.5 (ninhydrine) 
Elemental analysis: (Found: C, 48.65; H, 7.16; N, 12.20; S, 9.38, C I ~ H ~ ~ N ~ O ~ S  
requires C, 48.40; H, 7.25; N, 12.09; S, 9.23 %) 
NMR data: 6 ~ ( 2 5 0  MHz; solvent DMSO; standard TMS) 1.2 (3 H, -CH3), 3.1 (1 H, 
SH), 3-2 (10 H, N-CHZ), 3.7 (6 H, -C&), 3.8 (2 H, CH2-SH), 8.2 - 8.5 
(2 H,-NH) 
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14. N-ALKYLATED MERCAPTOACETYL GLYCINE DERIVATIVES AS 
MULTIPUIRPOSE LIGANDS IN RADIO TRACER DESIGN 
PART 11: FORMATION AND BIODISTRIBUTION OF TECHNETIUM 
COMPLEX]ES 
B. Noll, St. Noll, H. Spies, B. Johannsen, L. ~ incke lbor~l ,  W. ~emmlerl 
Institut fiir Diagnostikforschung Berlin 
NI-alkylated mercaptoacetyl glycine ligands were labelled with technetium-99m and the 
formed products analyzed by chromatographic methods. Biodistribution patterns of the re- 
sulting species were determined in Wistar rats. The compounds were tested with regard to 
their ability to be accumulated in arterioclerotic plaques. 
Experimental 
Methods 
TLC: Silicagel (Kieselgel 60/Merck)// ethanollwater /l 9515. 
HPLC: RP 18 column (Nucleosil, 25 cm), 0.5 M phosphate buffer pH 7.4 . 
Thin layer electrophoresis on special sheets coated with silicagel and phosphate buffer solu- 
tion pH 7.0 respectively glycine buffer 2, electric field strength of 20 Vlcm. 
Biodistwibution 
74 kBq of the complexes were intravenously injected into mice. The animals were sacrificed 
after 0.5, 1, 3 and 5 h. The percentage of the injected dose (% ID) as well as the percent- 
age of the injected dose per gram of tissue (% IDlg) were determined. 
The accumulatiorv was in ateriosclerotic lesions was determined in aortae derived from 
WHHL rabbits. 74 MBq of the complexes were intravenously injected into WHHL rabbits. 
5 h later the rabbits were sacrificed, the aorta was removed and a sudan-111-staining as well 
as an autoradiography were performed. The ratio of accumulation between the arterioscle- 
rotic lesions and normal vessel walls for the various N-alkyl-MAG derivatives was esti- 
mated by autoradil~graphy. 
Procedures 
9%~ gluconate 
2.0 m1 eluate of a 99~0'99m~c-generaror was added to 2 ml 0.1 M sodium glpleonate so- 
lution. Pertechnetslte was reduced with 10 m1 8.01 M sti~nnous chloride and the complete- 
ness of the reduction was proved by T W .  
9 9 ~ c  gluconiate 
9 9 ~ c  gluconate was prepared by addition of 1 x 106 m01 stannous chloride to 1 X 10-6 mol 
potassium pertechnetate in 2 ml 0.05 M sodium gluconate solution. 
Labelling procedures for animal studies 
Labelling of N-alkyl-MAGn was accomplished by reaction of the appropriate ligand with Tc 
gluconate, Ligands, reaction conditions and TLCIHPLC data are listed in Table 1. 
Table. l: Labelling conditions of MAGn derivatives according to the general procedure 
dPaem"narion ofthe molar ratio cat the c.a. level (general procedure) 
A smdl  wEume of the W-alkyl-MA$ solution was dropped into 2 m1 Tc gluconate solution 
(vc = 5 x 10-4 M) causing a significant change in volumes. After about 20 min the spec- 
aa of the gol~lcions were recorded by the UV/VIS spectrometer. 100 m1 1 N sodium 
hydroxide were added and measurement was repeated. The solutions were neutralized with 
100 m1 1 N hydrochloric acid. 
Results and discussion 
The reaction conditions for labelling N-alkyl-MAGn ligands according to the general proce- 
dure are listed in Table 1. The resulting preparations were used for animal studies. 
The analytical data of the species formed by the reaction of ligands 4 with Tc gluconate are 
summarized in Table 2. 
Experiments at c.a. level are described for two typical representatives, N-methyl-MAG3 
and N-methyl-MAGI . 
Tc N-methyl-MAG3 
Gradual addition of the ligand to Tc gluconate under UVIVIS spectral control showed a 
peak with an absorption maximum at 422 m. Varying the 1igandITc ratio, the maximum 
extinction was reached at 41. A pH shift from pH 7 to approx. pH 10 caused a drastic 
chanch of the absorption maximum to 360 m; the extinction coefficient remained un- 
changed. This reaction is reversible, a changing of the pH value back to 7 shifts the ab- 
sorption to 422 nm. Both absorption maxima coexist in the pH region 8 - 9. In electrepho- 
resis the complex with the absorption maximum at 422 nm migrated as an anion. 
Ligand exchange in alkaline solution was not successful. Only after gradual neutralization 
of the alkaline reaction mixture did a ligand exchange take place; the complex occured with 
an absorption maximum at 350 nm. Further neutralization led to a double peak. 
Table 2: Characterization of the Tc complexes with N-alkyl-MAGn ligands prepared by 
ligand exchange with Tc gluconate 
* dectrogfioresis was done both with phosphate buffer and phosphate buffer//MeCN 1: 1 
f see Fig. 1 
2 ligand exchange is only complete in excess of ligand (R 8-fold ) 
Fig. 1: UVIVIS spectra of the reaction mixture Tc gluconate/N-methyl-MAG3 at various 
ligandlmetal molar ratios prepared in neutral solution after raising pH > 11 
1: Tc gluconate; 2: molar ratio ligand Tc 1:l; 3: 2: 1; 4: 4: 1; 5: 8: 1 
Tc N-methyl-MAGI 
In neutral solution a yellow species was chiefly formed with an absorption maximum at 410 
nm. However, we were unable to determine a defined molar ligand/Tc ratio, The product 
decomposes during the electrophoresis both at pH 7 and pH 2. Increasing of pH values up 
to pH 10 results in a shift of the absorption maximum to h = 357 nm. With a sufficient ex- 
cess of ligand (molar ratio ligand/Tc > 4) the pH-dependent shift of the absorption maxi- 
mum is reversible. 
In alkaline solution @H > 11) only the complex with the absorption maximum at 357 m 
was formed, the molar ratio ligandflc of 2: 1 was well defined, 
Anionic mobility was detected in alkaline buffer solution at pH 10 only, because the com- 
plex is not stable at pH 2 and pH 7, and only Tc gluconate was found. 
Fig. 2: UVNIS spectra of the reaction mixture Tc-gluconatefN-methyl-MAGI at various 
ligandfmetal molar ratio both in neutral (a) and in alkaline solution (b) 
1: 1:l; 2: 2:l; 3: 8:l 
Discussion of biodistribution studies 
The ratio of accumulation of N-hexyl-MAG3 between the arteriosclerotic lesions and 
normal vessel walls was 4, as estimated by autoradiography. Renal excretion of N-hexyl- 
MAC3 is fast (5 h p.i.: 56 % ID) The renal excrection of N-octyl-MAG3 (5 h p.i.: 8 % 
ID) is much less, compared with N-hexyl-MAG3. The accumulation of N-octyl-MAG 3 in 
the liver (5 h p.i. : 28 % ID) is significantly higher than that of N-hexyl-MAG3 (5 h p i .  : l 
X ID). Because of a lower accumuIation of Tc N-octyl-MAG3 in normal vessel walls, the 
ratio of accumulation between the arteriosclerotic lesions and normal vessel walls (> 10) is 
higher to that of Tc N-hexyl-MAG3. 
Shortening the N-alkyl side chain to N-methyl leads to a renal excretion of 65 % ID (5 h 
pi.)  and an accumulation in the liver of 2 % ID (5 h pi .)  which is comparable to N-hexyl- 
MAC3. Hence the elongation of the alkyl side chain from methyl to N-hexyl has no pro- 
nounce~d effect on the biodistr&ution and elimination of the Tc labelled MAG3 complex. 
But a further elongation of the alkyl side chain fiom hexyl to octyl leads to a significant ac- 
cumulation of the Tc-MAG3 complex in the liver. The renal excretion of tc N-dodecyl- 
MAC3 amoun& to 16 % ID and hepatobilary excretion to 6 % ID 5 h p.i,. Accumulation of 
N-dodecyl-MA63 in the liver (5 h p i :  10 5% ID) was lower if compared to Tc N-octyl- 
MACi3. The concentration of Tc N-dodecyl-MAC3 in the blood was high ( 5 h p. i. : 3 1 % 
ID). 
b Compared with N-methyl-MAG3, N-methyl-MAGI shows an increased accumulation in the 
liver (5 h p. i. : 11 % ID) and a decreased renal excretion (5 h p.i. : 30 % ID). This tendency 
j is even more pronounced when the biodistribution and elimination values of N-hexyl- 
MAG3 are compared with those of Tc N-hexyl-MAGI. 5 h p.i. the accumulation of Tc N- 
hexyl-MAGI in the liver amounts to 75 % ID (5 h p.i.) and the renal excretion amounts to 
l 6 % ID. The higher accumulation in the liver as well as the lower renal excretion of Tc N- 
alkyl-MAGI derivatives compared with the Tc N-alkyl-MAG3 derivatives could be due to , 
the fact that N-alkyl-MAGI derivatives form 2:l complexes so that two alkyl groups pre- 
l sent in the molecule make the complex more lipophilic. 
, 
Conclusions 
, N-alkyl-MAGn (n = 1, 2, 3) ligands may act as monodentate, bidentate or, in the case of 
, N-alkyl-MAG3 as tetradentate ligands and form various complexes at the Tc(V) oxidation 
stage. 
l N-alkylation of MAGn favoures the formation of 2:l species, MAG3 i; lower than that of 
the "alkyl-free" Tc MAG3. 
1 
Some of the representatives tested in animals show a significant accumulation in arterioscle- 
p rotic plaques. 
P 
15. LIGAND EXCHANGE REACTION OF TECPLNETIUM GLUCONATE WITH 
D 
MERCAPTOACETYL GLYCINE (MAGI) AND N-METHYL 
, lMERCAPTOACETYL GLYCINE (CH3-MAGI) 
8 
B. Noll, B. Johannsen, St. Noll, H. Spies 
9 9 m ~ c  labelling of derivatives of mercaptoacetyl triglycine (MAG3) having fewer than 
three amide functions has been carried out by several authors [1,2J. The influence of a 
methyl substitution at the amide nitrogen on complex formation with technetium was stud- 
ied by comparing the reaction of mercaptoacetyl glycine and N-methyl-mercaptoacetyl gly- 
cine (N-methyl-MAGI) with Tc gluconate. Synthesis of M-methyl-mercqtoacetyl glycine is , 
described in 13'33. 
UVNIS spectra depending on the molar ratio Tc gluconakIlMBG derivative were recorded 
by means of the spectrophotometer Specord M4O. The chromatographic behaviour wm de- 
termined by thin layer chromatography on silica gel with aCf=tOnc: or 95 % ethano] as the 
solvent. The charge of the complexes was determined by thin layer e3.eetraphoresis with 
phosphate buffer so31ution pB 7 and glycine buffer solutioa pH 2,4) at an electric field 
strength af 20 Vl'cm. 
Tc-JUG1 
With molar ratios (1igand:Tc) ranging, the UVIVIS spectrum shows one maximum at 360 
nm with a shoulder at 480 nm. The extinction at 360 nm increases up to a molar ratio of 
2:l. At a ratio of 1: 1 50 % of the Tc gluconate remains unreacted. In TLC (silica gel195 X 
ethanol) the Tc gluconate remains at the starting point, the main component has the Rf 
value of 0.5 and is extractable in methylene chloride after addition of tetrabutylammonium 
bromide. Anionic mobility is the same both at pH 7 and 2. This fact may be explained by 
assluming the carboxylic group to be involved in binding technetium. 
At a molar ratio of 100:l a second component (about 15 %) occurs with Rf 0.1. 
Tc-&methyl-MAGI 
Gradual addition of an aqueous solution of N-methyl-MAGI to a neutral Tc gluconate solu- 
tion gives a peak at 422 nm, the maximum extinction is found at a molar ratio of 4:l 
(ligandw. The absorption maximum in the UVNIS-spectrum is shifted to 360 nm with 
the same extinction coefficient by adding 0.1 M NaOH. The pH-dependent conversion is 
reversible. In contrast to Tc MAGI the methylated species Tc methyl-MAGI cannot be ex- 
tracted into organic solvents either in neutral or in alkaline solution. The exchange reaction 
of N-methyl-MAGI and Tc gluconate did not proceed in an alkaline solution but after grad- 
ual neutralization of the solution it Was completed, with conversion to the same species as 
found above. 
A small variation of the complexing agent thus results in quite different Tc-complexes. 
While the unsubstituted MAGI forms a 2:l complex, N-methyl-MAGI forms predomi- 
nanitly a species which we consider to be a 4:l complex. This behaviour may be explained 
by the lack of the N-H proton (methyl substituted), resulting in a lower tendency of the 
mide  group to coordinate. 
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16. SYNTHESIS AND X-RAY CRYSTAL STRUCTUJUE OF AsP@~eO(MAG2)] 
B. Noll, P. Leibnitzl, St. Noll, B. Johannsen, G. ~ e c k l ,  H. Spies 
1 Bundesanstalt fiir Materialforschung, Berlin 
Formation and structures of rhenium complexes with mercaptoacetyl glycine are of interest 
in the context of our studies of technetium and rhenium complexes of mercapto-containing 
peptides [l]. 
The Re complex of the S,N,N,O-ligand mercaptoacetyl diglycine (MAG2) was prepared 
and characterized by X-ray structure determination. 
The ligand exchange reaction of a molar excess of MAG2 with Re gluconate in a neutral 
solution produces up to three species, whereas a single 1:l complex [ReO(MAG2)]- is ob- 
tained when Re(V) gluconate [2] is allowed to react with an equimolar amount of mercap- 
toacetyl diglycine (MAG2). The complex was isolated as tetraphenylarsonium salt and 
identified by elemental analysis, 1~ NMR, and infrared spectroscopy. 
The crystals formed are suitable for X-ray crystal structure determination, 
Procedure 
21 mg MAG2 (0.1 mmole) dissolved in 1 m1 0.1 N NaOH was dropped to 3 m1 (0.1 
mmole) aqueous Re(V) gluconate solution while stirring. After standing for 15 minutes, 42 
mg (0.1 mmole) tetraphenylarsonium chloride dissolved in 0.5 m1 water was added. The R- 
action mixture was extracted with methylene chloride (3 X 2 mf), the combined iexrhraca 
were dried over sodium sulphate and evaporated to dryness. The residue was recrystallized 
from acetone to give 54 mg (0.07 mmol = 70 %) ~f dark brown crystals, 
M.p.203 - 205 "C. 
Elemental analysis: (Found: C, 45.74; H, 3.30; N, 3.56; S, 4.07, CjgH26N20gSAsRe 
requires C ,  45.80; H, 3.31; N, 3.55; S ,  31-86 $6. 
IH NMR: 7.80 ppm (m, 20 H) phenyl, 4.8314.16 ppm (AB, 2 H) and 4.01 ppm ( S, 2 H) 
2x M-CH2, 3.89i3.62 ppm (AB, 2 H) S-CH2. 
IR (KBr): 976 cm-l (Re=€)) 
W-VIS absorptions: Xma/m(EtOH) 412 (log ddm3 mol-1 cm-l 2.15) 
X-ray crystal structure 
The structure of AsPhd[Re8(3113AG2)1 was confirm& by X-ray cqspsli91og~~phy. The c~y"sQ1 
structure eonsbts of discrete [fi:eO(MAG;?)]- aniom and  ASP^+ c8d:iom. 3312: gmmem of 
tfie  ASP^^^ =Gran is n ~ m a l  and regukes no furtkr diseusssbn. A perspective view of the 
c%rmpfex aaion pig, 1) shows that the compound h a  a distorM spwe-pyramidd aramge- 
merit. 
Fig. 1: CELLGRGF drawing of the [ReO(MAG2)]- anion 
It is distorted in the sense that the metal atom lies above the plane of the four basal ligands. 
(The rhenium atom is displaced towards the 0x0 ligand from the plane formed by the equa- 
torial S,N,N,O atoms. The corresponding value for [TcO(MAG2)]- is 0.756 W [l]). 
The observed square-pyramidal arrangement is found for a large number of five-coordinated 
technetium complexes as well as for rhenium complexes. The Re-01 bond length of is equal 
to that observed for the Tc=O structure element [3]. [ReO(MAG2)]- is related to the 
known technetium complex, and selected bond distances and angles (summarized in Table 
1) are very close to [TcO(MAG2)]-• Most values of bond lengths in the coordination sphere 
differ only in the third decimal place. 
Table 1: Selected bond distances and angles for [ReO(MAG2)]- 
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17. HYDROGEN-MEDIATED CLEAVAGE OF S-PROTECTED MERCAPTO- 
ACETYL TRIGLYCINE DERIVATIVES 
Having in mind a more general use of mercaptoacetyl glycine derived ligands as multifunc- 
tional chelators for technetium and rhenium, a suitable procedure for the removal of the 
protective group from the corresponding S-protected ligand precursor is required. This pro- 
cedure should be applicable not only to the parent compound MAG3, as already used in kit- 
based radiopharmaceutical preparation [l], but also to more sensitive derivatives without 
any change of structure. 
Several methods have been published for splitting the protective substituent from the sul- 
phur atom of mercaptoacetyltriglycine (MAG3) derivatives 123. Our current procedure in- 
volves saponification of S-benzoyl-protected MAG3 with sodium methylate, which pro- 
duces some amount of MAG3-SS-MAG3 disulphide and other by-products [3]. Catalytic 
hydrogenation could be an alternative, superior method for removal of the protective sub- 
stituent, as previously described 141. To optimize the reaction conditions for catalytic hy- 
drogenation, the influence of the catalyst was studied under the following reaction condi- 
tions: 
Solvent: 50 % aqueous ethanol 
Hydrogen pressure: 53 kPa 
Temperature: 18 "C 
Reaction time: 3 h 
The results are summarized in Table 1, showing the behaviour of bemyl-MAS.3 and de- 
rivatives (Nos.1 - 8) and of MAG3 (Nos. 9, 10). 
Initially, hydrogenation was carried out at 0.02 mm01 bemyl-MAG3-ergoline with both 
150 mg and 50 mg Pd-black. By decreasing the amount of catalyst, we achieved a small in- 
crease in splitting rate, but NMR spectr~scqic invatigation demonsmteil that nearly 50 % 
of the sulphur had been removed from the molecule. 
Further tests with bemyl-M;ACi3 dso resulted in an unsaisfactrary amount of unprotwted 
m C 3 ,  RegardIas of the type of ea~lys t  used, we obkined ace'tylglycine as the main 
product as well as some decomposition products. A similar product spectrum was obtained 
after hydrogenation of MAG3, benzoyl-MAG2 and benzoyl-MAGI. 
Table 1: Results of catalytic hydrogenation of protected mercaptoacetyl triglycine 
derivatives changing the catalyst 
30 % MAlG3-ergoline 
95 % acetylglycine 
90 % decomp.prod. 
90 % acetyltriglycine 
90 % acetyltriglycine 
95 % acetyltriglycine 
85 % decomp.prod. 
In view of these results it seems to be pointless to further optimize the catalyst; instead we 
should change the solvent and decrease the reaction time. 
A better method of splitting the protective substituent from the MAG derivatives without 
changing the structure of the molecule seems to be combining saponification with sodium 
methylate under hydrogen with the use of a catalyst. 
Thus, we developed the following procedure for splitting the protective group of MAG de- 
rivatives. 
The protected derivative was solved in anhydrous methanol in a round bottle. After addition 
of Pd/CaC03 (5 %) the bottle was connected to a vacuum apparatus, evacuated and then 
hydrogen was added to a pressure of 50 kPa. While stirring the reaction mixture vigor- 
ously, sodium methylate in anhydrous methanol was dropped into the solution over 15min. 
After neutralization with methanolic cationic exchange resin, the mixture was filtered and 
freeze-dried. The residue was extracted twice with benzene and purified by liquid chroma- 
tography on Sephadex G10. 
With this method we succeeded in splitting the protective group from a series of investi- 
gated MAG derivatives, with high yields and a small amount of by-products. 
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18. A NEW OXORHENIUM(V) COMPLEX CONTAINIRTG A STABLE 
RHENIUM-CHLORINE BOND. X-RAY STRUCTURE ANALYSIS OF 
(3-'IWL4PENTANE-1,5-DITHIOLATO) (CHLORO)OXORHENIUM(V) 
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Introduction 
A large number of precursors for ligand exchange reactions at transition metal cores contain 
chlorine as the leaving group. In many cases these metal-chlorine bonds are very sensitive 
to hydrolysis. Oxides and oxide hydrates of lower valences are obtained when these cornpo- 
unds come into contact with humid air or water-containing solvents. 
However, we have synthesized the new neutral stable oxorhenium(V) complex 
R~O(S-CH~-~HT~-~H~-~H~-S)(C~) from [BzNEt3][ReOC14] and bis(2-mercaptoethy1)- 
sulphide, with one chlorine atom still left at the core. The metal-chlorine bond in this corn- 
plex is even stable to boiling water. Another ligand exchange reaction is strongly retarded. 
This is similar to other oxorhenium(V) complexes containing very stable Re-Cl bonds after 
a pdclllar ligand exchange, cf. the stability of the thioether complexes Re0(R-S-CH2- 
CH2-S-R)(C1)2 [l]. The stability found in 5a enables us to transform the normal one-pot 
"3-k 1 " reaction into a two-step one. This may be important when the reactivities of the tri- 
dentate and monodentate ligands differ too much to guarantee a simultaneous attack of the 
ligands on the precursor. 
Experimental 
(3-Ria~entane-1.5-dithiolato) (~hloro)oxorhen&(~) 
5a: A solution of 27.8 mg (1 80 pmol) of "HS3Hn in 5 m1 chloroform is added over 15 mi- -
nut= to a stirred and cooled (0 "C) solution of 214.5 mg (200 pmol) of [ N B ~ E ~ ~ ] [ R ~ O C I ~ I  
1 in 10 mL chloroform and 1 m1 methanol. After stirring for another 30 minutes, the sol- - 
vent is removed by r o w  evaPoratiOn. The dark residue is several times with chlo- 
roform to give a blue powder- The product is recrystallized from acetonitrile to give dark- 
blue needles. 
Yield: 48 mg (68 % of the "HS3Hn), m+.: 221 - 223 "C (decamp). 
uV/vJS absorptions: hadnm (CH~CN) 572 (log ~1drn-l cm-l 2.0), 348 (3.2), 258 (3.9, 
232 (3.8). 
IH NMR data: solvent CD3CN; 4.22 ppm (m); 3.12.-.3.42 ppm (triplet of doublets); 
2-64 ppm (m). 
(3-Thiapentane-1.5-dithiolato)[l . 2-bis(etho~carbonyl)ethanethiolato]oxorhenium M : 
10.6 mg (27.2 pmol) of a is dissolved in 1 m1 of acetonitrile. 28 mg (136 pmol) of thio- 
malic acid diethyl ester is added and the mixture left at room temperature for four days. 
The colour of the mixture changes from blue to violet. The solvent is evaporated in a vac- 
uum without heating the mixture and the residue dissolved in chloroform. 6.4 mg (16.4 
pmol; 60.4 %) of the starting is recovered. 4.9 mg (8.8 pmol; 32.5 %) of the complex 
is isolated from the chloroform solution. 
(3-Thiapentane-1.5-dithiolato) (ethanethiolato)oxorhenium~ : 
400 p1 (5.4 mmol) ethane-thiol is dropped into a refluxing solution of 33.9 mg (87 ~ m o l )  of 
5a in 5 m1 acetonitrile. The mixture is refluxed for 10 minutes, Then the clear reddish- -
brown solution is evaporated to dryness and the residue dissolved in chloroform. The pro- 
duct is purified by column chromatography with silica gel 60 (0.063 - 0.1 mm) and chloro- 
form. Only a small amount of material remains at the starting point. One millilitre of etha- 
no1 is added to the eluate. 28.8 mg (80 %) of brown needles are obtained on slow evapo- 
ration. 
Results and discussion 
Our 3+1 concept is based on the idea of achieving small changes in the properties of the 
complexes (e.g. lipophilicity) by saturating three of the four free coordination sites (the co- 
ordination of a ligand into the tram-position towards the 0x0 group is unlikely) of the 
Re=03+ core with a relatively constant tridentate ligand 2_ (X=S; 0; NIGH,) and "tuning" 
the properties with a widely variable monodentate coligand 3 (R= $substituted] a w l ,  
[substituted] aryl) (see Fig. 1) [2]. 
f sH S HS-R ---+ 
Fig. l: Reaction schme for the preparation of "3 + I'bmp~lexes 
When 1, I(hrl=Rek, is reacted with & and several monothio1m 3, a lighz-tsllb~e by-product a n  
sometimes be is01ated. The s w e  mmpaund is obtained in high yields when the mon- 
odentate co-ligand fs omitted and only 0,9 equivaiena of bis~2-mer~pto&:thy1)~u~phide @%S- 
CX3[Z-CH2-$-CH2-CEir2-SB; 2rd) are draggc=d into the solution of ReOGI&-. M e n  m e x ~ = ~  
of & is wed, a brown oily cornp~und Io form& i m ~ a d  of B. m8 sbouid be &, but no 
er examination was m i e d  out due $0 failure of crys&lhtion. 
ri.a 
5a was found to be (3-thiapentane-l .S-dithiolato)(chloro)oxorhenium(V) . is soluble in -
acetonitrile, acetone and dimethylsulphoxide, sparingly soluble in chloroform and dichloro- 
methane and insoluble in diethylether, hexane, water and methanol. On slow evaporation of 
its solution in acetonitrile, 5a is obtained in the form of dark-blue needle-shaped crystals. 
Its IR spectrum exhibits the known strong Re=O valence band at v = 968 cm-l. Elenlental 
analysis of gives the proposed formula [C4H8C10ReS4J,. The electron impact mass spec- 
trum shows the m01 peak at mlz = 390; there are no signs of any structures with n > 1 
(see Fig. 2). 
Fig. 2: Electron impact mass spectrum of & 
The electron impact mass spectrum of 5a shows the molar mass of the complex to be 
~ = 3 9 1 )  gimol. Further peaks of interest are seen at mlz = 362 (first loss of -cH,-CH,-), 
mk 334 (second loss of an ethylene unit), mfz = 302 and 270 (losses of one and two 
sulphur atoms). There are also interesting images of binuolear Re species with m/z values 
higher than the molar p& of 59, 
Attempts to react 5 with a monothiol 3 in acetonitrile under the conditions of the classic 
3+ 1 reaction (equivalent amount of 3; 0 "C) as well as allowing it to stand for three days at 
room temperature were unsuccessful. For instance, 60 % of the used can be recovered 
after standing for three days with a fivefold excess of thiomalic acid diethyl ester. The re- 
action can be completed by adding a heavy excess of the monothiol3 and briefly heating of 
the mixture (see Experimental). Then the 3+ 1 complex is formed in a high yield and pu- 
rity. Since does not react with a monothiol under the conditions used for reactions ac- 
cording to Fig. 1, we assume that and 3 are attached to the core simultaneously and not, 
as postulated before, one after another. 
The oxygen analogue cannot be isolated after the reaction of 1 (M = Re) with 0.9 equi- 
valents of in acetonitrile. Immediately on addition of B, a blue colour is observed but 
after some ten seconds a reddish-brown precipitate is formed, which is completely insoluble 
in acetonitrile. Elemental analysis of this precipitate gives approximately the theoretical C, 
H and S values of the binuclear complex m. 
X-ray crystal structure of 3-(thiapentane-1.5-dithiolato)(chloro)oxorhenium(V) 
The X-ray crystal structure of 3-(thiapentane-1.5-dithiolato)(chloro)oxorhenium(V) 
shows a longer Re = 0 double bond (1.74 A) than (3-thiapentane-1.5-dithiolato)(ethane- 
thiolato)oxorhenium(V), where a bond length of 1.66 A was measured, Compared with the 
latter, the rhenium-sulphur distances are shorter in (mean lengths of the Re-Sfiol bonds 
is 2.251 A in S vs. 2.293 A; Re-Smo,,,,= 2.269 A in vs. 2.363 A). The Re atom is 
situated 0.673 A above the plane of the sulphur and chlorine atoms. 
Table 1: Selected bond lenghts and angles 
Fig. 3: X-ray crystal structure of compound a. 
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19. mCHLORO-BIS~HENYLPHOSPHANE)RHENIUM@I) 
COWLEXES COW-G ONE ISOCYANQ LIGAND 
M. Glaser, H. Spies, F. E. Hahnl, D. Schellerz 
"U Berlin, TU Dresden 
Rhenium complexes [ReCI,(CNR)(PR,)j may be useful as precursors for preparation of 
rhenium isocyanide/chelate mixed-ligand complexes [l]. 
Because only [ReC&(CNMe)(PPh$d had been previously reported by RICHARDS and 
ROUSCHMS [2], we sought to prepare and characterize further representatives of this class 
of @ompounds, 
233 pm01 [Re(MeCN)(PPh3),C13] 2 were dissolved in 10 m1 of degased benzene and 
348 pm01 of the appropriate isocyanide were added under nitrogen atmosphere. The mixtu- 
re was boiled under reflux for about 30 minutes and reduced in volume. Yellow-orange 
products precipitated (otherwise the product was dissolved in 2 m1 of methylene chloride 
and 5 m1 of ethanol were added). The raw materials were washed by diethyl ether and re- 
crystallized from ethanollmethylene chloride to give yellow crystals. 
Yields: 70 to 80 % 
NMR data of 
3a &(90 MHz; solvent CDC13; standard SiMe,): 7.89 (9 H, S, C-(CH,), 8.47 (6 H, " t", -
para-H), 8.72 (12 H, "t", meta-H) and 15.40 (12 H, "d", ortho-H) ppm 
&(90 MHz; solvent CDCl,; standard SiMe,): 3.74 (2 H, d, ortho-H), 4.65 (1 H, t, 
para-H), and 8.84 (18 H, m, meta and para-H in PPh,) ppm 
3c &(90 MHz; sollvent CDCI,; standard SiMe,): 4.25 (3 H, S, CH,), 7.7 (2 H, S, CH2), -
8.93 (1 8 M, m, meta- and para-H) and 15.65 (12 H, m, ortho-H) ppm 
3d &(90 MHz; solvent CDCI,; standard SiMe,): 2.94 and 3.94 (8 H, m, broad, mor- -
pholine-CH2), 5.65 and 7.35 (8 H, m, very broad, ethylene-CH,), 8.95 (18 H, m, 
meta-and para-H) and 15.50 (12 H, m, ortho-H) ppm 
Synthesis of [ReC13(CNR)(PPh3),3 3 has been accomplished both by reduction of 
[trans-ReOC13(PPlh3)d 1 and by selective exchange of the acetonitrile ligand in 2 against the 
appropriate isocyanides RNC as shown in Scheme 1. Considering the reaction of 1 to 3, tri- 
phenylphosphane seems to be essential as a reducing agent. Attempts to reduce the Re(V) 
core by means of the isocyanide failed. Using an excess of isocyanide instead of triphenyl- 
phosphane, the originally obtained blue species was decomposed. The substitution reactio~~ 
of 3 produced about 80 % of the theoretical yield and should be the preferred method of 
preparation. 
The structure of was investigated by X-ray crystal structure analysis, A persp~tive view 
of the complex (Fig. 1) shows that the compound has an octahedral mangement. Selected 
bond lengths and angles are listed in Table 1, It is worthy of note that there is no 1inait.y 
between C-l, N and C-2 as usually found in comparable compounds [3J. The Re-Cl-l a d  
Re-Cl-2 distances are in agreement with the values found in the literature 641. The ccs~rdina- 
ted t-butyl-isocyanide obviously causes stretching of the third chlorine bond. 
The infrared spectra of 3a-d show very broad v-(Cw absorptiom. The hyy,sochrsmic shifts 
of the coordinated CH-hnction - cetmgmed with the free isocqvanide in md dso im the 
case of N-morpholiny~-2-etfiyl-iSo~,yanide are unexpectd and inexglimble (set; Tabk 
2). A31 complexes && me pmmagnetic deeted by unusd  ~hermical shiftlr in the 
NMR spectrum, 
To sum up, one can say that the Re(II1) complexes presented could serve as precursors for 
the preparation of complexes containing a tripod ligand as shown for tris-(2-mercap- 
toethy1)amine in [l]. In view of the additional coupling of rhenium with "anchor groups", 
precursor & is of special interest: the presence of the ester group is expected to allow func- 
tionalizations and to become biochemically important. 
Scheme $. Synthesis of 3 
I 
Table 1: Selected bond lengths (A) and angles (deg) for & 
Fig. 1: X-ray structure of & 
Table 2: IR and UV/VIS data of 3a-d 
Table 3. Melting points and elemental analysis of 3a-d 
3 Formula m. W. m. p. in OC calc.1 found 
C H N C1 
a C4,H3,C13NP2Re 985 -21 - 188-194 51.20 4.19 1.42 17.99 
X CH,CI, (EtOHIMeCl,) 51.31 4.26 1.49 17.99 
b C4,H3,Cl3NP2Re 920.27 200-209 56.12 3.83 1.52 11.56 
(MeOHIMeCI,) 56.10 3.89 1.65 1 l .35 
g C43H35C13NP202Re 916.24 184-188 52.44 3.85 1.53 11.61 
(n-hexaneIMeC1,) 52.66 3.81 1.561 11.29 
d C43H,2Cl,N20P2Re 957.33 195-200 53.95 4.42 2.93 11.11 
(EtOHIMeCIJ 53.53 4.45 2.99 11.08 
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20. mIW,T.M COltIPEEXES WITH TRIS-(2-THIOLATOETHYL)~ 
N. Spies, M. Glaser, F. E. Hahnl 
3 PU Berlin 
The chemistry of technetium and rhenium tracers can be considered to be mainly a chemis- 
try of 0x0 compounds. In order to gain access to alternative "0x0-free" metals capable of 
bdng coupled to anchor groups, on complex formation studies were carried out with a tri- 
podal te:Eradenbte "umbreliia ligand" which to correspond with a monodentate neutral ligand 
in tram-position. 
24 @l (233 pmol) in 2 m1 MeC1, were slowly added to a solution of 100 mg (156 pmol) 
ReL(P"iBh3) h 5 m1 MeC12 at raoln temperame. TLC of the mixture (silica gel, MeCI,) in- 
dicates PPh3 (Rf = 0.75), 1 (Rf = 0.59) and the olive green coloured &j (Rf = 0.41). &j 
was isolated by column chromatography (Merck Kieselgel 60, 0 0.063 - 0.1 mm, column 
15 X 250 mm, Mecld. 
Yield: 46 mg (64 %); rhomboedric plates suitable for X-ray analysis from EtOH; 
m.p, 238 - 242 OC (decornp.) 
Elemental analysis: Found C, 28.77; H, 4.60; N, 5.86; S, 20.80, 
Cl1H2,N2S3 requires C, 28.49; H, 4.56; N, 6.04; S 20.74 % 
IR absorptions: C-/cm-l (KBr) 1976 br. v(NC) 
UVIVIS absorptions: Wnm (MeCl,) 250 (log ddm3 mol-l cm-l 4.23), 312 (3.98), 350 
(3.11) and 448 nm (3.26) 
NMR data: &(g0 MHz; solvent CDCI,; standard SiMe,) 1.54 (9 H, S, CH3 ) and 2.98 ppm 
(12 H, m, CHz) 
Tris(2-thiolatoethy1)amine-isocyanoacetic acid-methylester-rhenium(lll) 
3b was prepared as described for a. -
Yield: 62 % of the theory; rhomboedric plates; (crystals for X-ray analysis from 
Et,OlMeCl,); m-p. 205 - 212 OC 
Elemental analysis: Found C, 25.37; H, 3.56; N, 5.68; S, 19.79, 
C,,H,,N202S3Re requires C, 25.04; H, 3.57; N, 5.84; S, 20.05 % 
IR absorptions: C-/crn-l (KBr) 1940 br. (vNC) 
UVNIS absorptions: h/nm (MeCl,): 25 1 (4.20), 3 14 (3.84), 355 (2.98) and 437 nm (3.12) 
NMR data: &(g0 MHz; solvent CDC1,; standard SiMe,): 3.02 (12 H, m, CH2), 3.81 (3 H, 
S, OCH,) and 5.46 ppm (2 H, S, CH$ 
The best results were obtained with tris-(2-mercaptoethflamine LE3 111. Five-coordinated 
Re(II1) complexes [ReL(PR3)] and [ReL(CNR)] were prepared and their structure determi- 
ned by X-ray crystal structure analysis (Figs. l and 2). Scheme 1 shows all important ga- 
thways finally leading to complexes 1 and 3. 
Reduction of NH4Re04 by treatment with LH3, an excess of cone. hydroebloric acid and a 
phosphane resulted in formation of the green compounds &@ in EtOH. The obvirausly fa- 
stest reaction occurred in the case of PPh3. 
The isocyanides are stronger K-acids than the phosphane. It is therefore very w y  to re- 
place the phospbane by the isocyanide to prepare k f  (room 'tt:mperature). We found a si- 
gnificant equilibrium reaction when we excha~fged P P 4  as verigerj. by TLC (siilim $@l, 
chloroform). WorEing up the reaction mixture by column chomatogqhy resul& in a high 
proportion of the starting product @Q g), Better yields we obaine-el neing fRe'f,(PPhbiQj 
lc (i. e, 93 96 formation of 3c), -
Scheme 1. Synthesis of 1 and 3 
Re0,- tran~-ReOCl,(PPh~)~ ReCS(PPh,),(MeCN) 
R'NC 
ReL(PR3) ReL(RrNC) 




d CN Q 
By the second route 3 was pfodusd from 2 in the presence of LHJ - also under moderate 
reaction conditiom. Finally, 3 can be synthesized by reaction of [ ~ ~ ~ 1 , ( p p h , ) , M e C ~  with 
m gqrmi~?~ofw mkme ofthe &ipod ligand a d  an isocyanide. ~ u t  the most route 
is the use of the ghoqhanehipod substituted  r recur so^^"^ 
Complexes 3b, c permit the formation of further derivatives by subsequent reaction at the 
ester group. They might thus have some potential in the design of bifunctional rhenium 
tracers. For instance, we prepared the amides by reaction with ammonia, morpholine and 
benzyl amine. Saponification experiments and others are still in progress, 
Fig, 1: X-ray structure of 2 
The X-ray structural analysis of and 3a. b confirmed the supposed coordination of the 
trigonal bipyramidal type (see Figs. 1 and 2). 
Only two technetium compounds of comparable structures have so far been described: 
[Tc(PS,)(CN-i-Pr)] (PS, = tris(o-thiolatopheny1)phosphine) and [IrcL(PPh,)] [2,3]. 
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21. TECHNETZUM AND RHENIUM COMPLEXES WITH THIOETHER 
LIGANDS 
4. SYNTHESXS AND S'I'RUCTUBAL C ~ C T E R I Z A T I O N  OF 




1 TU Dresden, 
H. Spies, K. ~lostermannl, P. ~ e i b n i t z ~ ,  G. ~ e c k 2 ,  J. ~ e ~ e r 3 ,  
2 Bundesanstalt fur Materialforschung Berlin, 3 Bergakademie Freiberg 
Recently we found that neutral oxotechnetium(V) complexes are formed when TcOC14- re- 
acts with bidentate thioethers in methanolic solution [1,2]. 
In view of the fact that the rhenium nuclides 1 8 6 ~ e  and 188~e emit p- particles with thera- 
peutically useful energies, rhenium is included in our efforts to evaluate novel thioether 
complexes as potential tracers for radiodiagnostic and radiotherapeutic purposes. 
lfn this paper we describe the synthesis and structure of binuclear oxorhenium(V) complexes 
derived from bidentate thioethers. 
Neutral, bidentate dithiaalkanes such as 5, gdithiadodecane and 3,6-dithiaoctane (" S2 ") re- 
act, with Re8C14- in acetone/methanol with a partial exchange of chloride ligands by the S 
a t m s  of dithia ligands. 
Analytically pure, dark green 0x0 complexes of the composition [ReO("S2")C12]20 1, 2 
prsipitate from the reaction mixtures by slow evaporation of the solvent. 
"s21 
-----..-h--------- -W--- -------- > [ReO("S2")C12]20 
aeetone/methanol 
1 "S2": C4HgSCH2CH2SC4H9 -
2 "S2": C2H5SCH2CH2SC2H5 
l The neutral complexes are stable on exposure to air and, except for acetone and acetonitrile 
insoluble in the common organic solvents. Elemental analyses are consistent with the propo- 
I sed formulations. 
In the infrared spectra broad absorptions between 650 and 700 cm-l indicate the O=Re-0- , 
Re=O moiety. Peaks which can be assigned to the ~ e = 0 3 +  cores are not observed. 
The structure of complex 1 was determined by X-ray structure analysis. Suitable crystals 
i 
were obtained from acetone/methanol. Drawings of 1 are shown in Figs. l and 2. Selected 
l bond angles and distances are listed in Table 1. 
The crystal structure of 1 consists of two independent ReO("S2")C12 units bridged by an 
oxygen atom. 
The characteristic feature is the presence of the O=Re-0-Re=O group. In this respect the 
structure of 1 is comparable to those of [ReO@yr)2Cl2]20 @yr = pyridine) [3], 
[TcO("S2 ")C12120 (32"  = bidentate thioether) [l], rcO(salpd)]20 (salpd = N,N'-pro- 
pane-1,3-diylbis-(salicylideneiminate) [4], and ucO(N2S2)]20 (N2S2 = N,N'-ethylene- 
bis(thio-acetylacetone-iminate) 151. 
Fig. 1: CELLGWFf6j-drawing of [ReO(5,8-dithiildod 
Fig. 2: Molecular geometry of [Re0(5, S-dithiadodecane)2Cl2]20 viewed perpendicular 
(on the left) and parallel to the 01, Rel, 03,  Re2, 0 2  axis 
The rhenium atoms are centred in a flattened octahedron with the equatorial plane formed 
by a S2C12 donor set, in which the rhenium atoms Re1 and Re2 are 0.12 A out of plane 
towards 01 and 0 2  respectively. The S2C12 planes are almost parallel with a small devia- 
tion of 0.013 A; the dihedral angle is 2.6 ". The sulphur and chlorine donor atoms of the 
units are in the anti position with respect to the bridging oxygen. 
The bond lengths of the Re=0 cores with 1.705 and 1.735 A, are in the range generally 
found for these units (1.61- 1.75 4, but they are in between those in the octahedral 
O=Re=Q compounds and in square-pyramidal Re=O complexes. This corresponds to the 
relatively low value of Re=O absorption in the infrared spectrum. 
The bridging Re-0 distances (Rel-03 1 .g08 A and Re2-03 1.946 A) are intermediate bet- 
ween the average %=O length and the average Re-0 bond distance which are observed 
bdng in the range 1.98- 2.09 A [3,7-103. 
This new class of rhenium complexes is worthy of special interest as manifolde subsequent 
reactions; am be anricipated. Diversity is given in ligand exchange reactions by various Lea- 
ving goups in the coordination sphere. New radiopharmacologically relevant compounds 
may &us bewms cdecmfpible- Studies on the reactivity of the described complexes will fol- 
law, 
Tab. 1 : Bond lengths (A) and angles (") for [Re0(5,8-dithiadodecane)2C12]20 
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22. TECHNETIUM AND RHENIUM COMPLEXES WITH THLOETHER 
LIGANDS 
5. SYNTIIESIS AND STRUCTURAL CHARACTERIZATION OF 
NEUTRAL OXORHENIUM(V) COMPLEXES WITH PO'IENTIALLY 
TETRADENTATE THIOETHERS 
H.-J. Pietzsch, H. Spies, K. ~lostermannl, P. Leibnitz2, G .  ~ e c k 2 ,  J. ~ e ~ e r 3 ,  R. 
~acobi3 
1 TU Dresden, 2 Bundesanstalt fiir Materialforschung Berlin, 
3 Bergakademie Freiberg 
Ligand exchange reaction of the potentially tetradentate ligand 1,8-dihydroxy-3,6-dithiaoc- 
tane ("S2(0H)2") with ReOC14- leads to the formation of a violet microcrystalline com- 
pound which precipitates from the reaction mixture. The elemental analysis is consistent 
with the formulation [ReO("S20(0H) ")C12]. 
**S2(OH)2" 
Re0Cl4- > [ReO("S20(OH) ")Cl2] 
acetonelmethanol 
"S2(0H)2": HO-cH2CH2SCH2CH2SCH2C)IT2-OH 
The complex is practically insoluble in all common organic solvents; attempts to obtain cry- 
stals suitable for X-ray structure analysis were therefore unsuccessful. 
The inftared spectrum shows the characteristc strong absorption at 940 cm-l indicating the 
~ e = 0 3 +  core. 
By analogy with the appropriate technetium complex [l] compound (1) should consist of 
discrete m~nomo~ecuiar units containing the O=Re-0- core as illustrated in Fig. 1. 
The proposed structure of is supported by the FAB mass spectrum (Fig. 2). It is charac- 
terized by typical metal-containing fragment ions. The parent peak is found at m/z = 455 
(M+H). 
The isotope patterns caused by the metal and the Cl- ligands correspond to the calculated 
isotope pattern shown in Fig. 3. 
Fig. 2: FAB mass spectrum of [ReOf 8-hydroxy-3,6-dithiaoctan-l-olato-(l 
(region between m/z= 435 and 490) 
Rhenium complex with I-hydroxy-3,6-dithia-9-oxaundecane 
Ligand exchange reaction of ReOC14- with l-hydroxy-$6-dithia-9-oxaundecane 
("S20(0H)") in acetone/methanol leads to the formation of a violet compound which can 
be precipitated from the reaction mixture by diethylether. The complex recrystallizes from 
chloroform/diethylether as violet needles. 
According to the elemental analysis and the infrared spectrum which shows an absorption at 
948 cm-l, indicating the ~ e = 0 ~ +  core, compound Q.) is a rnononuclear complex of the 
formulation [ReO("S202 ")C12]. 
This is confirmed by the FD mass spectrum (Fig. 4) and the X-ray structure analysis. Suit- 
able crystals were obtained from chloroform/diethylether. Drawing of a is shown in Fig. 
5. Selected bond angles and distances are listed in Table 1. 
~ i g .  4: FD mass spectrum of lRe0(3,6-dithia-9-oxaunde~an- l -01ato-(0, S ,S))C121 
mshowing the characteristic isotope pattern of a ReS2C12 complex 
and the parent peak at m/z = 482, 
Fig. 5: CELLGRAF [4] drawing of we0{3,6-dithia-9-oxaundecan-l-oiato-(0,) l @ 
Complex (2) consists of discrete monomolecular units containing the O=Re-O- core. 
In general, the structure strongly resembles that of the technetium [1,23 and rhenium com- 
plexes derived from dithiaoctane 131. 
However, while in the dinuclear species the trans-position is occupied by a bridging oxygen 
which may come from traces of water present in the reaction mixture, the tram position in 
complex (2) is occupied by the oxygen of the terminal hydroxy group. 
The S atoms of the dithioether and the two C1 atoms which remain at the metal due to the 
incomplete exchange at the tetrachlosooxotechnetium ion form a cis-arrangement in the 
equatorial plane. 
Such compounds with a single bonded oxygen tram to the M=O core (M=Tc$ Re) have 
been hardly described so far. 
The length of the Re-Q bond (1.912 A) is comparable to that found in other tram-Q=M-0- 
groups (M=Tc, Re) [S-83, 
Table 1: Bond lengths (A) and angles (") for 
Fe0{3,6-dithia-9-oxaundecan-l-olato-(O,S,S)) C121 Q) 
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23. ELECTROCHEMICAL INVESTIGATIONS INTO RHENIUM0 
THIOETHER COMPLEXES 
I. Hoffmann, H.-J. Pietzsch 
Introduction 
Rhenium complexes of the general formula Re203X4(L)4 are known with several ligands 
L, and electrochemical studies have been carried out, for examples, with complexes where 
L = pyridine [l]. Analogous rhenium complexes with thioethers have now been prepared 
by us [2] (Fig. 1). Their electrochemical behaviour was characterized by cyclic voltamme- 
try, d.c. polarography and coulometry. Special attention was devoted to similarities and dif- 
ferences between Re-S-(thioether)- and Re-N-(pyridine) compounds. 
Fig. 1: General formula of the rhenium(\/) thioether complexes 
Experimental 
Chemicals 
supporting electrolyte: 0.1 M Bu4NPQ.j in anhydrous dichloromethane (Aldrich Chem.) 
Re complexes with thioethers were prepared according to [;23 (Fig, l+)* 
All solutions were deoxygenated by argon (99.998 %), 
Apparm 
Cyclic- volfammogaph (CV - 27, BA5)* DC!AC poImogrqh ( G m  673, m G  Ser1id 
Elec~~odes 
Working efec&ode: Pt  bum^ els&r)de, static mercury drop elm@ode (OQH am, ZWG 
Berlin] 
Refference electrode: saturated calomel electrode 
Counter electrode: Pt electrode or Hg-pool 
Results and discussion 
Five rhenium thioether complexes (Fig. 1) were electrochemically investigated in the sup- 
porting electrolyte of 0.1 M Bu4NPF6 in CH2C12 at Pt electrodes. The supporting electro- 
lyte used allows measurements within the potential range from +l500 to -1800 mV vs. 
SCE. The cyclic voltammograms of all compounds investigated are nearly identical. In 
comparison with the Re(V) pyridine compounds [l] the investigated complexes show a 
similar reduction behaviour. Two reduction steps (A,B) are observed in this potential range 
(see Fig. 2). The first reduction peak at -790 mV vs. SCE (A) indicates a reversible l-elec- 
tron process because the voltage difference to the corresponding anodic peak (C) is about 60 
mV. The peak magnitude of the first reduction process (A) depends on the potential sweep 
rate in accordance with the theory of a reversible electron transfer. The second cathodic 
peak at -1600 mV vs. SCE (B), close to cathodic decomposition of the supporting electro- 
lyte, has no counterpart in anodic direction. This electrode reaction is therefore irrevers- 
ible. In the case of the corresponding pyridine compounds, the reduction peak at this poten- 
tial has a reversible oxidation peak [l]. 
1 
r 1.1 AI 
Fig. 2: Cyclic voltammogram of complex (b) in 0.1 M Bu4NPF6/CH2C12 





Fig.3: Proposed mmhanism for redrtctim 
89 
During the anodic scan a second oxidation peak (D) was found near the above-mentioned 
reversible oxidation peak (C). That means that the reduced compound consists of two elec- 
trochemically different forms. As shown in the lower part of (Fig. 2) these peaks (C, D) 
exist without a previous scan up to -1800 mV vs. SCE and are therefore independent of re- 
duction step (B). This process differs from the reduction of Re dioxo complexes with pyri- 
dine. Pyridine complexes only split into two parts after the reduction step at more negative 
potentials [l]. 
Despite the splitting of the oxidation process into two parts (C, D) the original amount of 
the complex is formed again by recombination. That was concluded from the observation 
that the peak magnitude (A) did not decrease after some potential runs. 
This behaviour can be interpreted as both Re atoms being reduced at the same potential by 
1- electron transfer and split into two parts with different potentials for reoxidation (C, D). 
The mechanism (formulated in Fig. 3) can be discussed on the analogy of the rhenium 
pyridine complexes [l]. The data obtained are in accordance with this scheme (Fig. 3). 
Fig. 4: Cyclic vokmmogram of complex (C) in 0.1 M Bu4NpF6/CH2Cl2 at different scan 
rat=, (c(,) = 1.5 X 10-3 M) 
Fig. 4 shows the cyclic vo1Wm~)grams of the complex compound (c) at various 
sweep rates. The peak magnitude (A) increases with increasing sweep rate. The peak paten- 
of A and C are near1~ consfant but that of peak (D) depends on sweep rate, and the 
peak dbtan~e (CjD) That nWtiE that the reaction will be more irseversible. The 
relation of the peak magnitudes (D) and (C) changes with the potential sweep rate and the 
90 
reaction time. The magnitude of peak (D) increases with sweep rate and time in the same 
measure as peak (C) decreases. 
At potential B (Fig. 2) rhenium (IV) is probably reduced to rhenium (11). The height of the 
wave in the DC polarograms suggests a 2-electron process. Coulometric measurements at 
the mercury pool are disturbed by other reactions. 
Oxidation of Re(V) thioether complexes is more difficult than oxidation of pyridine com- 
plexes because the oxidation peak is up to 300 mV more positive than that of pyridine 
complexes. In the potential range only one oxidation peak was found at +l300 mV. This 
oxidation seems to be irreversible. 
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24. RHENIUMfv) COMPLEXES WITH meso-DMSA 
PART III: X-RAY CRYSTAL STRUCTURlE OF 
Ph@smeO@MSA)2] x 2 ACETONE AND IDE-ICATION OF THE 
POSSIBLE ISOMERS 
S. Seifert, H, Spies, P. kibnitz, G. Reck 
1 8 6 / 1 8 8 ~ e ( V ) r n e s o - ~ ~ ~ ~ ,  a potential therapeutic tumour seeking agent, exists in three 
stereoisomeric forms (syn-endo, syn-exa, anti) which can be detected by WPLC a n d l ~  
NMR andyses as described in several articles [1,2,J]. Previous studies l43 showed that an 
equilibrium exim between the three species, depending on the sdvent, pH value, tempem 
ture, and the age of the complex solution. 
The time dependence of formation of an anti and another syn borner from a pure isolichted 
syn isomer in aqueous solution was studied by HPLC and 1 ~ :  NMR -1yses I5,63, 
For a complete. *signmen$ X-ray mysMlography of at least one immer Is requked, One 
such assignment was c m i d  out by [S] using a prepaap&tion iiaf Et4N/ReO(BMSA)z] in 
aqueoas sslatiom, We determind X-ray e r y s ~ l  stmemre of PhAsIReQ(DMSA)2] ob&in& 
from an amtsnb sdutictn, 
Experimental 
PhqAs[ReO(DMSA)2] was prepared in an acetonic solution starting from [ReOC14]- and 
characterized by elemental analysis, IR and UVMS spectroscopy, HPLC and 1~ NMR 
analysis [6]. An alternative route uses ReOC13(PPh3)2 as the precursor. 
X-ray analysis was carried out on orange-red crystals obtained by fractional crystallization 
of the tetraphenylarsonium salt from acetonic solution. 
Crystal data: C3gH320gSqAsRe X 2 CH3COCH3, molecular weight 941.92, triclinic, 
space group PI, a = 12.792(2) A, b = 13.953(2) A, c = 14.842(3) A, a = 116.40(1) O ,  
p = 101.63(1) ", y = 104.28(2) ", V = 2146.48 A3; Z = 2, DC = 1.456 g/cmf, 
Data collection: The intensity data of an orange crystal (size 0.13 X 0.45 X 0.45 mm) were 
recorded at room temperature by mans of an automatic Enraf Nonius CAD4-diffractometer 
with graphite filtered MO K, radiation (h = 0.71073 A, p = 38.556 cm-l, F(000) = 
1148) using the 0-28 scan procedure with a variable scan rate of 1.1 - 4.8 "/min. A total of 
6239 unique reflections were measured and 5628 were used for structure determination. 
Refinement converged with R = 0.026. 
Results and discussion 
The molecular structure of the complex anion with the atomic numbering scheme is given in 
Fig. 1. Selected interatomic distances and angles are summarized in Table 1. 
In the crystal the complex anion adopts an approximate square-pyramidal configuration as 
expected from known data [51. The Pure isomer 11 of PhqAs[Reo(~~SA)21 according to 
elution order in HPLC reveals a syn-endo configuration of the carboxylic acid groups of 
both DMSA ligands. The correct configuration of the possible meso isomers of 
[ReO(DMSA)2]- can be assigned as follows: 
Isomer I: anti, isomer II: syn-endo, isomer III: syn-exo. 
Fig. 1: X-ray analysis of the pure isomer I1 of [ReO(DMSA)2]- 
Tab. 1: Selected bond distances (A) and angles (") for PhqAs[ReO(DMSA)2] X 2 acetone 
Fig. 2 confiims the bonding of two acetone molwula per complex anion by fnydrogera 
bridges and shows the arrangement of the pertinent te-%:aphenylmsonium cation, 
Fig. 2: Molecular structure of P~~AS[R~O(DMSA)~] X 2 acetone 
The differences in the 0-Re-S angles are smaller (108-110 ") than described by [5] for 
EtdN[ReO(DMSA)2] x 1112 H20 (105 - 113 "1. However, the Re-0 distance (1.699 A) 
and also the Re-S bond lenghts (2.286 - 2.329 A) are comparable. Weak but significant 
contacts were found between the rhenyl oxygen atom and two methylene hydnogens of the 
tetraethylammonium ion forming a loose ring structure with 0--H contacts of 2.434 and 
2.460 A. The crystal structure of the complex under investigation shows hydrogen bonds 
between the acetone molecules and the carbox~lic acid groups on the one side and between 
the carboxylic acid groups of two molecules on the other. The distances of tlne 0--H con- 
tacts are slightly longer (2.605 - 2.691 A) than described for the Et4N[ReO(DMSA)~] 
complex. This results in an arrangement of "endless" chains of complex anions as shown in 
Fig. 3. The acetone molecules are situated between these chains. The tetraphenylarsonium 
cations, omitted in the figure for clarity's sake, are also located between the complex anion 
chains. 
Fig. 3: Crystal structure of PhqAs[ReO(DMSA)2] x 2 CH3COCH3 
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S. Seifert, F. Schneider, H.-3. Bietzsch, H. Spies 
In connection with our work on ReO- ;Lnd TcO-BMSA and DMS ester complexe?~; attemp@ 
were made to prepare and characterize the conesponding ReN- and TcN-compounds of the 
same ligands, 
The stildies i~vofve preparation of ReN-DMSA and ReN-DMS ester wmplexa as well m 
speetrg~cstpi~ and chrowtogaphie chatat:&riZation and elemenbi ana9pk. 
Experimental 
The ReN-complexes were obtained by reaction of ReNC12(Me2PhP)3 with the BMSA lig- 
ands in acetonic solution. 
35 mg ReNC12(MqPhP)g (5.1 X 1 0 - ~  mol) were dissolved in 5 m1 dry acetone while stir- 
ring and 23 mg meso-DMSA (1.2 X I O - ~  mol) (A) or 40 mg meso-BMS dimethylester (1.9 
X 10-4 mol) (B), also dissolved in acetone, were added. After stirring for 3 h at room tem- 
perature, the reaction was completed and the colour of the solution turned from yellow to 
brown. 
The solutions were filtered and concentrated by bubbling nitrogen through the acetonic 
complex solution. Recrystallization from acetonelmethanol gave microcrystailine products, 
which were characterized by elemental analysis, IH NMR, HPLC, UVNIS and IR spec- 
troscopy, and electrophoresis. 
The orange brown reaction products are soluble in DMSO, hot methanol, ethanol, acetoni- 
trile, CH2C12 and acetone. They are insoluble in water, ethers and hydrocabons. 
Results and discussion 
The formation of the ReN-DMSA complexes has to proceed in dry organic solvents, prefer- 
ably acetone, and at room temperature. Higher temperatures and the presence of water re- 
sult in the formation of ReO-DMSA complexes as found by HPLC. 
HPLC studies were performed using a PRP-1 column (Hamilton, 150 x 4.1 mm) in oon- 
junction with a linear gradient system (+ 1.0) of 0.1 % trifluoroacetic acid in water (A)/lO. 1 
% trifluoroacetic acid in acetonitrile (B). [t(min),B(%)]: L5 ,O], [10,20], [5,30], [l ,501, 
[5,50]. The effluent from the column (flow rate 2.0 mllmin) was monitored by UV absor- 
bance at 300 m. 
In accordance with the HPLC analyses of the ReO-DMSA complexes, three peaks of the 
~ossible stereoisomers are expected to occur in the ligand exchange reaction of 
ReNC12(Me2PhP)3 and DMSA or DMS dimethylester. 
Fig. 1 shows the expected chromatograms obtained from the reaction solutions after filtra- 
tion. When such solutions are concentrated a brown precipitate is formed and can be sepa- 
rated by centrifugation. Further concentration and addition of cold methanol or water to the 
remaining complex solution results in further precipitation of the complex without decom- 
position. The isomeric compositions of these precipitates differ clearly from each other as 
shown in Fig. 2. 
Fig. 1: HPLC chromatograms of reaction solutions of ReN-meso-DMSA (A) and 
ReN-meso-DMS dimethylester (B) complexes 
Elemental analyses: 
[ReNHC(CH3)2(DMSA)2PMe2Ph] (A): @bun& C, 29.0, H, 3.5, N. 2.0, S, 115.7, 
C19H260gNSqPRe requires C, 29.4, H, 3.4, N, 1.8, S, 16.5 X) 
mHC(C&$2@MS dimethylester)2PMe2Ph] (B): (Fonnd: C!, 35.3, H, 4.3, 
N, 1.7, S, 15.8, C23B340gNS4PReCl requires C, 34.6, H, 4.1, N, 1.8, S, 16. 1 %"o) 
UV/VIS absorptions; h,ax/nm (acetone) 268 and 302 
TR absorptions vm,/crn-l (A): 3432, 29208 1708, 1630, 1480, 1440, 1312, 1280, 1184, 
1080, 1080,916,744,688,592,464 
Fig. 2: HPLC analyses of precipitates of ReN-DMS dimethylester complex dissolved in 
acetonitrile: I: 1st precipitate, 11: 2nd precipitate (sample for elemental 
analysis and 1~ NMR), 111: 3rd precipitate 
Electrophoretic studies on silica gel in DMSOIl % NaC104 solution (20 Vlcm) revealed the 
surprising fact that the yellowish-brown complex does not migrate. 
Elemental analysis shows an unexpected remaining coordination of a phosphine molecule in 
the complex. This result is confirmed by 3 1 ~  and 1~ NMR studies carried out in DMSO. 
Fig. 3 shows the NMR spectrum of (B). The sharp signals indicate that the Re(V) com- 
pound is diamagnetic. The five phenyl protons at 7.6 - 7.8 ppm indicate the coordination of 
one dimethylphenylphosphine molecule. The sum of all integrated protons shows that in 
addition to the C-H and 0-CH3 protons of the DMS dimethylester ligands and the CH3 
protons of the phosphine another constituent containing 6 methyl protons must still be co- 
ordinated. A possible explanation is that reaction of the solvent acetone with the ReN core 
leads to a Schiff base coordination sphere ReN=C(CH3)2. However, this formulation is 
still rather speculative and will be clarified by mass spectrometry and X-ray analysis. 
Fig. 3: IH NMR spectrum of B in DMSO-D6 
Alternatively, a nucleophilic attack by the free triphenylphosphine ligand on the nitrido 
group could be assumed. Such a reaction has been observed between m Re(V)nitrido corn- 
pound and triphenylphosphine [l]. However the concomitant v(N-P) vibration at 1134 cmm1 
was not found for the complex under investigation. 
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26. TECHNETIUM(V) COMPLEX WITH MESO-2,3-DTMERCHTOSUCCINIC 
ACID MONOHEXYLESTER FOR ARTERIOSCLEROTIC PLAQUE 
ACCUMULATION 
B. Noll, H.-J. Pietzsch, H. Spies, L. ~ inke lbo r~ l ,  B. Johannsen, W. ~ernmlerl 
11nstitut fiir Diagnostikforschung Berlin 
Proceeding from the assumption that the presence of a carboxylic group and a longer alkyl 
chain in the ligand molecule of complexes fulfil the requirements of arterirasclerotie plaque 
accumulation, the complexation reaction of 2,3-dimercaptosu~cinic acid (DMSA) monsl- 
hexyl ester with technetium and the biodistribution of the resulting product were investi- 
gated. Since DMSA forms stereoisomers of a 2: 1 TcvO complex [TeO(DMSA)2]- with sul- 
phur coordination and four unbounded carboxylic groups [l], a corresponding Tc(V) com- 
plex with two lipophilic alkyl ester groups is expected when the monoester of DMSA con- 
taining a lipophilic alcohol is used as ligand. 
The TcVO complex with 2,3-dimercaptosuccinic acid monohexylester was tested for its 
ability to be accumulated in arteriosclerotic plaques. 
Synthesis involves conversion of meso-DMSA into its anhydride by acetyl chloride and sub- 
sequent reaction with n-hexanol. 
m ~ c o o *  CH3COC1+ n-hexanol COON 
coo* / " c*o 
Experimental 
2,3-dimercaptosuccinic acid anhydride: 
1 g 2.3-dimercaptosuccinic acid (DMSA) is suspended in 250 m1 acetylchloride and re- 
fluxed for 16 hours. Over this period the acid dissolves. Subsequent evaporation of acetyl- 
chloride and lyophilization of the yellow residue gives the crude product. 
2.3-dimercaptosuccinic acid monohexylester: - 
1 g of the crude 2.3-dimercaptosuccinic acid anhydride is suspended in 40 m1 n-hexanol. 
The reaction mixture is heated at 100 - 110 OC for 4 hours while stirring vigorously. 
Over this period the product dissolves. After standing overnight the solvent is evaporated in 
vacuo. The residual oil is treated with n-heptane. As a result a white wax product is ob- 
tained. A k r  washing with n-heptane the substance is dried in vacuo. 
Yield: 38 % related to DMSA 
Elemental analysis (Calc./Found, %): C 45,1/45,6; H 6,8/6,9; S 24,1/24,2 
IH NMR (chloroform): 
1 
3 1 3,6 P P ~  (2H) 
" f c ; ~ ~  
2 34 1096 2,44 2  ppm (1H) 2 H
Hs c,o 8 5 127 PPm(2H) 
7 6-8 1,3 PPm 
9 029 PPP (3H) 
Complex formation with technetium(V) at c.a. level 
Complexes were prepared at 1,3 X 1 0 - ~  M by ligand exchange reactions starting from the 
Tc(V) gluconate precursors with varying molar ratios ligand 1 Tc in the range from 1:l to 
10:l. Thin layer chromatography, electrophoresis and UVIVIS spectroscopy were used to 
investigate the complexation and to characterize the products in solution. 
Ligand exchange reaction with technetiumm gluconate at n.c.a. level 
1 mg monohexyl ester of DMSA dissolved in 100 p1 ethanol is added to 2 m1 9 9 m ~ c  gluco- 
nate prepared according to [3]. After 15 min. the reaction mixture is ready for injection. 
Biodistribution of 9 9 m ~ c  DMSA nwnohexylester 
Biodistribution and elimination were investigated in mice. 74 kBq of the complexes were in- 
travenously injected into mice. The animals were sacrificed after 0.5, l, 3 and 5 h. The 
percentage of the injected dose (% ID) as well as the percentage of the injected dose per 
gram of tissue (% ID/g) were determined. Accumulation in ateriosclerotic lesions was de- 
termined in aortae derived from WHHL rabbits. 74 MBq of the complexes were intrave- 
nously injected into WHHL rabbits. 5 h later the rabbits were sacrificed, the aorta removed 
and a sudan-111-staining as well as an autoradiography were performed, 
Results and discussion 
Ligand exchange of Tc(V) gluconate with an excess of 2 .34imer~tosuccini~ acid mono- 
hexyl ester gives two products with a IigandITc ratio of 2: 1 having an absoqtion mairntam 
in the UVNIS spectrum at 420 nm (E = 2580 I/mol-cm), With a molar ratis of 1: 1 about 
50 9% of the Tc g3ucsnate complex (Rf = 0) was found because of an heomplete exchange. 
The occmrence of ltws components separated by TLC (silimge1JlethmoBBwater 955  (Fig. 
1)) may be expfahd by the fwa t ion  of komeric forms, Isomers are oirxpeett3wl to be ei&er 
ck-tram forms remding the position of the ester groups or stereoisom~r~, as obsewed m- 
lier for Te manplexes with DMgA and it9 ater  f l] 
There is no difference in composition between the complexes prepared at c.a. and n.c.a. 
level. 
Fig. l: Separation of the reaction mixtures of ligand exchange Tc-gluconate / DMSA 
monohexyl ester for various molar ratios, by thin layer chromatography on silica 
gel(Kieselgel60/Merck) and ethanoVwater 9515 (v/v) as the eluent. 
The 99mTc tracer is poorly eliminated via the kidneys (5 h p. i. : 3 % ID). 5 h p. i. accumu- 
lation in the liver (5 h p.i.: 32 % ID) and in the intestines (5 h psi.: 24 % ID) is high. The 
ratio of accumulation of the DMSA monohexylester between the arteriosclerotic lesions and 
normal vessel walls was > 10, as estimated by a~toradiograph~. The total amount of Tc- 
99m-DMSA monohexylester in the arteriosclerotic lesions was not significantly higher than 
it was with our alternative tracer candidates, such as the T C - N - ~ ~ ~ ~ ~ - M A G ,  complexes [4]. 
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27. ESTER-BEARING OXORHENIUM(V) COMPLEXES - 
SMVTHESIS, CHARACTERIZATION AND REACTIONS 
H. Spies, Th. Fietz, H.-J. Pietzsch, D. Schellerl 
Technische Universitiit Dresden; Institut f ir  Analytische Chemie 
Introduction 
The biodistribution of Tc/Re tracers may be influenced by built-in ester groups provided the 
ester is capable of being cleaved enzymatically in vivo [l]. It is therefore necessary to cany 
out studies on enzymatic cleavage in order to enlarge our rather limited knowledge of the 
conditions and structural requirements essential for cleavage of this special type of com- 
pounds, where the ester groups are linked to metal complexes. 
This article describes the preparation and characterization of a series of rhenium complexes 
as substrates for hydrolysis experiments with esterases. The neutral oxorhenium (V) com- 
pounds contain mercaptoacetic 1 and thiomalic acid esters 2 as constituents, The alcohol 
component is systematically altered from cl to c6. 
SH SH COOR 
Experimental. 
(3-~iiapentane-l.5-dithioEat0)[~ethx~pcarbony~) ~ethafzethi~~toJoxa~hd~"1furn~ &g 
28.8 mg (186 pmol) "H2S3* and 22.4 mg (186 pmef) h are mix& in inbapat I mL awtoni- 
trde and added to a cooled (8°C) and st&d solation of 100 mg (586 pmoI] 
[N23zEtt,3LReQCf,f in 1 1 acetsnitrib. Then one drop of eiethylmine is addd  to the re- 
action mixture, %@ coloar of &e mktu~e turns dark brown, sowe i~i801ubIe by+prod8?ic& 
are deposited, After kzfir;~ two horns of gtining, the sol~$~nt  is wnmptf:&By remov& a ~ d  &E 
raw produet digss1vM in a sm31 vaIume of heat$ ~hl~roform,. The i a ~ ~ ~ l u b b  residue is re- 
moved and the solution purified by column chromatography (silica gd, chlor~form). On re- 
ducing the solvent to a small volume, 50 mg (57 %) of the pure product is ob~tained. 
In the same way the compounds 3b-3i, 6a and a. are obtained in yields from 30 to 55 %. 
(3-~iapentane-l.5-dithiolato)[(N-mo7pholinocarbonyl)methanethblato]oxorhenE'um~) 3: 
100 mg is dissolved in 5 mL chloroform, 10 drops of morpholine are added and the mix- 
ture is refluxed for 15 hours. The product is purified by preparative thin-layer chromatog- 
raphy using silica gel and chloroform/ethanol 3: 1. The yield of the pure cofngsund was 33 
mg (35 %). 
Results and discussion 
The ester complexes 3a-3h as well as 3, which contains mercaptoacel;ic acid, were obtained 
as analytically pure solids by reacting tetrachloro-oxorhena:te(V) with biis(2-mercapto- 
ethy1)sulphide (HS-CH2-CH2-S-CH2-CH2-SH; "H2S3") and the respective mercaptoacetic 
acid ester I. When using bis(2-mercaptoethy1)ether (HS-CH~-CEI~-O-CH~CH~-~H; 
"W2SOS ") and l, the corresponding complexes and are formed. However, attempts to 
isolate the latter compounds in crystalline form have failed up to now. 
3a-3 X=S - - 5 R' = N-morpholino~ 
4a, X=O -
(For nomenclature of R see la-li) 
For examination of the reactivity of the ester function, mainly to establish the possibili~ of 
coupling the chelate to the amino group of biomolecules, we tried to convert &e compounds 
into arnides. For this puspose, we added an excess of morpholine to a solution of complex 
3a in chloroform and left it at room temperature for a f m  days, When thin layer chroma- -
tography (chlorofom/ethanol 3: 1 vfv) showed insignificant changes of the ester complex, 
the mixme was refluxed. After a few hours no more - 3a was detectable by TLC. The mar- 
pholide 5 was purified by preparative TLC (chlor0fonnleth~~~l3: 1 v/V) to give light brown 
plates. ~&xing oily with morpholine resulted in decomposition of complex. 
6a R = CH, 
6b R = C2H5 
6c R = H  -
A second group of complexes 6 derives from thiomalic acid. The esters and 23 were 
synthesized by bubbling dry HCI into solutions of the diacid in the respective alcohol and 
purified by vacuum distillation &: b.p.,: 97 "C; B: b . ~ . ~ :  95 - 100 "C). Reactions of the 
esters with "H2S3" and ReOC14- give the products l& and f& which were purified by col- 
umn chromatography with chloroform. Compared with &, @ shows a significantly lower 
Rf value due to its increased polarity. The diacid complex & was eluated from the column 
by water. It has not yet been possible to crystallize this compound, but it can be used as a 
standard in saponification experiments. 
Table 1: List of compounds and selected analytical data. All compounds listed in Table 1 
have satisfactory elemental analysis. 
The compounds 3a-3i, f& and 6b show very similar spectroscopical properties. Their 
UV/VIS spectra in acetonitrile exhibit four peaks between 498...504 nm (log E = 
2.1.--2.3), 372-.-375 nrn (log E = 3.4.--3.61, 258.~~262 nrn (log E = 3.8-.-3.9) and 
228s.-230 nm (log E =  4.0-a.4.2). In the spectrum of 5 in acetonitrile, only two peaks are 
visable at 502 nm (log E = 2.2) and 378 nm (log E = 3.5), whereas the other two bands are 
transformed into shoulders. 
The 1H NMR spectra of 3a and 6b have been recorded in CD,CN. exhibits values for 
the protons of the tridentate ligand which are comparable to those of other "3 + 1 " com- 
plexes: 1.98...2.05 pprn (2 H); 3.11-.-3.19 ppm (2 H); 3.93s.-3.97 pprn (2 H); and 
4.28~---4.33 pprn (2 H). The methyl group of the ester function is depicted at 1.27... 1.30 
ppm; the ester's methylene protons at 4.21 .S-4.23 ppm (2 H) and the methylene protons of 
the mercapioacetic acid at 3.76 pprn (S, 2 H). 
The proton signals of the tridentate ligand in Cib are exhibited at 1.85.--2.25 ppm (2 H), 
among two large assemblies of signals between 2.80 and 3.40 pprn and 3.82 and 4.45 ppm, 
respectively; each accompanied with signals of the CO-ligand's protons. The methyl protons 
of tlme two ester groups are seen at 1.16-- - 1.35 ppm (triplet of doublets, 6 H) whereas the 
single proton near the sulphur atom of the CO-ligand is depicted at 5.3 -5.5 1 ppm (q; 1 H). 
The methylene protons of the ester functions arle accompanied with signals of the tridentate 
ligand between 3.82 and 4.45 ppm; whereas the methylene protons of the thiomalic acid are 
very closed to another signal group of the tridentate ligand between 2.80 and 3.40 ppm. 
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28. ROLUSIS STUDIES OF ESTER SUBSTITUTED OXORHENIUM(V) 
c0haPmXEs 
S. Seifert, R. Syhre, Th. Fietz, H. Spies 
In connection with m work on technetium and rhenium tracers with metabolizable ester 
functim El], preliminary studies were carried out preparatory to the proposed investiga- 
t i~ns  into ewmatic deavage af ester groups in Tc and Re chelates, This includes installa- 
tion of an WPLC system suitable for evaluating the cleavage reaction and characterizing the 
reaction products, chemical saponification experiments, and elaboration of a procedure for 
measuring enzymatic cleavage of the proposed chelate-bound ester groups. The compounds 
used (1-9) are neutral oxorhenium(V) complexes with tridentelmonodente sulphur donor 
ligand coordination, having metabolizable ester functions at the monodentate ligand; they 
are listed alongside the structure of the complexes- 
CWR Tridentate ligand: bis(2-mercaptoethy1)sulphide 
(HS-CH2-CH2-S-CHrCH2-SH; "HS3H ") 
o Monodentate ligand: mercaptoacetic acid (l) or its esters R (2)-(9) 
Experiments 
The Re complexes were prepared by ligand exchange reaction starting with tetrachloro-oxo- 
rhenate(V) as described in [2]. 
For characterization by HPLC 1 - 2 mg of the pure complexes containing various ester 
groups were dissolved in 0.5 m1 acetonitrile. The HPLC analyses were carried out with a 
PRP-1 column (Hamilton, 150 X 4.1 mm) using an isocratic mixture (AIB = 30170) of 0,l 
% trifluoroacetic acid in water (A) and 0.1 % trifluoroacetic acid in acetonitrile (€3). The 
effluent from the column (flow rate 2 ml/min) was monitored by UV absorbance at 370 nm. 
For hydrolysis studies the pH of the samples was adjusted to 12 by adding 0.1 N NaOI-I. 
To determine whether or not the ester bond in the Re complexes was susceptible to cleavage 
by esterases, we carried out incubation experiments with blood plasma of rats and humans, 
diluted 50/50 with phosphate buffer of pH 7-4, and pig liver esteme dissolved in the same 
buffer. 0.05 m1 of the complex solution was generally added to 0.45 m1 of the esterase- 
containing samples. The complexes were incubated at 37 "C for 10 - 1126 minutes. After in- 
cubation the samples were fifered through a 0.22 pm cellulose acetate filter and analymd 
by HPLC. 
Results and discussion 
Fig. 1 shows chromatograms of (2) and the eo~~esponding complex with merc@~oam~c 
acid (l) as fie monoden- ligmd This mmplex was obtaipted by direct preg~n%ation as; we18 
as hydrolysation in alkaline solution, Pox esmplete: hydrolysation of the wte~-gro~-c8n~aian~ 
ing ligand the so"dution bm to ba heated far several hours. Far ins&nce, at bast 48 h at. pH 
12 and room temperature are r e q ~ r d  in order to conuert about 50 % of (21 80 (l), 
Fig. 1: HPLC chromatograms of (2) (I), a hydrolysation mixture 
(48 h, pH 12,22 "C) (11) and (1) (111) 
The retention times of the various complexes parallel their lipophilicity on account of the 
greater chain lengths of the ester groups (Table 1). 
Table 1: Rt-values of the Re complexes as a function of the length of the alkyl residues 
It is remarkable that complexes with n-dkyl groups are eluted faster than Con- 
taining the corresponding  SO-dkyl residues. This behaviour could be caused by the steric 
configuration of the a%$ groups in the ester molecule and by their interaction with the col- 
umn material. Whether the increasing retention time does, in fact, correlate with the lipo- 
philicity of the compounds remains to be proved. 
The enzymatic hydrolysis of the monodentate ligand was investigated using the ethyl, n- 
propyl, and n-butyl esters of mercaptoacetic acid. In rat plasma the cleavage of all ester 
complexes proceeds quickly. After five minutes of incubation the esters are quantitatively 
hydrolysed. In human plasma solutions, on the other hand, the complexes differ in their hy- 
drolysis behaviour. The ethyl ester complex is only partially hydrolysed ( ~ 4 0  %) after two 
hours' incubation time, while a complete cleavage is observed for the propyl and butyl ester 
complexes as shown in Fig. 2. 
Fig. 2 HPLC chromatograms of the ethyl (I), n-propyl (II), and n-butyf (111) ester 
complexes after incubation in human plasma (phosphate buffer pll7.4,37 "C, 2 h) 
Differences in hydrolysis are also observed after incubation with pig lives ersterae (Fig, 3). 
While two hours after incubation all three ester comglexw are qwntitati~ely hydrcstyzd, 
the HPLC chromatograms after 10 minutes still show portions of the ethyl and butyl ester 
complexes. 
In summaryf one can say that the hvestigated e~tomplexe with one ester groap at the 
BEerenm in the kinetics of &e emymatie hydroliges smd'rd ril m& p@&%% human plsma 
and pig liver- esterase point m spec-Is-re1.akd differenm bemeen the ewme sys~im wed, 
Fig. 3: HPLC chromatograms of ethyl (I), n-propyl (II), and n-butyl (111) ester 
complexes after incubation with pig liver esterase 
(phosphate buffer pH 7.4, 37 "C,  10 min) 
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29. TME LABELLING YIELD OF THE TECHNETIUMmMAG3 AS A 
mJHVCTION OF THE CONTENT OF MERCAPTOACETYL 
TRIGEYCINE DISULPHIDE IN THE MAG3 KIT 
B. Noll, St. Noll, B. Grosse, K. Landrock, A. Teich, H. Spies, B. Johannsen 
0. ~ u t h l ,  K. ~antschl 
l ~ e r e i n  fur Kernverfahrenstechnik und Analytik 
Technetium-99m mercaptoacetyl triglycine ( ~ ~ ~ T c - M A G ~ )  has been used extensively as a 
renal function agent for several years. The commercial available kit prepared in Rossendorf 
is based on S-unprotected mercaptoacetyl triglycine. The use of S-unprotected ligand makes 
it possible to avoid heating the radiopharmaceutical preparation during the lab~elling proce- 
dure [l]. However, sulphhydryl group in MAG3 may be oxidized by air during storage to 
give MAG3 disulphide. The presence of MAG3 disulphide may effect the quality of the re- 
nal function agent, e.g. by decreasing the amount of stannous (11) chloride which acts as a 
reducing agent in the kit. For evaluation of the ~ ~ ~ T C - M A G ~  kit several impurities have to 
be taken into consideration: 
99mTc tartrate which serves as the precursor of the ~ ~ ~ T C - M A G ~  complex in the 
kit formulation, 
Pertechnetate caused by incomplete reduction of the 9 g m ~ c  generator eluate due to 
a decrease of the amount of stannous (11) chloride by oxidants like MAG3 disulphide 
and 
Tc-MAG3 complexes containing two or more ligands per technetium 
[Tc-(MAG3),]. Their content depends on the reaction time, the pH value and the 
total amount of MAG3 ligand [2]. 
The quality of the labelling product - the content of the desired Tc-MAG3 complex should 
be greater than 90 % and it should be free from pertechnetate - will also depend on the pu- 
rity of the MAG3 ligand. The occurrence of pertechnetate may be due to the presence of 
MAG3 disulphide. We therefore studied the influence of MAG3 disulphide on the labelling 
yield and the formation of by-products in commercial kits, 
The kilt preparations were carried out at the kit production facility. The content of MAG3 
disulphide in MAG3 ligand used was determined by polarography and HPLC. The radio- 
chemical purity of the radiopharmaceutical preparations was determined by TLC on silica 
gel // ethanollwater 9515 and by HPLC on RP18 column with phosphate buffer pH 5.85 // 
methanol 85/15 as the eluent. 
Labelling procedure 
A volume of 2 m1 generator eluate was added to the kit vial containing a lyophilized mix- 
ture of 0.2 mg MAG3, 22 mg sodium tartrate, 60 pg SnC12-2H20 and 1.6 mg NaOH. Af- 
ter 10 minutes 2 m1 isotonic sodium phosphate buffer solution, pH 7.4, was added to neu- 
tralize the solution. 
The labelling yields and -the contents of all radiochemical impurities of several kit series 
containing different amounts of MAC3 dlsulphide are shown in Table l. The radiochemimi 
impurities found in the g g m ~ c - ~ ~ ~ ~  preparations are the ~ ~ ~ T G - ( M A G ~ ) ~ $ ( ~  > 1) and 
free pertechoetate199m~c tartrate. 9 9 m ~ c  tartrate cannot be differentiated from pertechne- 
tate either by TLC or by HPLC [2] 
As shown in Tlabk 1, there is no sttong correlation beween ithe eanent of" MAG3 distnlphide 
and the labelling yield. Ef the kit conbim more tban 49 5% distzlphide the moulla of M A Q  
ligand is too small for a complete conversion of 99m~c into ~ ~ ~ T & M A G ~ .  
The occurrence of 9 9 m ~ c  tartratelpertechnetate in series 4 and 5 cannot be due to MAG3 
disulphide because its content is low. More likely, the decrease in the content of stannous 
(11) chloride in the kits was caused by air being present during manufacture of the kit for- 
mulation. 
Generally, it must be said that a high content of MAG3 disulphide decreases the labelling 
yield, while a low content of MAG3 disulphide (< 15 %) does not significantly influence 
the labelling yield of ~ ~ ~ T c - M A G ~ .  
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30. AN EFFICIENT HPLC-METHOD FOR DETERMINATION OF THE 
CHEMICAL PURITY OF HM-PAO LIGAND AND KIT PREPARATIONS 
S. Seifert, F. Schneider 
99mTc-d, l HMPAO intravenous injection is used for regional cerebral blood flow scintigra- 
phy. Commercially available kits (Ceretec, Neurospect) contain 0.5 mg of the ligand 
(RR,SS)-4,8-diaza-3,6,6,9-tetramethylundecane-,-dione bisoxime (d, l HM-PAO) per 
vial. The synthesis of the ligand HM-PAO results in a mixture of diastereoisomers, which 
are separated by repeateid recrystallization from acetic acid ethyl ester. 
Unlike Tc-d,l HM-PAO, the Tc complex with the stereoisomeric meso HM-PAO is weakly 
accumulated in the brain and the retention time is shorter [l]. A high stereochemical purity 
of d,l HM-PAO is therefore needed to ensure high quality kit preparations. The stereo- 
chemical purity of the samples of d,l HM-PAO obtained by recrystallization has to be de- 
termined quickly and reliably. HPLC analysis represents a suitable procedure as an alterna- 
tive method to 1 3 ~  NMR analysis, which is also used for quality control. An HPLC proce- 
dure was previously developed 121, but no separation conditions have been reported. 
We obtained good separation results using a normal phase NH2-modified silica gel column 
(LiGhrospher NH2) and gradient elution with a mixture of isopropanol and hexane. 
Separation conditions: 
Column: LilChrospher NH2 (250 X 4 mm) 
Eluant : Isopropanol (A)/hexane (B), gradient -4 
l0 min from 0 to 20 % A 
Flow rate: 1.0 mllmin 
UV detection at 210 nm 
Fig. 1 shows the HPLC patterns of meso and d, l HM-PAO as well as a mixture of both. 
The separation allows a quantitative determination of the isomer composition of the frac- 
tions obtained by repeated recrystallization. A comparison of HPLC and 1 3 ~  NMR analy- 
ses of three samples of HM-PAO demonstrates good conformity of the results (Table 1). 
Fig. 1 : HPLC chromatograms of meso (A), d, l (B) and a mixture (C) of WM-PAO 
Table 1: Comparison of HPLC and 1 3 ~  NMR analyses for determination of d,l HM-PAO 
content [%] of various samples 
The HPLC procedure makes it possible to determine the content of d,l HM-PAO of a kit 
vial. We now use this method for routine quality control of HM-PAO. In the case of our 
Neurospect preparations a ligand containing 94 96 d,l HM-PAO was usexcl, After lysphiliiza- 
tion the same yield was found by dissolving the contents of the vial in 200 pil me&ano1, $51- 
tering the solutim &rou$h a 0.22 pm cellulose acetate filter and performing RPLC analy- 
ses. This shows that the ligmd does not change its isorvlde cgrnpositio~. A co~npxison 
with Ceretec kits from Amersham showed no difference in the quality of the HM-PAO lig- 
and (Fig. 2). 
In order to obtain a radiopharmaceutical with a high degree of accumulation in the brain, lit 
is recommended that more than 90% of the HM-PAO ligand used for kit formulation be in 
the d,l form. 
Fig. 2: HPLC analyses of the d,l HM-PAO content of Ceretec and Neurospect kit vials 
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31. POLAR0 C DETERMINATION OF TIN@) IN WMPAO KITS 
I. Woffmann 
Stannous chloride is an essential constituent in kits for preparation of 9 9 m ~ c - ~ ~ ~ ~ ~ .  Its 
content is very low. Each kit vial contains 5....7.6 pg stannous chloride. Because the qual- 
ity of the radiopharmaceutical depends very much on the availability of "effective" stannous 
ions, a sensitive method is needed for selective determination of Sn(1I) as distinct from 
Sn(IV). While general methods are available to determine the total of the stannous and 
stannic content, electrochemical methods are preferred because they make it possible to dis- 
criminate between the oxidized and reduced forms. 
The article describes the determination of Sn(I1) in the presence of Sn(1V) at low concen- 
trations by DC polarography. 
Experimental 
Chemicals 
Supporting electrolyte: phosphate buffer (Sorensen) pH = 7.7 
For standard addition: 0.007 M solution of SnC12-2H20 (p.a.) in 0.1 M HCl 
HMPAO kits of varying Sn(I1) content 
All solutions were deoxygenated by argon (99.998 %). 
Apparatus 
DCIAC polarograph (GWP 673, ZWG Berlin) 
Results and discussion 
The half-wave potential of the Sn(I1) reduction step depends on pH. In phosphate buffer 
(Sorensen) pH = 7.7 this potential was found at -750 mV vs. SCE. No influence of HM- 
PAO can be observed because the half-wave potential of Sn(II)/Sn(O) is much more nega- 
tive than that of HMPAO reduction. The Sn(I1) clontent was determined by measuring the 
diffusion current. The proportionality of the Sn(I1) concentration (concentration range from 
10-6 M to 10-4 M) and the diffusion current was proved experimentally. At this low con- 
centration it is especially important to work in the absence of any traces of oxygen. 
For analysis about 5 m1 of buffer solution are filled into the polarographic cell, and oxygen 
is removed with argon. The base line is recorded in the potential range from -400 to -1208 
mV vs. SCE. The solution is bubbled with argon until no reduction wave of dissolved oxy- 
gen can be observed. 4 m1 of this solution are injected into the kit. After solution of the 
substance 3.5 m1 are transfered into the cell. Traces of oxygen are removed with argon, and 
the polarogram is recorded in the same potential range. By compensation of the load current 
the diffusion current of Sn(1I) was made independent of potential. The Sn(I1) content is de- 
termined by addition of small portions of Sn(l1) standard solution (see Fig. l).The Sn(1I) 
content of the standard solution was determined iodometrically. 
The results are summarized in Table 1. The SnCI2 content of about 2.5 pg can be deter- 
mined with an error of f 10 %. The detection limit for the Sn(I1) content was found to be 
about 0.2 pgikit. The kits A, B, C contain additional Sn(I1). The experimentally determined 
SnCl2 content is about 5 pg lower than the original value at a concentration of 7.6 pg and 
higher (samples A, B, C and 1-9). With smaller original amounts of SnC12 and 3.8 pg) 
the losses of Sn(l1) are lower, as shown by Table 1. It can be assumed that the differences 
in content of Sn(I1) are caused by oxidation during preparation of the kit. At this low con- 
centration an additional small decrease can be observed during repeat& mauremena be- 
cause Sn(1I) is reduced at the dropping mtcury electrode. 
Fig, 1: DC polarogram of the reduction wave of Sn(I1) in HMPAO kit (-) and after 
addition of Sn(1I)-standard solution (-----) ( ~ ~ ~ ( 1 1 )  = 5 X 10-6 M in 
phosphate buffer (Sorensen) pH = 7.7) 
Table 1: Theoretical and polarographically determined Sn(I1)-content in various vials of 
7.6, 5.0, 3.8 pg batches (1-1 1) and of additional Sn(I1) (A, B, C) 
Preparation Sn(I1) content [ pg SnC12 2 H20 ] 
theoretical polarographically determined 
Kit A 17.6 12.6 
~ Kit B 26.6 
Kit C 45.6 41.5 
Kit 1 7.6 2.5 
1 Kit 2 7.6 2.6 









32. ISOLATION AND CULTURE OF CELLS DERIVED BROM A BRAIN 
MICROVESSEL PREPARATION 
S .  Matys, U. Wenzel, G.  Kampf l ,  R. Bergmann, B. Ahlemeyer and P. Brust 
1 Dresden Technical University, University Clinics, Clinic of Nuclear Medicine 
Introduction 
~adiopharmaceuticals designed for studying the functions of the central nervous system 
have to pass the so-called "blood-brain barrier" (BBB) between the circulating blood into 
which the tracers are normally injected and the brain where they accumulate depending on 
the metabolism of the different brain cells. Morphologically, the BBB consists of brain 
endothelial cells which are joined together by tight intercellular junctions. In the pat ,  
information about the accumulation of radiopharmaceuticals in the brain w a  obtained from 
animal experiments, such as biodistribution studies or in vivit, meaurements of BlBB 
transport. Recently, there have been attempts by several groups to study the function of the 
BBB in vitro [l]. The basic problem of these studies is the induction of tight junctions on 
cultured brain endothelial cells to obtain a high transendothelial resistance. Dehouck et al. 
[2] describe induction of tight junctions during CO-culture of bovine brain sndothelial cells 
with rat astrocytes. Using this model, the authors studied the transport of various 
pharmaceuticals and obtained a correlation between in vivo and in vitro data [3J. The 
present study was performed in order to establish a similar model for measurement of the 
BBB transport of radiopharmaceuticals. In most cases preparations of brain microvessels are 
used to obtain endothelid cell cultures I4 - 61. Our method follows a similar strategy. 
Materials and methods 
Preparation of isolated capillaries ffom rat and pig brain 
The experiments were undertaken in order to find the best method for isolation of brain mi- 
crovessels. The experimental procedure was varied using different physiological buffers 
(sucrose, Krebs-Ringer salts) and medium 199 with 15 mM HEPES. Rat and pig brains 
were stored in ice-cooled buffer or medium 199 (Tecnomara) with 15 mM ~ ~ ~ ~ S - b u f f e r  
(Boehringer Mannheim). After weighing, the cortical tissue was homogenized in buffer or 
medium 199 in a volume 9 times greater than the initial volume of the tissue. 
The tissue was homogenized using a syringe with a Luer-Lock conus and then pressed 
through nylon filters (SST Thal) of various pore sizes (125 pm - 225 pm). 
The remaining capillaries on the filter Were collected, diluted with fresh buffer or medium 
199 and centrifuged at 150 X g for 5 - 10 minutes at 4 OC. The pellet was resuspended in 
DMEM, RPM1 1640 or medium 199 with 10 % fetal calf serum (Sigma) and seeded in 
plastic culture flash (25 cm2, Primaria, Falcon). 
Fig. 1: Isolated capillaries from rat cerebral cortex (magnification 1:25). 
Preparation of brain celb from rat cortical capillaries by ertzymtic digestion 
Isolated capillaries of rat cortex were centrifuged for 5 - 10 min at 150 X g and 4 "C and 
resuspended in medium 199 containing 200 Ulml penicillin, 1 200 pglml streptomycin 
(Serva). The suspension was incubated at 37 "C in a shaker after addition of 1 % 
collagenase/dispase (Boehringer Mannheim) for 2 - 3 h. The digestion process was observed 
using a phase contrast microscope. The suspension was centrifuged for 5 - 10 min at 150 x 
g and 20 "C a d  the pellet was washed twice with 2 m1 medium 199. 
Following thii, the pellet was resuspended in medium 199 with 10 96 neonatal calf serum 
(Signa) and 15 mM HEPES and layered onto a preformed 35 5% percoll gradient (Sigma) 
[7] and then cautiously centrifuged for 10 min at 1000 X g and 20 "C . Two fractions were 
separated from the gradient, the lower band containing the brain cells was washed three 
times with medium 199 with neonatal calf serum (10 2%). The upper band consisted of cell 
debris. 
The mixture of brain cells was again centrifuged and resuspended in medium 199 conwining 
10 2% fetal calf serum (Sigma), 2 ngJml basic fibroblast growth factor (Sigma) and Pm 
U/m1 penicillinllOO pglml streptomycin. The cells were seeded in 1 9% gelatine (Sigmal- 
coated petri dishes (8 cm2, Primaria, Falcon), U~coated petri dishes were used as a conrol 
for cell attachment. The cell cultures were passaged weekly and exmind using a p h ~ e  
contrast microscope, AB immunohistochemical charaeterhtion of the cells with specific 
antibardies to detect ~0nt;tminating cell types will be neetitssay before swing  f d e r  
eexper imenb . 
Fig. 2: Third passage of brain cells from rat cerebral cortex after 4 days in culture 
(magnification l :4) 
Results and discussion 
In our studies the use of the percol1 gradient proved to be suitable for separation of viable 
cells from cell debris. The best ~ ~ u l t s  in terms of tissue preparation and cell growth Were 
obtained with medium 199. Coating the culture flasks with gelatine increased cell adherence 
and proliferation. Passage of the cell cultures was not always successful. Very low seeding 
densities led to a stagnation of cell proliferation. It is our intention to optimize the method 
of cell preparation and culture conditions, e.g. by addition of endothelial growth factor and 
heparin to the culture medium. 
Further investigations will be aimed at growing cell cultures of pig endothelial cells with 
and without ~ ~ c ~ l t u r e  of WocYtes and neurons to obtain an in vitro model of the blood- 
brain barrier. 
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33. DEVELOPMENTAL CHANGES IN ENZYlMES INVOLVED IM PEPTIDE- 
DEGRADATION IN ISOLATED RAT BRAIN MICROVESSELS 
P. Brust, A. ~ e c h l  and R. Bergmann 
1 University of Leipzig, Department of Biosciences 
The endothelial cell layer of brain capillaries representing the blood-brain barrier @BB) is a 
target for some endogenous peptides [for review see l]. Circulating peptides interact with 
specific binding sites on brain endothelial cells [2,3], and the metabolism of peptides is a 
prerequisite for the BBB to be a regulatory interface. Several peptide-metabolizing emyynes 
have been detected in the cerebral microvasculature [for review see 43, Membrane-bound 
peptidases may control the biological activity of peptide molecules when they contact the 
endothelial wall or pass through the BBB. 
Recently, labelled somatosfatin analogues have been used as an irnaging modality for in 
vivo localization of somatostatin receptor-positive tumors, which were found also in the 
brain [5-73. Stability against degrading enzymes is a prerequisite for these tracers to be ;of 
clinical interest. 
In this study, we have measured peptidases expected to be inv~lved in the degadatisn of 
somatostatin in the rat brain and in brain microvessels derived from the rat, Until now, it is 
still open whether the peptidases are equally distributed in the different cdlula compart- 
ments of the brain (e.g. neurons, glial cells, endothelial m11~). Therefore, we have eb08r:w 
these two preparations. In addition, rats of different ages were wed to Gad out twhe&er de- 
velopmental changes in the enzyme activities exist as has alrmdy been dac:rib& for 
BBB marker enzyme gammaag1utamy1-&%n$peptidiis@;, 
md metho* 
M& and femaie Wism rats (equally dis~ributed) i~ groups of 4 differ~at ages (6 - 8, 13 
15, 26 - 30, 54 - 58 days) were used, Brain mgilliarlm tvere kola&d m d&crib& by %I&@ 
et a1, {this volume), TMs pgepwatie~ consisM primwity of ~apiilmies but also wa@iad 
m i m  man& of snnaltli zt@rlolm?;, 7 % ~  puriv af aacB ~CI IOV&~& &&ction m wnfumed 
by light microscopy and the enrichment in alkaline phosphatase and y-glutamyl transpepti- 
dase activities. Three different isolation procedures wefie performed for each group of ani- 
mals. The number of brains pooled at various ages was for each experiment: 30 - 35 (d,ays 
6 - 8), 20 - 25 (days 13 - 15), 13 - 17 (days 26 - 30) and 12 at days 54 - 58. 
Enzyme measurements 
g-Gl~tamyltran,.rferase (g-GT) 
g-GT activity was measured at 25 OC, in Tris buffer (100 mmolll) pH 8.25 with 6.0 mmolll 
L-g-glutamyl-3-carboxy-4-nitroanilide as donor and glycylglycine (150 mmol/l) as acceptor. 
The increase in absorbance was measured continuously at 405 m. The enzyme activities 
- 8.800 mol-l X cm-l. were calculated using an e,=,,, ,
Alkaline phosphatase (ALP) 
ALP activity was determined at 25 OC, in diethanolaminle buffer (1.0 molll) pH 9.8 with 
hIg++ (500 mmolll) and as substrate 10 mmol/l p-nitrophenylphosphate. The increase olf 
absorbance was measured continuously at 420 nm. The enzyme activities were calculated 
using an ej=420 , = 17.300 mol-I X cm-l of 4-nitrophenol. 
Amino peptidase A (APA), amino peptidase M @PM), and dipeptidyl-dipeptidase IV (DPEV 
The different enzymes were measured using L-glutamic a~id-4-rn~th~~~-2-~aphtylamide 
(APA), L-leucine-2-naphtylamide (APM) and glycyl-proline-4-methoxy-2-naphtylamide 
(DP IV), respectively, as substrate (40 mM) in phosphatle buffer (100 mM, pH 7,4) for 1120 
to 240 min at 37 OC. After incubation (end volume 574) p1) the samples were mixed with 
500 @l Fast Blue B (1 mglml) for 5 min at room temperature. The protein was 
with trichloro acetic acid (50 gll). The same volume (1500 of ethyl acetate was added to 
the supernatant, mixed and centrifuged. The organic phase was measured at 525 nm (d = 1 
cm). The activity was calculated using standards of 4 - m e r t h o ~ y - 2 - ~ ~ ~ h t ~ l ~ ~ i d  (MNA). 
Protein determination 
Protein was measured with the protein assay kit from SIGMA after solubilization with de- 
oxycholate and precipitation with trichloroacetic acid according to Lowry. 
Results zurd discussion 
Alkaline phosphatase and GGT are known as BBB specific enzymes. Enrichment of these 
enzymes is used as a measure of the enrichment of the microvessel fraction obtained frrom 
brain tissue. The activities of GGT and ALP in the brain cortex and cortical microvesseI~ of 
rats of difEerent ages are shown in Tables 1 and 2. The enrichment of these enzymes in rthe 
microvessd fiaction is between factor 7 and factor 33, which is in accordance with 
studies 18-$01. It confirms the suitability of our method for obtaining a highly enriched 
capillary fraction of the brain. 
Developmental changes of the specific activity of GGT have already been described 
[50,111]. It was co~~luded  that G ~ ? '  might be considered an element involved in the mam- 
ration of the BBB [10]. However, in that study the number of observations was too small to 
perform a statistical analysis. In our investigation we obtained similar results (Table 1). A 
significant increase of GGT activity during the first 30 days after birth was observed. In 
contrast, the ALP activity in microvessels increased between day 7 and day 14, and de- 
creased between 2 and 6 weeks (Table 2). In the cortical tissue the ALP activity tended to 
decline. 
Table 1: Specific activity of y-Glutamyl transpeptidase measured at 25 OC in isolated rat 
brain microvessels and total brain homogenate 
Results are expressed as mean f S.D. Number of determinations is shown in parentheses, 
Table 2: Specific activity of alkaline phosphatase measured at 25 OC in isolated rat brain 
microvessels and total brain homogenate 
ap 5 0-01 
Results are expressed as mean f S,D. Humber of determimtiom is shown in psantheges. 
Until now only a few data are available about develogmepf@I changes of the speciEc activi- 
ties of peptidass in the brain, Thus, Bamh et al. [P21 r9;pofi &at peptiibm in the mouse 
brain display4 differendad ontogenie profilm and spwuiat: an a puative roie of the en- 
q m m  maturilti~n or diff~ren~ation psseessa. 
The distribution of the various peptidases measured in this study was similar in the cortical 
tissue and the microvessels. Only a small enrichment in the microvessel fraction was ob- 
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Fig. 1: Specific activity of dipeptidyl aminopeptidase IV measured at 37 OC in isolated 
rat brain microvessels and total brain homogenate of rats of different ages 
Age (weeks) 
Fig. 2: Spmific activity of aminopeptidase M measured at 37 OC in isolated rat brain mi- 
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Fig. 3: Specific activity of aminopeptidase A measured at 37 OC in isolated rat brain mi- 
crovessels and total brain homogenate of rats of different ages 
Also, the changes of the specific activities of these peptidases during development are simi- 
lar in both preparations. We found a 5-fold increase in the activity of the membrane-bound 
serine peptidase dipeptidyl peptidase IV (DP IV; E6 3,4.14,5) during the first W0 months 
after blirth (Fig. 1). This is in contrast to immunohistochemical studies in which the DP I V  
activity in brain capillaries appears to decline after birth in humans and rats [13,14]. In 
mice the specific activities of DP IV and the mefalloemyme aminopeptidae M (APM; BC 
3.4.11.2) did not vary significantly from day 9 before to month 2 after birth [12], The sen- 
sitivity of the various methods and species-related differences may awunt  for this discrep- 
ancy. Fig. 2 shows that APM activity in brain tissue and microvessets increases by factor 
1.5 and 2, respectively. The aminopeptidmtse A (APA) activity d e e r e ~ ~  bemeen day "and 
day 14 after birth and increases thereafter. 
Cerebsovascular APM and DP IV are probably involved in the mrs&bolism of somatosatie 
[4,15], a peptide whieh has been found to have an inhibitory effeet on the growh af vaiopas 
tumours L16J. The developmenra3 changes of the activitie of both emme% may be of im- 
portance for the evaluation of the &~,rapeudc and diagnostic use of sofniatos&ti~~ and S Q ~ B -  
tostatin analogues. 
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34. CHARACTERIZATION OF SEROTONIN UPTAKE SITES ON 
ISOLATED BRAIN MICROVESSELS 
R. Bergmann, R. Berger and P. Brust 
The blood-brain barrier (BBB) represents a complex epithelia1 interface in vertebrates that 
separates the blood compartment from the extracellular fluid compartment of the brain [l]. 
Isolated microvessels represent a tool to study the function of this interface in vitro [2,3]. In 
the past they were used to characterize binding sites for different hormones and neuro- 
transmitters [l ,3,4]. 
It was shown that imipramin blocks the neuronal uptake of the neurotransmitter serotonin 
[5]. High affinity 3~-imipramin binding was used to characterize the distribution of sero- 
tonin uptake sites in the mammalian brain [6,51. However, until now there has been no data 
about the binding of 3~-imipramin on brain endothelial cells. Here we report on attempts to 
characterize serotonin uptake sites on microvessel preparations from the pig hippocampus. 
eri& and methods 
f i e  hippocampi of about 100 pig brain hemispheres were used for the study. Microvessels 
h m  this material were obtained by a sirniliar procedure as described by Matys et al. (this 
volume). The mi~rovesseis and hippocampal tissue were homogenized in 10 volumes of ice- 
cold buffer (10 mM sodium phosphate containing 0.32 M sucrose, pH 7.4) with an Ultra- 
Turrax T25. The homogenate was centrifuged at 20.000 g for 10 min. The resulting pellet 
was resuspended with the Ultra-Turrax and centrifuged again at 20.000 g for 10 min. After 
repeating the same procedure the pellet was resuspended in 10 volumes of buffer and stored 
at -20 OC until use in the binding studies. 
Fig. 1: Time dependency of 3~-imi~ramin binding to membranes from pig hippocampus. 
The time dependency of imipramin binding was studied on membrane preparations of hip- 
pocampal tissue (0.4 ml; 0.2 mg protein). The samples were incubated at 4 for various 
periods with [2,4,6,8-3~]imipramin hydrochloride (888 GBqimmol, Amersham) in the 
presence and absence of a 10,000-fold excess of unlabelled imipramin. For inhibition 
studies samples of microvessels (0.4 ml; 0.05 mg protein) and hippocampal tissue were in- 
cubated at 4 OC for 60 min. The binding assays were terminated by rapid filtration through 
GF/B glass fibre filters (Whatman, Maidstone, EngIand). The filters were rapidly washed 
with four 4 m1 portions of ice-cold buffer, transferred to 18 mP scintillatiarn fluid QUftima- 
Gold, Packard) and analy%ed for radioactivity. Aliqusts of the in~ubatim fluid were meas- 
ured as well. Corrections were made for binding of 3 ~ - i m i ~ m i n  re, the filzer5, The pmkin 
content of the membrane suspensions was atimat&$ acmrding to the method of knrwsy et 
al. [8j. Tht= enrichment of the capillary fratiom d~ermined by nnmuremen~ of dk1irne 
phosphatase activity was 28-fold, 
Fig. 2: Relationship between 3~-imipramin binding and protein concentration 
Results and discussion 
The time dependency of 3~-imipramin binding to membranes from the pig hippocampus is 
shown in Fig. 1. Equilibrium is reached at about 30 minutes. Therefore, in accordance with 
other studies [6,9] an incubation time of 60 min was chosen for the inhibition studies. Fig. 
2 shows the dependency of the specific 3~-imipramin binding on hippocampal membranes 
on the protein concentration. The binding increases linearly with increasing concentration of 
protein. Hence, we used lower protein concentrations for measurement of 3~- imi~ramin  
binding on brain microvessels. 
Table 1: Parameters of 3~-irnipamin binding 
Different concentrations of unlabelled imipramin were used to inhibit the binding of 3 ~ -  
imipramin on hippoampal membranes and on microvessels (Fig. 3). In the hippocampus a 
two-site model gives a better fit to the data than a one-side model. In the microuessel~ only 
a one-side model fits the data. The parameters obtained are shown in Table 1. In accor- 
dance with studies in rats and humans [6,7,91 a high- and low-affiniw binding site for 3% 
imipramin was also detected in the pig hippocampus. However in the hippocampal mi- 
crovessels only the low-affinity site could be demonstrated. 
Fig. 3: Inhibition of 3~-imi~ramin binding by unlabelled imipramin. 
Fig 4:Inhibition of 3I3-imipramin binding by various inhibitors of serotonin 
uptake sites 
Imipramin binding on this low-afinity site was inhibit& by pilloxetin, fluoxetin and sero- 
tonin (Fig. 4). Paroxetin and fluoextin are known as poteat inhibitors or the serotonin 
transporter. Therefore we mnclude that 2~-imi-imipramin iabels serotonin uptake sites local- 
ized on fh~z brain mkrov~sels. This is the first in&ation of the ppesenm of &is tpampopter 
on brain enrtotheliitl cells whik it r ~ a s  aIr&y dernomwa~d on endo&eliai edls derivd 
from pulmonary arteries [IQ, 111. AS stated by several authors, use of 3~-imi~ramin is 
complicated by the fact that part of the specific binding of this tracer on neuronal mem- 
branes is apparently not localized on the serotonin transporter 1121. 3~-~aroxe t in  s a better 
candidate for studying serotonin uptake. Therefore we intend to perform similar experi- 
ments using this tracer. 
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35. A COMPARISON OF ANALYTICAL METHODS FOR. DETECTION OF 
[ ~ ~ q m c m o R O  ACETIC ACID-DERIVED WIOACTlVITY IN 
WEDLES AND B I U W ~ S  OF SPRUCE (PZCEA SP.) 
M. Kretzschmar, M. ~ubnerl ,  M. Matucha2, H. uhlirova3 
1 Institute of Radiochemistry, 
%hed-~ Academy of Science, Prague, Institute of Experimental Botany, 
3 ~ o r e s t r ~  and Game Management Research Institute, Prague 
It is assumed that chlorocarbons as environmental pollutants will be oxidized by UV light Qr 
ozon into trichloro acetic acid. Their biotransformation can only be examined by tracer 
techniques. [14~]frichloro acetic acid Was therefore synthesized according to a previously 
described procedure [1]. 'This compound was added to the solution for cut-off 
spruce branches with the aim of showing the uptake and distribution of trichloro acetic acid 
in these plant pieces. 
Materials and methods 
The branches (wood and needles) of spruces of varying age tre,ated with [14~]trichloro ace- 
tic acid (3.7 GBqImmol) were studied, using the following methods: 
Qualitative: 
-conventional macroautoradiography with X-ray film and histological classification. 
Quantitative: 
- 1 4 ~  combustion analysis with the sample oxidizer A 307 (Canberralpackard] 
followed by measurement of radioactivity using the LS counter 6000 (Beckman 
Instruments ) 
- digital autoradiography with the Digital Autoradiograph LB 286 (Berthold GmbH) 
- digital autoradiography with the Bio-imaging Analyzer BAS 2000 (Fuji Film Co.) 
Conventional macroautoradiography and digital autoradiography with the BAS 2000 Ana- 
lyzer were carried out as described in [2]. The needles were cut lengthwise and the wood 
crosswise.The slice thickness was 40 pm. The exposure time for conventional autoradiog- 
raphs was 1.5 weeks for fresh needles and last year's wood and 3 weeks for the last year's 
needles and fresh wood. The same slices were exposed on the EP (imaging plate) of the BAS 
2000 Analyzer for 18 hours. 
Using digital autoradiography with the LB 286 device, a multiwire proportional counter, the 
radioactivity in the whole needle was measured. 
In addition, the amount of volatile 1 4 ~  components in the needles was estimated from val- 
ues measured after lyophilization in the vacuum apparatus and on fkozen sections used for 
exposure on X-ray film. 
Results 
The autoradiographs in Figs. 1 and 2 show a high accumulation of 1 4 ~  radioactivity, espe- 
cially in the tips of the needles and in the cork cambium of the branches. Also the epider- 
mis, cork, phloem, cambium and xylem of the bran~hes tore the I4c compsund. Odg the 
pith does not contain any radioactive material. 
A different distribution of radioactivity was obsewed in needks &om the same branch 
(Fig. l). 
Fig.1: Conventional autoradiograph of whole spruce needles f m  one brarreh after incuba- 
tion with a solution containing [14~ltrichloro acetic acid (magnification 3.7  fold)^ 
Fig. 2: a) Conventional autoradiograph from a cross-section of the branch b) to a) accom- 
panying histological section; E = epidermis, C = cork, Cc = cork, cambium, 
P = pith, Ph = phloem, Ca = cambium, X = xylem (magnification 9 fold) 
The quantiative methods confirm the ~Croautoradiographic findings amrding to which a 
higher radioactivity ~ptake Was  found in the needle tip than in the needle base (see Fig. 3)- 
I Combustion analysis showed a radioactivity concentration of 3100 Bq/g for fresh needles 
and 1000 Bqlg for last yearJs needles. The 1 4 ~  uptake of this yearOs wood was 1450 Bq/g 
1 and of last year's wood 2609 Bqlg. The values obtained by the BAS 2000 analysis were 
similar (2800 Bqlg fresh needles, 2000 Bqlg last year's wood). The radioactivity ratios be- 
tween needle tip (one third of the needle) and needle base (two thirds of the needle) was 1 : 
I l .  1 by combustion analysis and 1 : 1-2 using the BAS 2000 device. 
Fig. 4 demonstrates the 1 4 ~  radioactivity distribution in the cross section of the same 
I 
branch as shown in Fig. 2 but measured with the BAS 2000 Analyzer. Three ROI's 
(regions of interest) were drawn. Only a small radioactive concentration was measured in 
R01 1 (= 858 Bqlg) corresponding to the pith. Higher radioactivity accumulation was 
found in ROI's 2 (= 2220 Bqlg) and 3 (= 1961 Bq/g) corresponding to the phloem, cam- 
biurn, xylem and cork tissue. The highest uptake of radioactivity in the cork cambium (see 
Fig. 2) was not registered by the BAS 2000 Analyzer, 
Fig. 3 : BAS 2000 autoradiographic represemion of the 14~-disaibution in s 40 pm thick 
needle longitudinal section (magniemtion 7.5 fold), The radi~atctivi~ mf the needle 
was measured in 18 segments betwmn tip b base; 1 -- 1568 BqJg, h? = 2098 1F3q8g9 
3 = 1861 Bqlg, 4 = 1743 Bglg, 5 -- 1525 Bqlg* fi = P454 BqIg, 7 =c I202 Bqjg, 
8 = 9'73 Bgig ,9 = 751 Bqig ,IQ = 714 BqIg . 
The relative amount of volatile substances was less than 10 %. No radioactivity was meas- 
ured by the Digital Autoradiograph LB 286. The concentration of the plant pieces was 
obviously below its limit of detection. 
Fig. 4: BAS 2000 autoradiographic representation of the 1 4 ~  distribution in the cross- . 
section of a branch as shown in Fig. 2 (magnification 8 fold), left side 1 4 ~  profile 
display of the section ( 1 = 858 Bq/g , 2 = 2220 ~ q / ~ ,  3 = 1961 ~ g / ~  ). 
Discussion 
This study demonstrated that [ 1 4 ~ ~ t r i ~ h l ~ r ~  acetic acid or its metabolites are easily tram- 
mitted from the conducting vessels into branches and needles. A high accumulation was ob- 
served in the cork cambium and the tips of the needles. Conventional and digital autoradio- 
graphy are suitable for ma~urement of this biodistribution. Nevertheless, the resolution of 
the BAS 2000 Analyzer is lower than that of the conventional a~tor~diography. Structures 
below 100 pm (cf. the cork cmbium) were no longer distinguishable. 
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36. ATTEMPTS AT QUANTIFICATION OF 3~ AND DISTRIBUTIONS 
IN TISSUE SECTIONS USING VARIOUS METHODS 
M. Kretzschmar, H. ~ ix tack i l ,  R. ~ a h n l  
l ~ a ~ t e s t  I otopenmessgerate GmbH,Straubenhardt 1 
Introduction 
Whole body and single organ autoradiography has been much improved and widely applied 
in the field of pharmacology and toxicoloy. Quantitative autoradiography (QAR) is a pow- 
erful tool for high spatial resolution determination of tissue concentrations of radiolabelled 
tracers. QAR provides values of the biodistribution of tracers in small histological structures 
within organs, especially in the neurosciences is the great heterogeneity of cerebral meta- 
bolic activity throughout the brain clearly visible. 
Several methods have been developed in the last few years to determine the radioactivity 
concentrations in tissue sections. The traditional method is autoradiography with X-ray or 
3~ film [l]. The principle of this type of QAR is densitometry. The degree to which a film 
is exposed to a radioactive substance determines the density of silver grains on tbe devel- 
oped film. A densitometer measures the amount of light passing through the film compared 
with the amount of light transmitted through air. The unit of measurement is the optical 
density (OD). The OD of the autoradiograms produced from radioactively labelled thin tis- 
sue sections can be quantitatively converted into radioactive concentration by comparison 
with radioactive standard scales, The modern method is digital autoradiography 123, The 
position and intensity of 2-dimensional radioactivity distributions are quantitatively meas- 
ured by a device. The traditional X-ray or 3~ film has been replaced by a multiwire pro- 
portional counter or the phosphor imaging plate. 
Materials and methods 
Two different methods of quantification should be eompard: 
- densitometry with film and the Photo ~inishTM software, and 
- digital autoradiography with the BAS 2000 bio-imaging AnaIy~r  fmrn the: Fuji Film CO. 
Using the densitometric method, the tissue sections were put on X-ray QP 3~]iiTfi!m and ex- 
posed for days or wwks. The resulting auto radiogram^ wepc swned  by the; Wewfett 
Packard Scan Jet 11 c and handled by the image processing soh- ~ h o @ ~ n h h T M .  The 
ODs of the autoradiogm were analfled as grey values on the dispH8y screeab of the Pc. 
The optical raolution of the Scan Jet amounted to 400 ddpi. The influence of several spteltna 
parameters, such ;as enhmmment, brightnms,c~ntrast,~a~~~mi~~iern sf smn area, em~n%~ion 
side of the film, was detf:rai~&, 
Using digital autoradiography, the tissue sections were exposed in a brightly lit cassette on 
the imaging plate (IP) for several hours. The IP contained an image sensing layer with fine 
crystals of photostimulable phosphor (BaFBr: EL?+) on a polyester plate.When the ex- 
posed IP is inserted into an image reading unit and then scanned with a fine laser beam$ 
emits luminescence in proportion to the recorded radiation intensity .This luminescence 
(PSL = photostimulated luminescence) is collected in a photomultiplier tube and converted 
into electrical signals.The radioactive image recorded on the IP during exposure is read as 
high resolution digital data of 10 pixelsl mm and recorded in an analyzing unit. After 
reading ,all the image data recorded on the IP can be erased by exposing the IB to uniform 
light in an IP eraser attached. The IP can then be reused. 
With both methods it is necessary to calibrate the grey values and the PSL data by means of 
radioactive standard scales and to convert them into radioactivity units. The commercial 
Amersham 3 ~ -  microscales were used as radioactive standards. In addition 1 4 ~  standards 
of benzylic acid -1,l [14c3 dimethylpiperidinylesteriodide were prepared in a radioactivity 
concentration from 277 Bqlg (7 nCilg) to 296 Wqlg (8 pCi1g) 133). 
The biodistribution in rats of 3H -1eucine and of the laxative 14c-Rhein was measured 30 
min after application. One male Wistar rat (120 g) was i.v. injected with 19.2 MBq (520 
&i) 3~-leucine dissolved in 30 % ethanolic solution. Another Wistar rat (137 g) was given 
an oral dose of 888 kBq (24 pCi) 14C-~hein dissolved in sodium phosphate buffer pH 8. 
The rats were frozen in ethanolldry ice solution and sectioned in a cryomicrotome at -200 
C. The slice thickness was 40 pm and 50 pm in the case of 14c-Rhein. The tissue sections 
were freeze-dried for 48 hours in the apparatus. 
The 3~-labelled sections were exposed to 3~-~l t rof i lm for 5 and 7 weeks and in the case 
of 14c-Ithein to RF64 X-ray film for 2 and 4 weeks. In order to ensure identical exposure 
conditions and good contact of the films to the tissue sections, the exposure was carried out 
in a screwpress. 
The same tissue sections were exposed on the IP for 15 hours (3H-leucine) and 21.5 hours 
(14C-Rhein). 
R&& 
Fig. la  and lb  show the standard curves of the 3~-microscales. Fig. l a  demonstrates that 
fie standard curves can only be used for calculation of tissue radioactivity from the meas- 
ured grey values in the range between 0 - 370 kBqlg (10 pCi1g) in case of 5 weeks' expo- 
sure, and in the range from 0- 185 kBq/g ( 5 pcilg) in case of 15 weeks' exposure. 
The standard curve of 3~-microscales obtained by the BAS 2000 (Fig, lb) shows linearity 
in the whole range between 0 and 1224 WqIg (0 - 33.1 pCi1g) using only a short exposure 
rime of 15 hours. 
fig. 18: 3~-rnicroscdes tandard curve for = 5 - 7 = 9 and = 15 
weeks exposure time.Abscissa represents tissue equivalent %l-concentration, at~d utdilmtr 
the corresponding grey values derived by Photo Finisit. 
Fig. Lbi 3~-ndcroscales slandwdcuwe For 15 horn tbeAbcissa mprescnts tissec 
quivalent 311- eoncentmlrjion and ordinale fhe romponding PSL vdaes derived witlg the 
13A.S 2iOa0d&m, 
Fig. Za : 1 4 ~ - ~ t ~ ~ d ~ ~ d  c u m  for - = 2 and m = 4.5 weeks exposure ti~se.l\l~scissa 
,presents the 14~-concentration , nnd the ordinate the corresponding grey values derived 
Photo Finish- 
Fig. Zb : Idc-standard curve for 21.5 horn exposure time.Abscisss represalts the 14c- 
concentratioqmd the ordinate the corresponding PSL values derived wit!, t i e  BAS 2000 
device. ' 
Fig. 2a illustrates the standard curves of the 14c scale with an exposure time of between 2 
and 4.5 weeks. A quantitative evaluation is only possible in the range between 0 and 4.4 
kBq1g (120 nCi1g) .Beyond this radioactivity the film is overexposed and the grey values 
remain uninfluenced by an increase in radioactivity. The standard curve obtained by the 
BAS 2000 device (Fig 2b) shows linearity in the whole range between 277 Bqlg (7.5 nCi1g) 
and 296 kBq/g (8 pCilg). The exposure time was only 21.5 hours . 
Fig. 3b shows the 14c radioactivity standard used. The profile across the standard (Fig. 3c) 
demonstrates that higher radioactivity cannot be measured under these conditions. The up- 
per horizontal line in Fig. 3c represents the maximum PSL which is measurable. For higher 
radioactivity the exposure time must therefore be reduced. 
Tables 1 and 2 show the radioactivity concentrations after application of 3~-leucine and 
14c-.Rhein, respectively in several organs of rats calculated from densitometric and lumi- 
nescence measurements. With only a few exceptions (hippocampus) the values obtained 
, with the BAS system lie between the values obtained by the densitometric method after 5 
and 7 weeks. 
Table l: Comparison of the biodistribution of 3~-leucine in rats 30 min after i.v. applica- 
tion , quantified by densitometry and luminescence measurement 
Table 2: Comparison of the biodistribution of 14c-~hein in rats 30 min after oral 
application, quantified by densitometry and luminescence measurement 
Organ I tissue radioactivity with I tissue radioactivity 
I PhotoFinish (Bqlg) I with BAS 2000 
I exposure time (weeks) I (BqIg) 
1 4.5 1 exposure time 
21.5 hours 
skeletal muscle 148.0 5 14.1 166.5 + 12.8 159.1 
stomach content overexvosed 177600.0 
liver 814.0 k39.4 788.1 f 45.0 777.0 
kidney 
medulla 2300.0577.5 2328.0k47.0 2368.0 
cortex 2923 - 0 5  83.5 overex. 2997.0 
lung 647.5k32.8 666.0k29.7 662.3 
% differences BAS I 
2000 and PhotoFinish I 
exposure time (weeks) I 
Table 3: Comparison of conventional autoradiography and digital autoradiography with 
BAS 2000 
conventional autoradiogra- digital autoradiography 
P ~ Y  with BAS 2000 device 
with Photo-Finish 
resolution good 10-20 pm good 100 pm 
measuring value registration good with pixel, especially good with ROIs, especially 
[from the display I for small structures 
exposure time for 1 3~ (20 kBqig) 1 long - 7 weeks 
I 14c (277 Bqlg) - 3 weeks 
image development process - 1 hour for development 
measuring value range slow dynamic range of the 
order of - 101, several film 
exposures are necessary for 
the whole measuring range 
short 
l - 15 hours 
- 21 hours 
- 3 min for scanning and 
development 
wider dynamic range of the 
order of - 104, only one 
exposure is necessary for the 
whole measuring range 
I I 
use of the film and IF only once lIP for 3~ 5 - 10 X 
IP for 1% -- 1000 x 
price film for 3~ - 25 DM IP for 3~ 540 DM 
l film for 1 4 ~  - 6 DM l IP for 1 4 ~  l l00 DM 
Table 3 summarizes the advantages and disadvantages of both methods 
Fig.3 : Representation from a) 14c-~hein biodistribution 30 min p i .  in rats, b) 14~-radio- 
activity standard in the range between 277Bqig (7.5 nCliig) and 296 MSq& (8 p(l=ilg) 
c) profile display of the 14~-radioactivity standard in b) 
Further studies are planned for the assessmeat of the merfiods. 
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37. SUITABILITY OF INCUBATION OF RAT BRAIN SECTIONS FOR 
EVALUATION OF POTENTIAL DOPAMINERGIC Re- OR Tc- 
COORDINATION COMPOUNDS 
U. Wenzel, R. Syhre, R. Berger, R. Bergmann 
Introduction 
One aim of radiotracer research is the design of receptorbinding substances to which 99mTc 
is coordinated. Some first steps are taken with the preparation of Re- and Tc-model 
compounds respectively, which are similar in chemical structure [la,b]. Characterization of 
these substances requires methods of evaluation by which the affinity to receptors, in the 
present case to D, receptors, can be quickly and reliably established, first of all in the 
process of in vitro screening. 
Several methods to perform these experiments in vitro have been described, among them in- 
vestigations using homogenates of the receptorbearing brain regions and incubation [2]. In 
the present study we use in vitro incubation of brain sections. The advantages of this 
method are that it requires only minimal amounts of radioactive material and a very small 
number of test animals. The method was calibrated using [3H]spiperone as the ligand and 
(+)butaclamol as a displacer. At the moment only nonradioactive Re complexes are 
available. Indications concerning any specific binding of Re-coordination compounds to D, 
receptors are therefore gained indirectly derived from competition with labelled spiperone, 
compared with the effect of (+)butaclamol. 
Materials arrd methods 
We modified the method described by M. J. Kuhar and J. R. Unnerstall [3]. In brief, after 
a short ether anaesthesia the animals (male Wistar rats, 150 - 200 g of weight) were 
sacrificed by decapitation. The brains were quickly removed and frozen in a mixture of dry 
ice and ethanol (-70 OC). After a short time at -20 OC brains were glued onto microtomic 
chucks by Compound (Leica Instruments, Nussloch, Germany). A number of consecutive 
horizontal sections were cut in the region of the Interaural line 2.9 - 6.4 mm (according to 
the rat brain atlas of Paxinos and Watson 141) in 20 pm thickness and then thaw-mounted on 
rnicrotomic glass slides, coated with gelatine-chrome alum (ORWO, Wolfen, Germany). 
The slides can be stored for two months at -20 [5]. One day before the tests, the test 
seceons were dried at room temperature. In general, consecutive sections were incubated 
for 30 min at room temperature in a bath of: 
A: Incubation buffer, containing 0.1 nM [3H]spiperone (spec. act. 3.55 mq/mmol, 
Amersham, Braunschweig, Germany) in tris-HCl, 10 mM ascorbic acid and lCcM 
pargyline ( B I ,  Cologne, Germany), pH 7.6 
B: Errcub8tian buffer as under A, containing 3 PM of the antagonist (+)butaclamol (=I) 
C: Incubation buffer as under A, containing the test substance, in this case 3 pM of 
derivative 3 of an Re-complex [l], dissolved in acetone/propyleneglycol 
D: Incubation buffer as under B, containing the same solvents as C 
In the last experiments, the sections were surrounded by a barrier of an inert material [PAP- 
PEN (Plano, Marburg, Germany)J, for optimization of the incubation conditions. 
Everything points to the fact that surrounding the tissue section by a barrier rather than 
using a diving bath has the following advantages: 
1. Minimizing the radioactivity applied 
2. Exact dose of the labelled ligand 
3. No contamination of the glass slides outside the barrier 
After incubation the sections were washed twice for 5 min in the non-radioactive buffer at 
4 OC, dipped shortly into distilled water at room temperature and dried in a stream of cold 
air. From each series some sections were wiped off (wet or dried) and, after shaking for 
several hours in the LS cocktail Ultima Gold (Canberra Packard, Frankfurt, Germany) they 
were measured by the LS spectrometer (Beckman, Dfisseldorf, Germany). The rarlioactiviv 
of the dried sections was measured together with [3H]micro-scales (RPA 510, Amersham), 
either directly by the Digital Autoradiograph (LB 286, Berthold, Wildbad, Germany) or 
indirectly. First by fixing them to Imaging Plates on light-tight cas~Ees (Raytest, 
Straubenhardt, Germany) for exposure overnight. The exposed Imaging Plates were then 
scanned by a laser beam and assessed by BAS 2000 (Raytea), For autoraelio&raphy, the 
same sections were brought into contact with l3H] Ulttofilm in au&r&fiogaphic film 
cassettes (Amersham) for up to 12 weeks' exposure. Development and fixation of the film 
plates follows standard procedures. In some of the resulting autQradisgr;ams the optical 
density (OD) of regions of interest was measured for quantification by a CCD vMes camera 
coupled to a computerized image analysis system, using the PhotsFinish progrm. 
Results and discussion 
Reference substance: For comparison, the displacement of the PHjspipcr~ane binding ts h e  
D,-receptors by the antagonist (S)butaclamol [2] as a reference subs&n@e was wed as a 
measure of the unspecific binding in the four metboctz: of qumtifimti~n- I-23 meamemem of 
the brain section. is a rapid and simpfe method to aim& the mnge of idibition in the 
whole brain ( ~ 6 8  96, Fig. l), 
Fig 1: Two representative series of 
measurements by LSC ( n = 5 ) 
A = Incubation with [3H]spiperone 
B = Incubation with [3H);spiperone in 
the presence of the reference 
substance 
C = Incubation with [Wjspiperone in 
the presence of the test substance 
The Digital Autoradiograph (DAR) serves for direct measurement of the radiation from the 
incubated section. However, the resolution of 1 mm is not sufficient for exact localization 
of the binding sites. The resolution of the indirect measurement by the Imaging Plates 
(Raytest) and the evaluation of autoradiographs on film by the PhstoFinish program is 
about 100 pm and 10 pm, respectively. Regions of interest inside the brain, in our case the 
caudatefputamen and the CA, field of hippocampus, which are rich in D,-receptors [2], can 
thus be measured in detail. The results are shown in Fig. 2. 
I I 
m 
$. 800 0 [H3]spiperon 











Fig. 2: Measurement of putam~en 
bound activities of various concen- 
trations [3H]spiperone by PhotoFin- 
ish. While the inhibition by (+)but- 
aclamol in the whole brain section 
was nearly 80 %, in the caudatefpu- 
tamen it was as higlh as 89 %, 
measured by BAS 2000. 
In view of the number of series analysed (n = 6)  we can assume that the results are 
representative. 
Test substance: Using a Re coordination compound [la,b] for inhibition, we found the dis- 
placement of the spiperone binding to be about 52 % in the whole brain section (see C, Fig. 
3) and about 39 % for the caudatefputamen (see C, Fig. 3). Although inhibition by 
(+)butaclamol was higher than by the test substance (see B, b, Fig. 3), it can nevertheless 
be inferred that this method is suitable for characterization of Re complexes as regards their 
possible binding to D2 receptors. Better results in terms of minimizing unspecific binding 
can be expected by preincubation of the sections with the same buffer [2]. 
The solution of (+)butaclamol in the same solvents as used for the Re complexes did not 
show any influence in our investigations (see D, materials and methods). 
144 
l.: Horizontal brain secti Fig. 3: Presentation of a typical ex- 
periment 
A, B, C = whole brain section 
a, b, c = caudatelputamen 
A,a: Total binding of the ligand 
PHJspiperone 
B,b: Binding in the presence of 
( +)butaclamol 
C,c: Binding in the presence of the 
Re coordination compound 
Calibration: In all methods, [3H]micro-scales of known polymer activity and the estimated 
equivalent of tissue activity 161 were usled for calibration. The standards were measured to- 
gether with our labelled brain sections. The calibration results are shown in Fig. 4. 
Pig, 4: Comparison of calibration 
c w e s  of [~~]micso-scales 
Photo = PhotoFinish 
BAS - BAS280Q 
-2 6 -1.0 -0.5 0.0 0.16 4.0 1.5 DAB = Digital Auto- 
radisgaph 
All curves permit statements concerning the measured activity of a substance of u h o w n  
biological behaviour. Measurement on BAS 2808 showed the best lineaity also h the 
nonlogarithmic low range. In the other cases, rhe dekraninatiran of r;;idisactivicy 
concentrations is less accurate for brain slices of high or low contamination, 
In the future we intend to use this method as a standard prseedwe in w n j W ~ n  wih mem- 
brane binding studies f7j. In this way we hope to be able se1wt sabsancm which we 
useful for SPECT invastigations in the brain. 
In the future we intend to use this method as a standard procedure in csnjuction with mem- 
brane binding studies [g. In this way we hope to be able to select substances which are 
useful for SPECT investigations in the brain. 
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RELATIONS BETWEEN THE UPTAKE OF THE RADIOMETAL 169yb 
INTO NORMAL AND TUMOUR CELLS AND THEIR METABOLIC 
ACTIVITY DEPENDING ON 2'HE LIGAND SPECIES 
G .  ~ a m ~ f l ,  G. Knopl, S. Matys, G.  KUm, U.  eme ell, R. Bergmann, 
W. -~.Frankel 
1 Dresden Technical University, University Clinics, Clinic of Nuclear Medicine 
Since some radioactive M3+ nuclides proved to be suitable for palliative therapy of bone 
metastases, several complexes of them were studied in our previous in re- 
spect of their biodistribution in rafs under the special aspect of influencing their accumula- 
tion in various tissues by ligand variation, preinjection of other ligands, and variation of li- 
gand concentration [l-41. 
However, from these studies as well as from studies by other authors it was not possible to 
draw any conclusions as to the nlechanism of uptake of the ~ 3 - k  nuclides into the tumour 
cell. For gaining insights into such basic processes, experiments at cellular level are more 
appropriate, since the influence of the whole organism leading to of proc- 
esses is absent in this case. We therefore decided to start experiments with cell cultures of 
normal and tumour cells in order to detect possible differences in the behaviour of these cell 
species and to find some indications concerning the uptake mechanism(s). 
This direction of research is moreover favoured at present on account of the possibility of 
reducing - and, in part, eliminating - animal experiments. 
This first study is aimed at detecting a relation between the metabolic activity of cells and 
their ~ 3 +  uptake using complexes with various ligands. 
Material and methods 
The radiometal 169Yb has been used up to now in the form of ~ 3 +  compounds because of 
its easy availability and relatively long physical half-time. It is a nuclide which shows a 
chemical behaviour analogous to that of the therapeutically used yttrium and is representa- 
tive of most of the lanthanides. 
The following compounds were chosen as ligands: citrate (CIT), diethylenetriaminepen- 
taacetic acid (DTPA), and ethylenediaminetetramethylenepho~phonic acid (EDTMP), which 
are already used routinely in nuclear medical practice, as well as nitrilotriacetate (NTA) and 
ethylenediaminetetraacetic acid (EDTA), the biodistribution of which is known from studies 
on tumour-bearing mice [5]. The compounds were labelled using 169ybC13 (Swierk, Po- 
land, spec. act. 15 GBqImg Yb), the chemical and radiochemical purity of the labelled 
complexes was checked by thin-layer chromatography and HP26. 
For comparison of the metabolic activities of the cell strains [l8~]-2-fluoro-2-deoxy-~- 
glucose ( [ 1 8 ~ ] F ~ ~ )  produced by the Rossendorf department of positron emission tomog- 
raphy was used, the uptake of which provides information on the degree of glucose utiliza- 
tion by the cells. 
The cell strains used were the hamster lung fibroblasts V79/4 (from the Max Delbriick Cen- 
tre Berlin) for a non-malignant cell line, and a human adenocarcinoma of the kidney, 
KTCTL-2, from the tumour bank of the DKFZ (German Cancer Research Center) H d e l -  
berg. 
The cells were cultured on plastic surfaces in RPM1 1640 medium with 18 96 of foetal calf 
serum in an atmosphere containing 5 5210 C02 for 46 - 48 hr before starting the experimea@ 
with the radioactive complexes. The labelled compound was added in a concenrration 
of 1 pCi/ml ([I~FJFDG: 8 pCiIml) together with fresh medium. 'I'he cell cultures were 
then incubated for various periods of time in the 5 $6 C02 atmosphere, 
After incubation the monolayers were thoroughly rinsed with iee-eoM buffer ssfutioa (A1 
further steps were carried out at 4 - 6 QC In order to m i n h h  ioisehemiml changw), &B- 
sociated with trypsin-EDTA, and washed 3 times with buffer, The radioacfivl~ of the 
pellets was then measured in a COBRA 11 Auto-Gamma (Pstck~i-l). 
Results and discussion 
Uptake of the glucose analogue [I~FIFDG 
Preliminary experiments with V79 cells showed - as expected - that [ ~ ~ F I F D G  was taken 
up to a much greater amount (by a factor of 3 - 4) by adherent cells in full metabolism than 
it was by cells in suspension. All following experiments were therefore performed with ad- 
herent cells. 
In spite of variations in the absolute amount of radioactivity taken up by the cells in the 
course of the various experiments it was observed that the well-established fibroblast cell 
line V7914 always showed a higher glucose metabolism (i.e. [ I ~ F ]  uptake) than the rela- 
tively young and still weakly growing tumour cell line KTCTL-2 (Fig. l),  The curves show 
a higher uptake during the first 15 min and then begin to flatten. Especially with the fibro- 
blasts the shape of the curve as a function of time corresponds to that obtained by us in 
previous studies on the isolated perfused rat heart [6]. 
Uptake of 1 6 9 ~  from the complexes 
Studying the uptake of the radiometal from the 169Yb citrate complex, we observed a clear 
relation between the radioactivity concentration in the cells and their [ ~ ~ F I F D G  uptake, i.e. 
their metabolic activity: the V79 cells with their higher metabolic activity showed a higher 
169yb uptake than the KTCTL-2 cells (Fig. 2). 
Quite another behaviour emerged when 169Yb complexes with NTA, DTPA, or EDTMP 
were offered to the cells. Apart from the generally lower uptake level , in all these cases the 
tumour cells took up more radioactivity than the fibroblasts (Fig. 3, EDTMP not shown). 
t l mln 
Fig.? Uptake of E~*UFDG by V79 end KTCTL-2 cells. Representation 
of a typical exparZment (n = 2). 
m = W79 cells, = K.bGTL-2 cells 
Fig.2 Uptake of 1 6 9 ~ b  from the 1 6 h i t r a t e  complex by V79 and 
KTCTL-2 cells. RepresentpUon of a typical experiment (n = 2-6). 
0 = V79 cells, P = KTCTL-2 cells 
I Nor does the uptake of from these complexes depend on the metabolic activity of the 
cells as it does in the case of the citrate complex. 
> 
p These results suggest the existence of different. transport or uptake mechanisms For the mdi- 
ometal from the citrate complex, on the one hand, arid from the NTA, DTPG, and 
9 
EDTMP complexes, on the other. 
f i .S 1JpLke cif 96eb from the q G % w ~ ~ ~  and the! 
q6%LLWiA complex by V)"I and KTC%i,=2 cells after 
4 hr inclabatien. {n = 8-12), 
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39. INFLUENCE OF THE STABILITY OF l69Yb LIGAM) COM3PLEXES ON 
THE UPTAKE OF THE METAL NUCLIDE IN C U ] [ 1 m D  CELLS 
G.  Kampfl, G .  Knopl, S. Matys, G. Kunz, U. ~ e n z e l l ,  R. Bergmann, 
W.-G. ~ranke l  
1 Dresden Technical University, University Clinics, Clinic of Nuclear Medicine 
In connection with the preceding report this communication presents the results of experi- 
ments performed with 169Yb ligand complexes of various stabilities. Materials and methods 
were exactly the same as described there. 
The role of the complex stability for the bio-availability of ~ 3 +  nuclides in animals has 
been discussed in detail by Schomacker [l]. In short, easily dissociating (labile) complexes 
lead to a greater amount of the metal being available for transport proteins in the blood. 
The stability of the complexes can be influenced by varying the metal as well ,as the ligand. 
Concerning the metal, the complex stability increases with decreasing ion radius, ytterbium 
being the second smallest among the lanthanides, i.e. it forms relatively stable complexes. 
Concerning the ligands, those used by us form complexes of increasing stability in the order 
CIT < NTA < EDTA < DTPA. 
Rsullts and discussion 
Our experiments with cultured cells show that the metal complexes with tri, tetra, and pen- 
acetate belong to a group of compounds from which only a small amount of the metal 
nuiclide is taken up by the cells. The Use of carrier-added preparations did not enhance the 
1 6 9 ~ b  uptake. 
From the citrate complex the radiometal is taken up to a much greater extent. In Fig. 1 the 
uptake levels are shown for KTCTL-2 cells; analogous results were obtained with V79 
cells. 
In the complexes studied the 169yb uptake is clearly related to the complex stability: within 
the ligand group of the aminocarbonic acids DTPA, EDTA, and NTA the uptake 
into the cells increases with decreasing complex stability. The differences in uptake are not 
high in this group, but they were reproducible in several experiments. 
The citrate complex has the lowest stability among the compounds tested, and it is from this 
complex that the greatest amount of the metal nuclide is taken up by our cultured cells. It is 
also known from numerous animal experiments that citrate complexes lead to high 
~ 3 +  uptakes in tumours but also in many normal cells, especially in the highly metaboliz- 
ing liver cells [2]. 
When only one metal nuclide is used, as in our case, the ligand species determines the 
complex stability; with decreasing complex stability the cellular uptake of the metal nuclide 
increases. This could perhaps be explained by better availability of the metal to the e l l ,  
possibly via a transporting compound. 
DTPA EBTA NTA CBT 
Fig.4 Uptake of 4@%b from the *I6%&- 
~3ompIesr@s with aminocarbsnic acids 
and with citmte by H;TC:Tt,-2 ce3fs. 
heorbation time 4 hr, n = 8-12. 
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Analytischer Bedarf bei der Entwichlung von Te~hnetium-Trace f& die M&$in 
BAM, Berlin, 27. Mai 1993 
Steinbach, J., B. Johamen 
Das PET-Zentnun Rosendorf 
Arbeitssagung *RadiochemieSRadi1)pInanrmif2,ie~'~ Deu~che GB, Nu&nwmetdi~In, 
Bastei, 13, - 15. Mai 1993 
Steinbach, J., B, 50hmsen 
Setting up a BET cen&e at uitossendo~ 
IAEA I n t e ~ e g i o d  Co~rse OD NucPw M&iei~a, 
Berlin, 2& S q t ,  - 15, Okt. l993 
Wagner, G., S. Seifert, A. Eckardt 
System for concentration and purification of pertechnetate solutions by chemical methods 
IAEA Research Coordination Meeting, Budapest, 8. - 14. Hebruar 1993 
POSTERS 
Steinbach, J., B. Johannsen, W.-G. Franke 
Radiopharmaceutical research and medical application at Rossendorf: The new PET proje~ct 
Sixth Symposium on the Medical Application of Cyclotrons, Turku, 31. Mai - 5, Juni 1992 
Syhre, R., S. Seifert 
Ex-vivo-Bindungsuntersuchungen - eine Moglichkeit der Reduzierung von Tierversuchen im 
biologischen Screening von Radiotracern 
m. GV-SOLAS Tagung, Salzburg, 22. - 25. September 1992 
Johannsen, B., B. Noll, P. Leibnitz, G.  Reck, St. Noll, H. Spies 
Occurence and nature of different Tc(V) and Re(V) complexes with mercapto/amide ligands 
Topical Symposium on the Behavior and Utilization of Technetium '93, Sendai, 
18. - 20. Miirz 1993 
Noll, B., B. Johannsen, St. Noll, H. Spies, P. Leibnitz, G. Reck 
~echnetium(V)- und Rhenium(V)-Komplexe mit ThiolatIAmid Koordination 
24. GDCh-Haupwersammlung, Hamburg, 5. - l l .  September 1993 
pie&sch, H.-J., S. Seifert, R. Syhre, H. Spies, B. Johannsen 
~echnetium(111) complexes with tetradentate thioether ligands: Preparation and preliminary 
biological evaluation 
Topical Symposium on the Behavior and Utilization of Technetium '93, Sendai, 
18. - 20. M5rz 1993 
pietzsch, W.-J., H. Spies, B, Johannsen 
Neue kationische Technetiumkomplexe mit Thioether-Liganden: Charakterisierung und 
erste biologische Bewertung 
~ ~ u t s c h e  ~esellschaft ffir Nuklearmedizin e. V., Jahrestagung, 15. - 17. April 1993 
pietzsch, H.-J., H. Spies, P- hibnitz, G .  Reck, B. Johamen 
~~hnetiumkomplexe mit mehrziihnigen Thioether-Liganden 
24, ~ ~ ~ h - ~ a u p ~ e r ~ a m m l u n g ,  Hambur , 5. - 11. September 1993 
Pietzsch, H.-J., M. Glaser, H. Spies, F. E. Hahn, A. Dittler-Klingemann 
Technetium- und Rheniumkomplexe mit Tris-(2-mercaptoethy1)amin 
24. GDCh-Hauptversammlung, Hamburg, 5. - 11. September 1993 
Seifert, S., L. Lindemann, H. Spies, B. Johannsen, H.-J. Pietzsch, P, Leibnitz, G. Resk 
The chemical identity and reactivity of individual technetium(V) and rhenium(\/)-meso- 
DMSA isomers 
Topical Symposium on the Behavior and Utilization of Technetium '93, Sedai, 
18. - 20. M&z 1993 
Seifert, S., H.-J. Pietzsch, H. Spies, R. Syhre, B. Johannsen 
Isomere Rhenium/Technetium-Komplexe mit 2,3 Dirnercaptobernsteinsiiure und deren Ester 
24. GDCh-Hauptversarnmlung, Hamburg, 5. - l l. September 1993 
Spies, H., H.-J. Pietzsch, R. Syhre, Th. Fietz, B. Johannsen 
The 3+ 1 concept in the synthesis strategy of novel technetium and rhenium tmers 
5. Europ. Symp . on Radiopharmacy and Radiopharmaceuticals, Cambridge, 
21. - 2.4. M&z 1993 
Spies, H., Th. Fietz, H.-J. Pietzsch, P. hibnitz, G .  Reck 
Neutrale Oxorhenium(V)-Komplexe mit Gemischtligandkoordination 
24. GDCh-Hauptversammlung, Hamburg, 5. - 1 l. geptember 1993 
Spies, H., S. Seifert, B. Johannseri, H.4.  Pietzseh 
Stereochemistry and unusual isomerization of DMSA complexes 
4th Intern. Symp. Chelating Agents in Pharmacolau, Toxicology and T'herapeuti~s, 
Pilsen,, 3. - 5. August 1993 
IV. 
SCIENTIFIC COOPERATION 
In multidisciplinary research such as carried out by this Institute, collaboration, the sharing 
of advanced equipment, and above all, exchanges of ideas and information obviously play 
an important role. Effective collaboration has been established with colleagues at 
universities, in research centres and hospitals. 
Cooperative relations and joint projects 
The Technische Universitut Dresden (Dr. Scheller, Dr. Klostermann, Inst. of Analytical 
Chemistry) plays an essential part in SPECT tracer research by performing analytical 
characterkition of new tracers and providing support with the synthesis of organic 
compounds (Dr. Habicher, Inst. of Organic Chemistry). 
Common objects of radiopharmacological and medical research link the Institute with the 
Universitatsklinikum "Car1 Gustav Curus", above all with its Departments of Nuclear 
Medicine (Prof. Franke), Psychiatry (Prof. Felber), and Neurology (Prof. Kunadt). A joint 
team of staff members from both the Institute and the Clinic of Nuclear Medicine are 
currently working at the Rossendorf PET centre. 
Very effective cooperation also exists with the Bundesanstalt f i r  Materialforschung Berlin 
(h. Reck, Mr. Leibnitz) who have carried out X-ray crystal structure analyses of new 
technetium and rhenium complexes. 
Our long-standing cooperation with the University of Padua (Prof. Mazzi) and the 
"Demokn'tos" National Research Centre for Physical Sciences in Athens (Dr. Chiotellis) has 
now been instrumental in advancing the chemistry of thioether complexes. 
Soinr work on technetium complexes with tripodal ligands has been carried out with the 
Fxede Universit& Berlin (Prof. Hahn, Inst. of Inorganic and Analytical Chemistry). 
Cooperation on a special research topic concerning technetium tracers is in progress with 
&I: Porsch~cn~szenmm Jiilich (Prof. Stocklin) . 
IdentiiFicatioam, of csmmon objects in radiopharmacy has led to collaborative research with! 
h e  Wlen&~Mf-Tb'bziversitiit BerJia (Dr. Michael of the "Charitk" Hospitals, Clinic of Nuclear 
Medicine) sad the rPniversitdt &t?@zig (Dr. Giinther, Radiology, Nuclear Medicine). 
In the field of PET tracers, cooperation exists with the Montreal Neurological Zmtitute 
(Prof. Gjedde, Prof. Thompson), the Turku Medical PET Centre (Prof. Wegelius, Dr. 
Solin) and the Institute of Nuclear Research, Debrecen, Hungary. 
The fruitful contacts to the Paul Scherrer Znstitut, Villigen, Switzerland, are very 
appreciated. 
In helpful discussions both abroad and at Rossendorf numerous colleagues have contributed 
to shaping projects and defining areas of cooperation. 
Special thanks go to Dr. K. Deutsch, Mallinckrodt Medical Inc., St. Louis, USA, Prof. 




IEiSirst Meeting of the DGN Group of Radiochemistry and Radiopharmacy 
In March 1992 the German Society of Nuclear Medicine, DGN, set up its Working Group 
of Radiochemistry and Radiopharmacy (headed by B. Johannsen, Rossendorf) to provide a 
suitable forum for scientists who are mainly engaged in the synthesis and characterization of 
radioactive compounds relevant to nuclear medicine. The objectives of the Group are 
dissemination of information, exchanges of ideas and specific radiochemical results, 
promotion of cooperation among individual members and institutions, particularly in 
Europe, addressing all radiochemical and radiopharmaceutical issues that may be relevant to 
nuclear medicine, and further education. To help achieve these objectives, regular meetings 
will be held under the auspices of the DGN. 
m e  Group convened for the first time at the Bastei hotel near Dresden on 13 - 15 May 
1993. 
The meeting, sponsored by the radiopharmaceutical industry and by the Research Center 
Rossendorf, was attended by 75 participants from Germany, Austria and Switzerland. It 
covered three areas of work: 
Tfie first session was held under the aspect of education, with reviews on the 
pharmacological fundamentals of receptors, PET tracers for neurotransmitter systems, and 
clinical relevance of receptor SPECT, presented by G. Lambrecht (Frankfurt), K. Herholz 
(slogne) and H.J .  Biersack (Bonn) as invited speakers. 
The second scientific session, dealing primarily with halogen-labelled compounds for 
diagnsstics and therapy, was opened by G. Stocklin (Jiilich) with an invited review on 
radiohalogenation-radiachemistry and pharmacology. Seven additional presentations and an 
intemive and fruitful discussion covered current activities - results and problems - in 
connection with 2 1 1 ~ t ,  1231, and labelling. Seven free papers dealt with the setting up 
of a PET centre, 1 1 ~  precursors and products, synthesis of 73?75~e compounds and 9 9 m ~ c  
compsunds, iduding 1 igand synthesis. 
'The bird s~s ion ,  devoted to questions of quality control, documentation and the handling 
of radioactive wate irn a raditlchemical laboratory, addressed tasks and issues radiochemists 
ape faced wi& in routine work, 
IAEA Study Tour to Rossendorf 
As a contribution to the IAEA Interregional Training Course on Nuclear Medicine for 
Developing Countries, held in Berlin between 20 September - 15 October 1993 (organized 
by H. Deckart), a visit to Rossendorf served to acquaint the participants with the 
Rossendorf research reactor and the set-up of a PET centre, The programme included 
lectures by B. Johannsen, P. Liewers and J. Steinbach, and visits to the facilities. 
VI. 
SEMINARS 
Prof. H. Bartunik, MPG-Arbeitsgruppe Hamburg 
Biologische und medizinische Anwendungen der Synchrotronstrahlang 
16. Dezember 1992 
Prof. M. WeiB, Maetin-Luther-Universitiit Halle 
Anwendung der Verweilzeittheorie in der Pharmakokinetik 
15, Januar 1993 
OA Dr. R. Aurisch, Humboldt-Universitiit Berlin 
Nuklearmedizinische Herzdiagnostik in der Vor-PET-Phase 
26. Februar 1993 
Prof. F. E. Hahn, FU Berlin 
Koordinationschemie tripodaler Liganden 
5. M&z 1993 
Prof. E. Uhlemann, Universitiit Potsdam 
Koordinationschemie des Vanadiums (aus bioanorganischer Sicht) 
23. April 1993 
Dr. Nebeling, KFA Jiilich 
Generelle Aspekte bei der Herstellung von PET-Tracern 
21. Mai 1993 
Dr. Knoop, Medizinische Hochschule Hannover 
Neue EntwicMungstendenzen von PET-Scannern; 
kistungsparameter, Quantifizierbarkeit und Q ~ a l i t B : & k ~ ~ b ~ l l ~  
3. Juni 1993 
Prof. C. Omig, University of British Columbia, Vancouver 
Medicine and Inorganic Chemistry - Vanadium and Diadetes 
8. Juni 1993 
Prof. Hmmann, Medizinische Akademie Dresden 
SuahlenefEekte der Lunge - Fmschungsschwerpunkt und Kooperationsm~glic~eit? 
24, Juni 1993 
Prof. Diemer, Universitiit Kopenhagen 
The role of glutamate transmission in focal and global ischemia 
9. September 1993 
Prof. Subramanian, State University of New York, Syracuse 
What is new in radiopharmaceuticals? 
1. Oktober 1993 
Prof. H. H. Coenen, Universitiit Essen 
Markierte Aminosauren fiir PET und SPECT 
11. Oktober 1993 
Dr. K. Deutsch, Mallinckrodt Medical Inc., St. Louis 
The chemistry underlying some new Mallinckrodt radiopharmaceutical products 
18. Oktober 1993 
Dr. K. Klostermann, TU Dresden 
Massenspektrometrie: Grundlagen und Anwendung 
19. November 1993 
VII. 
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The Institute is part of the Research Center Rossendorf Inc., which is financed by the Fed- 
eral Republic of Germany and the Free State of Saxony on a fifty-fifty basis. 
In addition, the Free State of Saxony provided support for three projects (FZlR/3, FZRIS 
and FZW17) covering the installation of positron emission tomography (PET), improved 
analytical equipment a d  measures required to meet legal standards for radiochemical labo- 
ratories. 
The research projects concerning technetium compounds and transport systems were sup- 
ported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. 
A number of projects were facilitated by financial and material support provided within a 
scientific job-creating programme (ABM). 
The work: on technetium chemistry was supported in part by a contract with the InstitutfiiP 
L%1:"ra~a~~ornchung, Berlin. 
$uppo@ by Bfalltnchodt Medical Inc., Petten, is highly appreciated. 
The jWemf6r~chungsze~trum Kartsmhe (Dr. Schweickert, Dr. Bechtold of the Cyclotron 
Dep-ent] esndnued in assigning a technology transfer project on 1231-radi~~harmaceuti- 
=Is .ts a group associated with the Institute. 
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I~stitiante genersusly helped to overcome the critical situation. We are particularly indebted 
ge, he C l i ~ c s  of Nu~Iear Medicine of the Technische Universitit Dresden and the Ham- 
holds Ua&emadt Berlin, 
